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1 Summary 
 
The transcription of protein coding genes is a key step in the conversion of genomic information 
into the content of a cell’s proteome. In eukaryotes, this process is performed by the multi-subunit 
DNA-dependent RNA polymerase (Pol) II and subject to intricate regulatory systems. During the 
consecutive phases of transcription, initiation, elongation and termination, Pol II associates with 
various factors that modulate its activity and thereby aid in the coordination of gene expression. 
Transcriptional control at the level of initiation is dominated by the general transcription factors 
(GTFs) TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH. At the core-promoter Pol II assembles 
with the GTFs in an ordered manner to form the pre-initiation complex (PIC), which is competent 
to induce the opening of promoter DNA and to commence RNA synthesis. The subsequent 
transition from initiation to the elongation phase is preluded by poorly understood events that 
result in detachment of Pol II from the promoter (‘promoter escape’) and disassembly of the 
initiation machinery. Both promoter opening and escape mark pivotal initiation checkpoints that 
are susceptible to regulation, and for both processes an ATP-dependent involvement of the TFIIH 
complex has been demonstrated. TFIIH equals Pol II in size and intricacy, consists of two 
dissociable ‘core’ and ‘kinase’ modules, and comprises three subunits with conserved enzymatic 
function. Two of these, a DNA-translocase and a kinase, act at the distinct stages of initiation, 
respectively. In addition to the GTFs, promoter-located Pol II associates with the global co-
activator Mediator. This multi-protein complex bridges between the initiation machinery and 
transcription factors bound at distant enhancer DNA elements and can adapt transcription in 
response to environmental and developmental stimuli. The ‘head’ and ‘middle’ module segments 
of Mediator (core Mediator, cMed) are essential and directly contact the initiation complex. 
Mediator promotes initiation by cooperatively enhancing the recruitment of Pol II and the GTFs 
to the core-promoter, stabilizing the assembled PIC and stimulating TFIIH kinase activity. Owing 
to the sheer size and complexity of Mediator and TFIIH, however, the underlying molecular 
mechanisms that govern the dynamic progression of the initiation machinery through the stages of 
PIC formation, promoter opening and promoter escape remain largely elusive. An extensive 
structural characterization of initiation complexes containing these factors may contribute to 
deduce their essential functions in detail but to date has been impeded by their flexibility and poor 
biochemical stability, as well as by the lack of highly pure samples for analysis.  
In an effort to overcome such limitations, the first protocol for the large-scale preparation 
of recombinant full-length TFIIH from the yeast Saccharomyces cerevisiae was established. This 
work describes effective co-expression approaches in Escherichia coli and insect cell systems that 
yielded various TFIIH subcomplexes. Using purified TFIIH core and kinase modules, the 
assembly of complete 10-subunit TFIIH was demonstrated. In addition, this work reports the in 
vitro reconstitution and cryo-electron microscopy (EM) analysis of the yeast PIC-cMed complex, 
a macromolecular 46-subunit assembly of ~2 MDa, which encompasses all initiation-related 
proteins essential for cell viability in yeast. Reconstructions of the TFIIH-comprising PIC and 
PIC-cMed complex were derived at nominal resolutions of 4.7 Å and 5.8 Å, respectively. The 
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obtained cryo-EM maps reveal secondary structure throughout and provide the first visualization 
of TFIIH within the initiation machinery at high resolution. To facilitate model building and 
placement into the density, crosslinking experiments were conducted, which in particular aided to 
identify interactions between TFIIE and TFIIH. Based on previously determined models for the 
cMed complex and the PIC without TFIIH (core PIC, cPIC), on newly generated homology and 
ab initio models for multiple domains in TFIIE and TFIIH, and on de-novo built segments, the to 
date most complete and accurate structure of a transcription initiation complex was compiled. The 
remaining, unassigned protein sequences largely comprise regions that are predicted to be 
disordered and thus likely adopt flexible conformations within the structure.  
The PIC and PIC-cMed models reveal interactions between cMed, the cPIC and TFIIH, 
and in particular demonstrate how TFIIE anchors TFIIH to the cPIC. The subunit arrangement 
within the cPIC and cMed, as well as previously proposed interfaces between cMed, the Rpb4/7 
stalk and the foot domain of Pol II, and TFIIB were confirmed and further explicated. Upon 
binding to the PIC, the cMed middle module undergoes significant rearrangements, which result 
in partial loss of its contacts to the head module and in ‘opening’ of the cMed structure. The 
previously observed ‘cradle’ that is formed by the cPIC and cMed and may accommodate the C-
terminal domain (CTD) of Pol II is further defined by TFIIH. The core-TFIIH module emanates 
from the cPIC in a crescent-like shape, with its ATPases Ssl2 (XPB in human) and Rad3 (XPD) at 
the ends of the lobes and in proximity to the cPIC. Rad3 is anchored to the cPIC by a TFIIH 
kinase module subunit, Tfb3 (MAT1), and Ssl2 engages with downstream promoter DNA. The 
ATPases are connected via the scaffolding subunits Ssl1 (p44), Tfb2 (p52), Tfb4 (p34) and Tb5 
(p8). The previously uncharacterized subunit Tfb1 (p62) serves as a flexible tether between 
various parts of core-TFIIH. Tfb3 directly contacts Pol II by binding in a groove between the Pol 
II stalk and the large TFIIE subunit Tfa1 (TFIIEα). To accommodate Tfb3, the stalk of Pol II is 
shifted in both structures. Additional interactions between TFIIH and the cPIC involve the C-
terminal section of Tfa1. Several novel Tfa1 elements that bind the TFIIH subunits Tfb1 and Ssl2 
were detected, thus indicating a mechanism for TFIIE-mediated TFIIH recruitment to the PIC. 
The structures also provide further information on the function of the catalytic TFIIH subunits 
during promoter opening and escape. The ATPase Ssl2, which is implicated in the unwinding of 
promoter DNA, is contacted by the newly assigned ‘E-bridge’ helix in Tfa1, suggesting a concept 
for TFIIE-stimulated DNA opening. Comparison of the Ssl2 ATPase domains to those of 
enzymes, which translocate on double-stranded DNA (dsDNA), revealed striking similarity and a 
respective Ssl2 translocation mechanism was proposed, consistent with biochemical evidence. 
The kinase module of TFIIH comprises the kinase Kin28 (CDK7), which phosphorylates the Pol 
II CTD and stimulates promoter escape. Except for the N-terminus of Tfb3, which anchors it to 
Rad3 and the cPIC, this module is flexible in the PIC structure. However, it adopts a preferred 
position outside of the cradle and in proximity to Mediator in the PIC-cMed complex. Moreover, 
it is located adjacently to one of two openings in the cradle that emerge after conformational 
rearrangement of cMed upon its PIC incorporation, thereby implying how Kin28 may access the 
CTD and how Mediator may enhance its kinase activity. 
Summary 
 
	 3 
In summary, the derived structures pose a major advance towards the elucidation of the 
molecular mechanisms governing transcription initiation and may be used as a framework and 
guidance for their further biochemical, functional and structural characterization. 
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2 Introduction 
 
2.1 Overview of transcription 
 
The central dogma of molecular biology, first formulated by Francis Crick in the 1950’s, outlines 
the unidirectional conversion of a cell’s genomic information into the content of its 
proteome1..Interpreted in a simplistic way, this information transfer is divided in two major 
processes that are coupled in prokaryotes but spatially and temporally segregated in eukaryotic 
cells. While the transcription of genomic DNA into RNA occurs in the nucleus, the subsequent 
translation is performed in the cytoplasm by ribosomes, which interpret the generated RNA 
transcripts and synthesize corresponding polypeptide chains2,3. In vivo, however, translation is not 
an exclusive or inevitable consequence of transcription. Instead it requires a particular form of 
RNA molecules, protein-coding messenger RNAs (mRNAs) that carry specific sequence features 
and modifications, as input templates. Further transcription products, which are generally referred 
to as non-coding RNAs, are highly variable and abundant within the cell, have a wide spectrum of 
regulatory functions and serve as structural components of intricate ribonucleoprotein (RNP) 
machineries4. Despite their diverse roles and features, all RNA transcripts are synthesized by one 
class of enzymes, the DNA-dependent RNA polymerases (Pols).  
Although these macromolecular multi-subunit complexes are highly conserved throughout 
the three kingdoms of life, archaea and bacteria comprise only one type of Pol, whereas a set of 
slightly divergent Pols has evolved in eukaryotes5. With the exception of chloroplasts and 
mitochondria, which contain bacterial- and phage-derived polymerases6,7, eukaryotic cells utilize 
up to five distinct nuclear Pols, referred to as Pol I – Pol V. They share a conserved core and 
active center and catalyze the same basic reaction but target different DNA templates and 
generate a variety of RNA classes8. Pol IV and Pol V, which synthesize non-coding RNAs 
involved in gene silencing, are plant-specific9 while Pol I – Pol III are common to all eukaryotic 
cells. Pol I and Pol III produce the precursor of the 5.8S, 18S and 28S ribosomal RNA (rRNA)10 
and other essential non-translated transcripts like transfer RNA (tRNA), the ribsosomal 5S rRNA, 
small nuclear RNA (snRNA) or small nucleolar RNA (snoRNA)11, respectively. Pol II, although 
also transcribing a variety of non-coding RNA classes, mainly generates pre-mRNAs, the mRNA 
precursors. Pre-mRNAs undergo co- and post-transcriptional processing in the nucleus and are 
exported to the cytoplasm as mature mRNAs for ribosomal translation12,13. Pol II mediated 
transcription is the cell’s sole source of mRNA transcripts and therefore a key determinant of its 
proteome. Owing to the pivotal role of Pol II and the high diversity of its DNA templates, which 
are located throughout the entire genome, its regulation requires a particularly sophisticated 
system of control mechanisms that have to engage effectively at various stages of the Pol II 
transcription cycle. 
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2.2 RNA Polymerase II transcription cycle and role of the CTD  
 
The transcription process can be divided into three discrete phases termed initiation, elongation 
and termination. After termination, the majority of polymerases undergo recycling and re-
initiation, thereby completing the transcription cycle (Fig. 1.1). Each stage of transcription is 
subject to various regulatory mechanisms that involve specific sets of auxiliary proteins, which 
directly or indirectly associate with Pol II, transcribed DNA, adjacent histones, or the nascent 
RNA chain, and are collectively termed transcription factors (TFs)14,15. In addition, the distinct 
phases are characterized by explicit modification patterns of the C-terminal domain (CTD) of 
Rpb1, the largest Pol II subunit. The CTD comprises a series of tandem heptapeptide repeats with 
the consensus sequence Y1S2P3T4S5P6S7, which constitute an unstructured, low complexity 
domain that protrudes from the Pol II core. The length of the CTD, i.e. the number of its repeats, 
and their individual divergence from the consensus sequence are species-specific16,17. During 
transcription, diverse post-translational modifications (PTMs) of the CTD, such as 
phosphorylation, proline-isomerization or methylation of non-canonical lysine and arginine 
residues, are dynamically introduced, interpreted and removed. These establish the ‘CTD code’, a 
key factor in the coordination of transcription-coupled signaling and transcriptional regulation18,19. 
While many types of PTMs have been reported, the effects of CTD phosphorylation at serine and 
tyrosine residues have been studied most extensively. The phosphorylation pattern of the CTD 
essentially impacts its propensity to serve as a docking platform for specific classes of accessory 
proteins throughout the transcription cycle and thus governs transitions between its consecutive 
(sub-)phases. For example, components of co-transcriptionally acting machineries, such as 
capping enzymes or splicing factors, are recruited to the transcribing Pol II in the early and 
productive stages of elongation by CTD residues that were phosphorylated in the respectively 
preceding initiation and early elongation phases20. The CTD is a unique feature of Pol II and 
homologous domains have not been observed for the remaining nuclear Pols, emphasizing the 
requirement of an intricate control system for this particular type of enzyme.  
The first stage of the transcription cycle, transcription initiation, begins with formation of 
the pre-initiation complex (PIC) when Pol II is recruited to promoters and assembles with the 
general transcription factors (GTFs) on closed DNA in proximity to the transcription start site 
(TSS)21,22. During transition from a closed to an open state of the PIC unwinding of a short 
promoter-specific DNA region is induced, resulting in generation of an initial ‘transcription 
bubble’. DNA opening permits positioning of the template DNA strand in the active center of Pol 
II and promotes subsequent synthesis of a complementary RNA strand23. Initiation complexes 
containing short RNA transcripts, referred to as initially transcribing complexes (ITCs), are 
unstable and can undergo abortive initiation24. When the nascent RNA exceeds a critical length of 
13-14 nucleotides, however, the initiation machinery disassembles in a poorly understood event 
termed promoter clearance or escape and the GTFs are exchanged with elongation factors25. In 
metazoans, the early elongation phase is frequently interrupted by promoter-proximal pausing of 
Pol II, particularly at genes that are part of stimulus-responsive pathways. Affected polymerases 
are sequestered by pausing factors in response to poorly characterized cellular signaling 
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mechanisms and stall after synthesis of 20-60 RNA nucleotides until the transcription block is 
relieved. The recruitment of pausing factors also correlates with a specific CTD phosphorylation 
pattern that is gradually transformed into that of an elongation-competent Pol II until pause 
release is triggered26,27. Subsequently, Pol II enters the phase of productive elongation, in which 
RNA transcripts are synthesized with rates of up to 4 kb/min28,29. The binding of elongation 
factors and the incorporation of the rigid DNA-RNA hybrid at the center of the elongation 
complex contribute to its enhanced stability, speed and processivity and assist in coordinating the 
action of co-transcriptional mRNA processing machineries and chromatin remodelers30-32. 
Although the architecture of an extended Pol II elongation complex, which contains multi-protein 
accessory factors like the polymerase associated factor 1 (Paf1)33, has only been determined on a 
topological level34, high-resolution models of the core elongation complex35,36 have been derived. 
In addition, details of the RNA nucleotide addition cycle, including RNA-base selection, its 
incorporation into the growing nucleotide chain and translocation of Pol II, have been revealed37.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 | The Pol II transcription cycle. To form the initiation complex Pol II assembles with the general transcription 
factors at the core-promoter in close proximity to the transcription start site (TSS). Following promoter opening, initial RNA 
synthesis and promoter escape, the nascent mRNA transcript is extended in the elongation phase. The end of a transcription 
unit (gene) is marked by the polyadenylation (polyA) site, which provides the signal for mRNA cleavage. Pol II dissociates 
from the DNA template downstream of the polyA site and may undergo recycling to begin a new round of transcription. 
Produced mRNAs are co- and post-transcriptionally processed by addition of a 5’ cap (red dot) and a 3’ poly(A) tail (An), 
respectively. Adapted from37. 
 
Once Pol II reaches the end of a transcription unit, marked by a polyadenylation (polyA) signal in 
the DNA sequence, the newly synthesized and partially processed mRNA transcript is released 
and transcription is terminated by dissociation of Pol II from the template DNA37. Amongst the 
distinct phases of the Pol II transcription cycle, termination remains most ambiguous and alternate 
concepts are still discussed. The allosteric model is based on an indirect destabilization and 
consequent disassembly of the elongation complex upon transcribing into the polyA site and 
binding of 3’ RNA-processing factors38, whereas the torpedo model suggests an active 
displacement of Pol II from the complex by a RNA-exonuclease that is recruited after release of 
the mRNA transcript39. However, prevalence of one of the proposed models, as well as the 
identity and function of further prospective termination factors remain yet elusive. Structural 
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information on termination intermediates is not available although conformational and 
compositional rearrangements in the elongation complex upon its transition into a pre-termination 
complex have been indicated40. Following Pol II dissociation from the DNA, the phosphorylation 
marks on the CTD are removed and its original hypo-phosphorylated state is restored. 
Regenerated, transcription-competent Pol II may then relocate to initiation complexes to restart a 
new transcription cycle. In a chromatin context this process is facilitated by gene-looping and 
auxiliary factors that mediate interactions between promoters and terminators and position them 
in close spatial proximity15. 
 
 
2.3 Outline of transcription initiation and its regulation by the general 
transcription factors  
 
The accurate yet dynamic regulation of Pol II is pivotal as it underlies developmental processes 
like cell fate determination and differentiation, but is simultaneously required for the maintenance 
of homeostasis within diverse cell types. Consequently, transcription undergoes constant and 
rapid adaptation in response to environmental signals or to changes in cellular or tissue 
context41,42. To sustain such a system, the Pol II machinery recruits a plethora of accessory 
proteins that coordinate transcriptional activity by conferring specificity to the Pol II enzyme, 
influencing its processivity and coupling pre-mRNA synthesis to co-transcriptional events. 
Although control mechanisms may take effect at all phases of the transcription cycle, they usually 
target the first stages of gene expression. Promoter-proximal pausing is typically observed as an 
early elongation checkpoint in metazoans26,43, but the precise regulation of transcription at the 
level of initiation is most common in all eukaryotic species44,45. In this phase the transcription 
machinery passes several key events that are prone to intervention, such as PIC assembly, DNA 
melting or promoter escape. To identify the respectively involved transcriptional regulators, 
numerous structural, biochemical, and system-wide studies aimed to dissect the intricate processes 
that govern the transitions between the intermediate states of initiation42,46-48.  
According to the classical model, the first major initiation intermediate, the PIC, is formed 
on promoter DNA by coordinated stepwise assembly of Pol II with the general (or basal) TFs 
TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH21. These subsequently aid Pol II during TSS 
selection, DNA melting, initial RNA synthesis, and promoter escape (Fig. 1.2, Table 1.1). 
Eukaryotic promoters comprise various target sites for DNA-binding transcription factors that are 
distributed throughout the core-promoter and adjacent promoter-proximal sequences. Metazoan 
cells additionally feature enhancer elements in distal regulatory DNA regions41,49. Upstream 
activating sequences (UAS), which were originally identified in the yeast Saccharomyces 
cerevisiae, are located more closely to core-promoters but are functionally related to 
enhancers50,51. Whereas the integration of signals from UAS- or enhancer-associated transcription 
factors requires bridging adapters like the co-activator Mediator52, the basal Pol II initiation 
machinery interacts with DNA directly at core-promoters. These encompass ~40-45 nucleotides 
in metazoans, extend asymmetrically over the TSS, and contain specific subsets of respective 
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core-promoter motifs53,54. Most biochemical and structural 
studies of Pol II initiation complexes were performed on 
core-promoter sequences with TATA-box motifs55 residing 
~25-30 nucleotides upstream of the TSS, although canonical 
TATA-box elements are present only at a minority (20-30%) 
of promoters and may be located further upstream, as 
observed in S. cerevisiae56,57. Core-promoters mark the site 
of DNA interaction for the multifunctional transcription 
factor TFIID, which comprises the TATA-box binding 
protein (TBP) and 13-14 TBP-associated factors (TAFs). 
The TAFs contribute to recognition of distinct core-promoter 
elements, modulate TBP specificity and supposedly assist in 
its correct positioning on promoter DNA in absence of 
canonical TATA-box motifs. However, they are still subject 
to intensive analysis48,54,58-60. In contrast, the structure and 
function of TBP, which is essential for canonical 
transcription and universally conserved, has been elucidated 
and extensively studied in various initiation complexes8. 
TBP binds promoter DNA upstream of the TSS, 
preferentially at TATA-box elements, and bends the DNA 
by ~90°, thus providing a pseudo-symmetric platform for the 
recruitment of further GTFs61-63. Owing to the complexity 
and poor biochemical stability of holo-TFIID, it is mostly 
substituted by TBP for in vitro experiments.  
TBP-DNA complexes are stabilized by the accessory 
factor TFIIA, which sequesters promoter DNA upstream of 
the TATA-box motif, inhibits attachment of regulatory 
proteins and stimulates basal and activated transcription64-67. 
Guided by its association with the TATA-box flanking 
regions that may contain up- or downstream positioned 
TFIIB recognition elements (BREs), TFIIB subsequently 
binds in a unidirectional mode, implying a mechanism for 
oriented PIC assembly despite the pseudo-symmetry of the 
TBP-DNA complex68-71. In addition to conferring 
directionality to the upstream promoter assembly, TFIIB is 
essential for the recruitment of Pol II to the TBP-DNA-
TFIIA-TFIIB complex72,73 and each of its functional 
domains engages in extensive interactions with various 
regions of Pol II74-76.  Moreover, it facilitates DNA bending 
by TBP77 and correct initial positioning of promoter DNA 
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Figure 1.2 | Schematic of Pol II initiation. Schematic representation of the classical stepwise model for PIC assembly and 
of the subsequent promoter opening and escape stages. Descriptions of the respective intermediate states are indicated on the 
left. PIC assembly begins with promoter recognition by TFIID (light brown) and binding to DNA (shades of blue). The 
TFIID subunit TBP (red) induces a kink in promoter DNA, which facilitates association of TFIIA (yellow) and TFIIB 
(green). TFIIA and TFIIB flank the TBP-DNA complex on both sides, thereby stabilizing the resulting upstream promoter 
assembly. TFIIB aids to recruit the Pol II-TFIIF complex (grey, purple). This intermediate is joined by TFIIE (magenta), 
forming the cPIC. TFIIE and TFIIF traverse the active center cleft of Pol II and interact with each other, thus further 
stabilizing the complex. PIC assembly is completed upon binding of TFIIH (light pink/orange). In an ATP-dependent 
mechanism, TFIIH induces melting of the DNA double strand and generates the initial ‘transcription bubble’. After the 
closed-to-open transition of the PIC, RNA synthesis in the Pol II active center begins. Once a critical length of the nascent 
transcript in the initially transcribing complex is reached, the initiation machinery disassembles and the general transcription 
factors on Pol II are exchanged for elongation factors (blue). The dissociable kinase module of TFIIH (orange) is displayed 
as a separate element. ATP, adenosine triphosphate; NTP, nucleoside triphosphate; PIC, pre-initiation complex; TAF, TBP-
associated factor; TBP, TATA-box binding protein. Adapted from42. 
 
over the Pol II active center cleft75,78. Pol II enters the PIC together with TFIIF (Fig. 1.2), an 
accessory factor that inhibits its unspecific binding to DNA42. TFIIF further enhances stability of 
the formed TBP-DNA-TFIIA-TFIIB-TFIIF-Pol II PIC intermediate79, in particular by supporting 
TFIIB80,81, and aids in TSS selection81,82. Similarly to TFIIB, TFIIF interactions also involve 
numerous contacts to promoter DNA and Pol II subunits83-89. Structural studies in the human 
system revealed that docking of TFIIF results in partial opening of the Pol II clamp and further 
sequestration and stabilization of the DNA strand within the PIC48,85,86, which may facilitate its 
accommodation and access to the active site cleft of Pol II. Consistently, in vitro promoter melting 
can be induced for specific DNA templates without the lastly recruited factors TFIIE and TFIIH, 
but not without TFIIB and TFIIF81,90-92.  
The final steps of PIC assembly encompass the integration of the GTFs TFIIE and TFIIH, 
which are primarily involved in promoter opening and the formation of an initial ‘transcription 
bubble’ (Fig. 1.2). In vitro experiments with pre-melted DNA heteroduplexes demonstrated 
successful transcription initiation in absence of these factors92-94. In the PIC, TFIIE is located 
between the Pol II clamp and stalk domains and is, similarly to TFIIB and TFIIF, tightly 
associated with the polymerase. TFIIE further contributes to PIC stabilization, partially by 
binding a TFIIF domain that traverses the Pol II active center cleft and thereby further encasing 
loaded promoter DNA86,89,95. In the S. cerevisiae system, an additional direct contact between 
TFIIE and the DNA strand at a position close to the upstream edge of the subsequently generated 
transcription bubble was observed89,96-98. This interaction presumably favors formation of an open 
promoter state89 and may relate to the previously reported ability of TFIIE to bind single-stranded 
DNA (ssDNA)99. Initiation complexes that contain TBP, DNA, TFIIA, TFIIB, TFIIE and TFIIF, 
but lack TFIIH, are referred to as core PICs (cPICs). As the GTFs TFIIB, TFIIE and TFIIF are 
highly modular, they assume their final conformations only upon incorporation into the cPIC and 
in presence of their interaction partners. Consequently, cPICs consist of an elaborate network of 
protein-protein and protein-DNA contacts that envelopes the TATA-box and adjacent core-
promoter sequences and is required for correct positioning of the initiation machinery on the DNA 
prior to promoter melting37. PIC formation is completed with the recruitment and integration of 
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the multi-subunit factor TFIIH, which is facilitated by TFIIE94,100. Although TFIIH has been 
structurally characterized within the context of the PIC only on a topological level85-87,101, an 
interaction between the large subunit of TFIIE and one of the TFIIH domains has been described 
in detail102. While the illustrated classical scheme for stepwise PIC formation is predominant, 
potential alternative pathways involving pre-assembled intermediates may be present in vivo. 
According to the canonical interpretation of initiation, TFIIH essentially promotes 
generation of the initial transcription bubble and TFIIH activity is indispensable for transition of 
the PIC from a closed to an open promoter state (Fig. 1.2). Structural studies, crosslinking 
experiments and biochemical probing have demonstrated that TFIIH comprises an ATP-
dependent double-stranded DNA (dsDNA) translocase, Ssl2/XPB (yeast, S. cerevisiae / H. 
sapiens)103-107, which is positioned on DNA downstream of the initially melted region85-87,96,98,108 
and presumably directed away from Pol II and the cPIC108,109. Within the restraints of the PIC, 
Ssl2/XPB translocase action on downstream DNA is assumed to orchestrate threading of DNA 
into the active center cleft of Pol II, which, in combination with a rotational movement and the 
generation of torque, promotes DNA unwinding96,108,109. The ATPase activity of Ssl2/XPB is 
stimulated in presence of TFIIE110,111. Pol II is the only nuclear polymerase that requires an ATP-
consuming co-factor for transcription initiation, reflecting its meticulous regulation. However, the 
exact mechanism of promoter DNA melting, the underlying principle of its TFIIE-mediated 
stimulation or the intermediate states adopted by the PIC machinery during initial bubble 
formation remain elusive. In addition, non-canonical DNA opening events in initiation complexes 
lacking TFIIH or Ssl2/XPB have been reported in vitro89 and in vivo112, suggesting the existence 
of further, yet unidentified processes that may be engaged in promoter melting. 
Emphasizing the cooperative and synergistic nature of the PIC and its components, TFIIB, 
TFIIE and TFIIF have been implicated in contributing to efficient DNA unwinding and in 
maintenance of the generated transcription bubble37,42. Consistently, structural analysis of yeast 
initiation complexes containing closed and open DNA scaffolds indicated significant 
rearrangements in the TFIIE domain that contacts promoter DNA close to the upstream bubble 
edge89. Both TFIIB and TFIIF fulfill additional post-opening roles in TSS selection76,82,113,114 and 
stimulation of initial RNA synthesis114-116. TFIIB assists in correct positioning of the DNA in the 
Pol II active site by interacting with the unwound template strand, and in stabilization of the early 
ITC74. Moreover it may be involved in separation of the DNA- and RNA strands and in directing 
the newly synthesized RNA chain to the Pol II exit tunnel76. TFIIF has been inferred to enhance 
Pol II processivity by reducing or suppressing pausing events116,117.  
In addition to its pivotal function in melting the DNA double strand during promoter 
opening, TFIIH also governs the transition from transcription initiation to the early elongation 
stage after incorporation of the first RNA nucleotides into the nascent pre-mRNA transcript. It 
comprises a highly active cyclin-dependent kinase, Kin28/CDK7, which targets the Ser5 and, to a 
lesser extent, Ser7 residues of the Pol II CTD118-122, as well as TFIIE110, the elongation factor p-
TEFb123 and transcriptional activators124,125. While transcription initiation experiments in 
reconstituted systems can be successfully performed in the absence of Kin28/CDK7126 a 
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requirement of TFIIH-dependent phosphorylation of Pol II for transcription has been 
demonstrated in vivo127-129. The Kin28/CDK7-mediated CTD phosphorylation pattern is 
associated with completion of the transcription initiation phase and subsequent disassembly of the 
ITC130,131, although the principles that underlie these events have not yet been resolved. Moreover, 
CTD phosphorylation by TFIIH has been correlated with dissociation of the co-activator Mediator 
from the basal transcription machinery in yeast132-134 consistent with the obligatory release of Pol 
II from promoter-associated auxiliary factors and its consequent escape from the promoter prior to 
elongation. Several studies also implied a stimulating function of the Ssl2/XPB ATPase for 
promoter clearance and subsequent productive transcription, albeit without proposing a coherent 
mechanism135-137. Another critical aspect of the initiation-to-elongation transition is the RNA-
induced displacement of TFIIB. Upon reaching a length of ~13-14 nucleotides and its emergence 
from the RNA exit tunnel, the nascent transcript is expected to sterically clash with the B-ribbon 
element of TFIIB, resulting in its destabilization and the dismissal of TFIIB from the ITC74,76. In 
summary, distinct processes cooperate to interfere with the stability of the initiation complex and 
promote the release of Pol II, which subsequently is able to re-associate with elongation factors 
and to proceed to the next transcription stage (Fig. 1.2). Nevertheless, promoter escape continues 
to be one of the most poorly understood checkpoints of the transcription cycle.  
 
Table 1.1 ⎟  Basal transcription factors of the Pol II initiation complex. List of the general transcription 
factors and their subunits from S. cerevisiae. The prevalent functions of the respective factors in  transcription 
initiation are indicated. Based on42. 
Factor Subunit(s) Function 
TFIIA Toa1, Toa2 stabilization of TBP/TFIID-DNA complex; suppression of negative regulatory factors 
TFIIB TFIIB 
stabilization of initiation complex; determination of 
transcriptional directionality; recruitment of Pol II-TFIIF 
complex; DNA positioning; TSS selection; stimulation of initial 
RNA synthesis 
TFIID TBP, TAF1-14 
initial promoter recognition; interaction with enhancer-bound 
transcriptional activators and nucleosomes; PIC-assembly 
platform 
TFIIE Tfa1, Tfa2 
stabilization of initiation complex; TFIIH recruitment; 
stimulation of TFIIH ATPase and kinase activity; stabilization 
of transcription bubble 
TFIIF Tfg1, Tfg2,             Tfg3 (TAF14)† 
stabilization of initiation complex (particularly TFIIB); DNA 
positioning‡; TSS selection; stimulation of initial RNA 
synthesis 
TFIIH Ccl1, Kin28, Rad3, Ssl1, Ssl2, Tfb1-5 
DNA unwinding during promoter opening; CTD-
phosphorylation; stimulation of promoter escape 
 
† Yeast-specific subunit; component of TFIID, TFIIF and chromatin remodelers; non-essential in TFIID and TFIIF42. 
‡ Evidence from structural analysis of initiation complexes in H. sapiens48,85,86. 
CTD, C-terminal domain; Pol, DNA-dependent RNA polymerase; TAF, TBP-associated factor; TBP, TATA-box binding 
protein; TSS, transcription start site. 
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While initiation complex disassembly involves the detachment of Pol II and TFIIF, it does not 
imply a complete disintegration of the initiation machinery. Several lines of evidence suggest that 
TFIIA, TFIID, TFIIE and TFIIH remain bound to DNA and co-activators at the promoter138,139. 
This scaffold complex15 may facilitate re-initiation of Pol II after its recycling via gene looping 
and TFIIB-mediated promoter-terminator interactions140-144, which in turn may be subject to 
regulation by the TFIIH kinase Kin28/CDK7143. 
 
 
2.4 The general transcription factor TFIIH 
 
The multi-protein initiation factor TFIIH (Table 1.2) is highly conserved in eukaryotes, comprises 
ten subunits and exceeds a molecular mass of 0.5 MDa in yeast, thereby resembling Pol II in size 
and complexity145. TFIIH is the largest factor required for constitutive transcription from core-
promoter sequences, since TFIID can be substituted by its subunit TBP if TATA-box motifs are 
present146. As a part of the basal initiation machinery TFIIH fulfills central roles in Pol II 
mediated transcription, including the unwinding of the DNA double helix to commence promoter 
melting and the phosphorylation of the Pol II CTD to facilitate promoter escape145,147,148. It is 
further involved in the coordination of transcriptional regulation, in transactivator signaling149,150, 
and, possibly, in RNA synthesis by Pol I and Pol III151-153. In addition, TFIIH is an essential 
component of the nucleotide excision repair (NER) pathway that unwinds dsDNA around 
damaged sequences and exposes the single strands. TFIIH is recruited to lesions by DNA damage 
sensors like Rad4/XPC or stalled Pol II elongation complexes and in turn provides access for 
downstream NER factors that protect ssDNA strands, perform strand incisions and resynthesize 
the removed fragments145,148,154. A functional link between DNA transcription and DNA repair 
was first established when TFIIH was found to participate in both of these fundamental 
processes155,156. Individual subunits or subassemblies of TFIIH can be independently engaged in 
mechanisms outside of transcription or DNA repair, such as in control of the metazoan cell 
cycle157,158 or in chromosome segregation159, reflecting the dynamic and comprehensive nature of 
the complex. Owing to its pivotal character, mutations in TFIIH underlie severe clinical diseases 
like xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or Cockayne syndrome (CS)160-162 
and multiple disease phenotypes can be linked to various of its functions147,148.  
TFIIH consists of two distinct subcomplexes, a three-subunit kinase module and a seven-
subunit core (Table 1.2). The interaction between both modules is sensitive to high salt conditions 
and their stability in isolation has been validated in vitro163-165, in accordance with the presence of 
holo-TFIIH, core-TFIIH and CAK (cyclin-dependent kinase (CDK)-activating kinase; metazoan 
terminology for the kinase module) complexes in the cell148. Whereas 10-subunit TFIIH is 
required for transcriptional processes119,166, the kinase module impedes NER activity167 and is 
displaced from the repair complex after initial bubble opening at DNA lesions, possibly by 
allosteric rearrangements upon incorporation of further NER factors168. The remaining core-
TFIIH is sufficient for DNA bubble expansion during the subsequent NER stages148.  
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Table 1.2 ⎟  Composition of the TFIIH complex. Assignment of subunits to core and kinase modules of TFIIH. 
Yeast subunits, their molecular mass and their most prevalent functions are indicated, respectively. In addition, 
corresponding human homologues are listed. Based on145. 
TFIIH 
Module 
Subunit  
in yeast 
(S. cerevisiae) 
Mass 
(kDa) 
Corresponding 
subunit in             
H. sapiens 
Function 
Kinase 
Ccl1 45.2 CycH regulation of kinase activity of Kin28/CDK7 
Kin28 35.2 CDK7 kinase (primary target: Pol II CTD) 
Tfb3 38.1 MAT1 structural function; stabilization of kinase module; interaction with XPD 
Core-TFIIH 
Rad3 89.8 XPD 
5′ to 3′ ATP-dependent helicase; 
bridge between the kinase and core 
module 
Ssl1 52.3 p44 
structural function; E3 ubiquitin 
ligase (yeast only); stimulation of 
helicase activity of XPD/Rad3  
Ssl2 95.3 XPB 3′ to 5′ ATP-dependent helicase; translocase 
Tfb1 72.9 p62 structural function; interaction with TFIIE and NER components 
Tfb2 58.5 p52 structural function; regulation of ATPase activity of XPB/Ssl2 
Tfb4 37.5 p34 structural function;  strong interaction with Ssl1/p44 
Tfb5 8.2 p8/TTDA regulation of ATPase activity of XPB/Ssl2  
 
CDK, cyclin-dependent kinase; CTD, C-terminal domain; MAT1, ménage à trois 1 (protein); TTD, trichothiodystrophy; 
NER, nucleotide excision repair; XPB, xeroderma pigmentosum group B protein; XPD, xeroderma pigmentosum group D 
protein. 
 
Three subunits of the holo-TFIIH complex possess intrinsic and conserved catalytic activity. The 
cyclin-dependent kinase Kin28/CDK7 (yeast, S. cerevisiae / H. sapiens) assembles with its 
regulatory cyclin Ccl1/CycH and the scaffolding factor Tfb3/MAT1 to form the TFIIH kinase 
module with essential roles in transcription and metazoan cell cycle control120,163,169,170. Core-
TFIIH contains the subunits Rad3/XPD, Ssl1/p44, Ssl2/XPB, Tfb1/p62, Tfb2/p52, Tfb4/p34 and 
Tfb5/p8. The two largest components of the core, Rad3/XPD and Ssl2/XPB, exhibit ATPase 
activity and are categorized as members of the DNA helicase superfamily 2 (SF2)171 but with 
opposite polarities147,172,173. This classification is, however, under debate. Rad3/XPD presumably 
acts as a conventional ATP-dependent helicase to unwind dsDNA173-175, whereas Ssl2/XPB 
displays weaker helicase activity172,173 and has been proposed to function rather as a dsDNA 
translocase108,109. While Ssl2/XPB suffices for promoter melting103,105,176 and escape135,136 during 
transcription initiation, both ATPases are actively involved in DNA opening during NER, 
although the exact mechanism of their cooperation remains controversial105,145. In addition to its 
catalytic role Rad3/XPD bridges between the core and kinase modules of TFIIH by interacting 
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with Ssl1/p44 and Tfb3/MAT1, respectively173,177. Associated Ssl1/p44, in turn, stimulates the 
activity of Rad3/XPD178,179. In yeast but not in metazoans, Ssl1 also appears to operate as an E3-
ubiqitin ligase, albeit with unknown cellular targets180. Ssl1 and the remaining non-enzymatic 
core-TFIIH subunits comprise folds that frequently participate in protein-protein interactions, 
such as von Willebrand factor A (vWA)179,181 or Really Important New Gene (RING)182 domains 
and Zn-fingers. Secondary structure predictions furthermore reveal a remarkably large proportion 
of α-helical segments within the least characterized core-TFIIH subunits Tfb1/p62 and Tfb2/p52, 
which are highly indicative of a structural role for these proteins. The pleckstrin homology 
domain (PHD) of Tfb1/p62 has been implicated in binding the large subunit of TFIIE, 
Tfa1/TFIIEα102, but likewise associates with distinct partners such as transcriptional activators183-
187 and NER factors188,189. The vWA-containing Ssl1/p44 and Tfb4/p34 proteins interact 
intimately and display strong structural homology, suggesting a common origin and evolution via 
gene duplication190. The smallest TFIIH subunit Tfb5/p8 and the C-terminus of Tfb2/p52 fold into 
a compact heterodimer that enhances Ssl2/XPB ATPase activity in NER191,192. In summary, the 
available data suggest that many core-TFIIH subunits primarily serve as scaffolding elements to 
provide a stable framework for the correct positioning and the stimulation of their catalytic 
counterparts Rad3/XPD and Ssl2/XPB within higher-order complexes in transcription and NER. 
 
 
2.5 Structural studies of TFIIH and its components 
 
Despite extensive efforts to determine the structure of TFIIH, its precise architecture remains 
elusive to date. The isolation and analysis of TFIIH are challenged by its complexity, poor 
stability and, in particular, biochemical heterogeneity. Only in the course of a century after its 
discovery as an essential in vitro transcription initiation factor193, researchers succeeded in 
assigning the DNA-dependent ATPase activity of TFIIH to the putative DNA repair helicases 
Rad3/XPD and Ssl2/XPB156,172,194,195, in identifying the remaining components of core-TFIIH196-
200 and in recognizing the association of core-TFIIH with a cell cycle kinase and its regulatory 
factors120,163. Whereas its subunit composition is now well-established, the preparation of TFIIH, 
which is still predominantly extracted from endogenous sources, remains laborious and 
ineffective85,201. Recent technical advances significantly increased the quality and yields of 10-
subunit TFIIH from yeast202 but further complications, such as latent sample heterogeneity, 
persist. Although alternative procedures involving recombinant production methods have been 
established in principle203,204, the more robust and sophisticated classical protocols prevail for 
large-scale approaches.  
Early analyses of endogenously prepared TFIIH by negative stain electron microscopy 
(EM) had revealed a rigid, ring-like shape with a protrusion that presumably encompassed the 
kinase module and provided indications for a modular arrangement of the complex205,206. 
Subsequent studies thus aimed to improve the resolution of the initial structures and to position 
TFIIH within the context of the transcription machinery85-87,101,165,201. Negative stain EM 
experiments with distinct yeast TFIIH subcomplexes, such as core-TFIIH, which was devoid of 
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one or both ATPases, yielded various reconstructions at resolutions of ~25-30 Å165. These 
confirmed the initially observed location of the kinase module and inferred the approximate 
positions of Rad3 and Ssl2 within TFIIH. The ATPases were situated adjacent to each other and 
to the kinase module while the scaffolding core-TFIIH subunits formed a semicircular connection 
between them. Subsequent, better resolved cryo-EM reconstructions of TFIIH-containing 
initiation complexes revealed an overall crescent-like shape of TFIIH and its position on 
downstream promoter DNA. Moreover, they indicated an interaction interface between TFIIH and 
the stalk of Pol II85-87. Inconsistencies between studies performed with PICs from yeast201 and H. 
sapiens85 were reconciled87, resulting in a unified topological model for the transcription initiation 
machinery and the location of TFIIH. The recent investigation of a PIC-Mediator complex from 
yeast101 confirmed these results at low resolution. Surprisingly, however, a weak additional 
density, which had been not been observed in previous PIC studies, was detected in proximity to 
the proposed position of Rad3 and assigned to the TFIIH kinase module based on crosslinking 
information. The findings suggest that the high mobility of this TFIIH subcomplex within the PIC 
context85,86 is reduced in presence of Mediator101. While the described EM-analyses provided 
multiple novel insights, none of the derived reconstructions exceeded a resolution of ~15 Å in the 
TFIIH segments, possibly due to insufficient sample quality. In combination with biochemical 
data, the respective EM maps thus permitted an approximate placement of homology models or 
atomic structures of TFIIH subunits, which had been determined by other methods86,87,101. Except 
for the ATPases Rad3/XPD and Ssl2/XPB, however, these models could not be unambiguously 
fitted and may be misoriented86. Therefore, although an evidently conserved position of TFIIH 
within the PIC has been established, the architecture of TFIIH has been revealed merely on a 
topological level and essential details like intermolecular interaction surfaces remain 
uncharacterized.  
Whereas high-resolution models of TFIIH have not yet been obtained, atomic structures of 
various subunits and domains, which have been derived by NMR or X-ray crystallography, are 
available. Structures of distinct archaeal homologues of the ATPases Rad3/XPD174,175,207,208 and 
Ssl2/XPD107,209 unanimously demonstrated that the enzymes are monomeric and comprise two 
ATPase domains, consistent with their allocation to the SF2 family of helicases. Rad3/XPD 
contains two insertions in ATPase lobe 1, a 4Fe4S cluster and the ‘ARCH’ domain, which have 
been implicated in its function as a NER helicase174,175,207,208. Ssl2/XPB resembles SWI/SNF-type 
ATPases86,107 and includes non-canonical N- and C-terminal extensions that may be involved in 
the recognition of damaged DNA and in DNA unwinding, thus legitimating its observed weak 
helicase activity107. Analyses of specific TFIIH domains, including the RING fingers at the 
Tfb3/MAT1 N-terminus210 and the Ssl1/p44 C-terminus182 or the vWA folds of Ssl1/p44179 and 
Tfb4/p34181, revealed the expected canonical motifs, albeit with unique features. To date, the 
model of a heterodimer between Tfb5/p8 and the C-terminus of Tfb2/p52 represents the only 
structural characterization of a protein-protein interaction within TFIIH. Both domains adopt 
equal folds and associate with each other into an uncommon, compact U-shaped ‘dimerization 
module’ via β-strand addition192. Structures of the Tfb1/p62 PHD in complex with numerous 
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peptide substrates, originating from NER components188,189, transcriptional activators183,185-187 or 
the acidic C-terminus of Tfa1/TFIIEα102, illustrated a variety of binding modes to this domain, 
which is frequently engaged in protein targeting. The H. sapiens TFIIH kinase CDK7211 and the 
associated CycH212 feature canonical folds with high resemblance to other cell cycle kinases and 
to the Mediator kinase-cyclin pair CDK8/CycC213. However, as most of the structures were 
derived from isolated fragments, they do not provide information on intermolecular arrangements 
or the overall assembly framework within core-TFIIH or the 10-subunit complex. Numerous 
biochemical, functional105,174,181,182,203,214-216, and crosslinking101,190,201 analyses, on the other hand, 
revealed an abundance of interactions within TFIIH, thereby permitting the approximate 
assignment of its subunit architecture. TFIIH may be conceptually divided into four distinct 
regions; a Ssl2/XPB-Tfb2/p52-Tfb5/p8 complex that resides on one lobe of the crescent, 
Rad3/XPD, which is located on the other lobe and anchors the kinase module via Tfb3/MAT1, 
and the Ssl1/p44-Tfb4/p34 dimer that constitutes the TFIIH ‘backbone’ and connects the lobes. 
Nevertheless, numerous cross-connections between the four modules were discovered, suggesting 
the presence of flexible domains and a partially intertwined organization of the complex, which 
specifically involves Tfb1/p62101,190,201. Moreover, the studies identified well-conserved sections 
with predicted secondary structure elements (SSEs) that were essential for TFIIH integrity within 
each subunit of the core module216.  
A plethora of functional and structural data on TFIIH has been gathered since its first 
description more than 25 years ago193. However, intriguing questions about its precise architecture 
and the mechanisms underlying its cooperation with the transcription and NER machineries 
remain, in particular as highly-resolved models of initiation complexes with TFIIH are still 
lacking and structural information on its role in NER has not yet been derived. 
 
 
2.6 The Mediator co-activator complex 
 
Constitutive transcription is primarily coordinated by auxiliary proteins that reside at core-
promoter regions or in their direct vicinity, such as the GTFs. The expression of a large proportion 
of genes, however, is also subject to regulation by transcription factors that bind to distant UAS- 
or enhancer motifs. These DNA sequences are of particular relevance for activator-dependent 
transcription, which commences in response to developmental or environmental signals. Although 
enhancers are specific for their respective promoters, they may be located thousands of 
nucleotides from their target TSSs in metazoans. Functional links between these promoters and 
enhancers are established by regulatory multi-protein co-activators, which operate as signal 
transduction hubs217. Via the simultaneous integration of enhancer-associated transcription factors 
and the basal transcription machinery at the core-promoter, such co-activators provide “a 
drawbridge across the enhancer-promoter divide”218 and mediate the crosstalk between the 
distinct transcriptional elements. 
The Mediator complex is a prominent and well-conserved member of the co-activator 
family. It is involved in transcription of nearly all protein-coding genes52,217 and thus considered 
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one of its global regulators219. An association of Mediator with Pol II and the initiation machinery 
(Fig. 1.3a) was first described more than two decades ago220. The molecular mechanisms by 
which Mediator acts on transcription, however, have been scarcely explored, owing to its sheer 
size and its conformational and compositional flexibility, which entail the substantial structural 
dynamicity of this complex. In yeast, Mediator comprises 1.4 MDa and 25 subunits, while 
metazoan Mediator complexes encompass additional subunits and may exist as cell-type specific 
variants that lack distinct components37,221. Early EM studies revealed a modular architecture of 
Mediator222,223 and accounted for its division in four topological segments: the tail, the head and 
the middle module, which are connected via the Med14 scaffold, and a reversibly associated 
kinase224. Whereas nearly all head and middle module subunits are essential for cell viability in 
yeast, Mediator kinase and Mediator tail can be ablated completely. The complex of the head and 
middle modules is therefore also termed ‘core Mediator’ (cMed)224,225. Mediator tail interacts with 
activation domains of gene-specific transcription factors and is thus the major determinant of 
Mediator recruitment to enhancers52,224. However, since several activators, such as p53, are able to 
contact additional subunits in the head and middle modules226, Mediator may undergo alternative 
modes of enhancer recruitment or cooperatively integrate signals from multiple transcription 
factors227. The head and middle modules interact intimately and are critical for the association of 
Mediator with Pol II and the GTFs. Moreover, they have been implicated in binding the 
unphosphorylated CTD of Pol II and thus in the presumed Mediator-dependent promoter 
recruitment mechanism for the initiation machinery220,228. Complex formation between Mediator 
and Pol II is impeded in presence of the kinase module since their interactions are mutually 
exclusive229,230. As the Mediator kinase antagonizes PIC assembly at Mediator-regulated 
promoters, it is generally considered as a transcriptional repressor128,223, although it performs also 
divergent, activating functions. It targets very distinct phosphorylation substrates, including the 
Pol II CTD, transcriptional activators or histone tails231,232, suggesting a versatile, yet poorly 
understood, role in transcriptional control.   
EM analyses have captured multiple conformational states of Mediator222,223,233, indicating 
a pronounced intrinsic flexibility of the complex. Consistent with the reported dynamic transitions 
and the various functionalities of Mediator, structural shifts upon its interaction with distinct 
binding partners have been observed52. A recent study demonstrated significant rearrangements in 
the middle module upon Mediator association with Pol II234. Similarly, the docking of 
transcriptional activators appears to induce conformational changes that propagate from their 
binding sites in the tail module to the Pol II interaction surface in the head- and middle 
modules223,235 and, in turn, stimulate Pol II transcriptional activity226. However, the nature of the 
involved rearrangements, the mechanism of their transmission throughout Mediator architecture, 
and their ultimate effect on initiation complex conformation remain subject to further 
investigation. The synergy between Mediator and Pol II enhances the efficiency of GTF 
recruitment during PIC assembly at core-promoters, as well as the activity of the engaged 
factors236,237. Genetic screens identified an interaction between the TFIIH ATPase Rad3/XPD and 
the middle module subunit Med11, suggesting a putative model for Mediator-stimulated TFIIH 
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recruitment238. In contrast to its assistance in PIC formation and stabilization, Mediator also 
contributes to the destabilization of the initiation machinery after promoter opening. It stimulates 
the activity of the TFIIH kinase Kin28/CDK7, which in turn hyper-phosphorylates the CTD of 
Pol II and induces disruption of the Mediator-Pol II interface, thereby ultimately facilitating 
initiation complex disassembly and promoter clearance19,133,239-242. The underlying principles of 
these events, however, are debated. While Mediator is an essential co-factor for transcription 
initiation, its capacities also extend to further phases of the transcription cycle. It has been 
implicated in elongation and promoter proximal pausing243 and supposedly promotes Pol II 
recycling and transcription re-initiation by stabilizing the promoter-retained scaffold complex138. 
In addition, Mediator assumes regulatory functions in a plethora of processes that range from 
genome organization or the reshaping of chromatin architecture52, to DNA repair244 and the 
integration of developmental cues via various signaling cascades52,245.  
 
 
 
 
 
 
 
 
 
 
Figure 1.3 | Structure of core Mediator. a, Schematic depiction of the PIC-Med complex. Modules of cMed were 
positioned on the cPIC89 based on data of an ITC-cMed complex88. The approximate position of the tail module was inferred 
from cryo-EM studies of free and PIC-bound endogenous Mediator101,246 at lower resolution. The approximate position of 
TFIIH was inferred from cryo-EM studies of the PIC86,87. Components, for which high-resolution information is available, 
are colored. Color code as in Fig. 1.1. The Mediator head and middle modules are depicted in cyan and in blue, respectively. 
b, Ribbon model of cMed. The model is based on the atomic Schizosaccharomyces pombe cMed structure247 (PDB code 
5N9J). The scaffold subunit Med14, which is assigned to the middle module, is highlighted (orange) and the tether helices of 
the head module are indicated. Color code and view as in a. The view corresponds to the ‘left’ side view described 
previously248. Adapted from247. 
 
The modular and dynamic nature of Mediator became apparent already from initial low-resolution 
EM reconstructions of endogenous complexes222,223. These studies indicated that a complete 
model of Mediator might only be derived by a divide-and-conquer approach utilizing smaller 
subassemblies. Consequently, numerous structures of isolated segments with various complexity, 
originating from all four Mediator modules, have been obtained to date249. However, only recent 
developments in the biochemical preparation and structural analysis of Mediator permitted the 
elucidation of higher order arrangements within the holo-complex. The first major breakthrough 
was marked by the successful isolation of the recombinant Mediator head module, which 
constitutes the best-conserved and least flexible region of the complex, and the determination of 
its atomic structure by X-ray crystallography248. Subsequent advances in cryo-EM and 
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crosslinking techniques furthermore facilitated the generation of more accurate topological 
models for Mediator architecture246,250-252 and, eventually, the positioning of the Mediator head 
module structure within the reconstruction of a minimal yeast ITC-cMed complex88. This model 
revealed a repositioning of the Pol II stalk upon Mediator binding and three interfaces between 
cMed, Pol II and TFIIB, consistent with the enhanced recruitment of TFIIB to Mediator-Pol II 
complexes237. A recent study additionally presented high-resolution cryo-EM reconstructions of 
Mediator from Schizosaccharomyces pombe without the kinase module in a free conformation 
and in association with Pol II, suggesting large rearrangements234. The to date best-resolved and 
most completely modeled structure, however, was derived by X-ray crystallography247 (Fig. 1.3b). 
It encompasses a recombinant cMed complex from S. pombe, which includes all head and middle 
module subunits, as well as parts of the Med14 scaffold, and identified four main head-middle 
contact interfaces that are well-conserved. Med14 is strongly involved in the intricate interaction 
between both modules and three ‘tether helices’ of Mediator head subunits undergo a domain 
swap to bridge to the middle module. Similar structures for the more flexible Mediator tail and 
kinase modules have not been determined. However, a low-resolution reconstruction of a PIC-
Mediator complex from yeast is available101 and confirms the previously inferred location of the 
tail in free Mediator246.   
 
 
2.7 Structural perspectives on transcription initiation 
 
The coordinated stepwise process of initiation and the option to trap or mimic several of the 
assumed intermediate states strongly facilitates the structural dissection of this phase of 
transcription. In order to reconstruct the stages of PIC assembly and to recapitulate 
conformational changes in the complex during promoter opening or initial RNA synthesis, 
multiple initiation states have been studied, frequently in combination with biochemical probing.  
The era of the high-resolution analysis of protein-coding gene transcription began with the 
determination of X-ray structures of TBP and the components of the upstream promoter assembly. 
These studies examined the DNA binding modes of the GTFs TFIIA65-67 and TFIIB253,254 and 
reported the characteristic 90° bend which the DNA undergoes upon TBP binding61,62. Soon after, 
structures of the 10-255 and the initiation-competent 12-subunit256 Pol II enzymes from yeast 
revealed the ultimate “basis of transcription”255. The investigation of Pol II-GTF complexes, 
however, proved to be challenging. Following analysis of Pol II-TFIIB assemblies by X-ray 
crystallography and crosslinking-mapping experiments74,75,78,257, the atomic model of an ITC-like 
Pol II-TFIIB-DNA complex eventually demonstrated the exact interaction of TFIIB with Pol II 
and identified the B-linker and B-reader elements, which contact and stabilize the template DNA 
strand in the Pol II active site76. Still, despite significant efforts, further co-crystal structures of 
initiation factors with Pol II could not be obtained. Instead, studies of the macromolecular 
transcription initiation machinery were promoted by the subsequent “resolution revolution”258 of 
cryo-EM. Initial analyses of various H. sapiens initiation intermediates implied conformational 
changes between the closed and open PIC states, such as closure of the Pol II clamp, and 
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positioned the GTFs TFIIE and TFIIF, which flank the promoter DNA on both sides of the Pol II 
active center cleft85. The EM-reconstructions were generally consistent with previously obtained 
models for the upstream promoter assembly and with locations of TFIIE and the TFIIF 
dimerization domain that had been inferred by biochemical and crosslinking studies81,83,84,95,97. 
Similar experiments performed with initiation complexes from yeast agreed well with the H. 
sapiens model once initial discrepancies201,259 were reconciled87,88. Recently, structures of cPICs 
from yeast and H. sapiens lacking TFIIH were independently derived at resolutions of 3.9 Å and 
3.6 Å, respectively. They revealed further details about the DNA contacts and the peripheral 
domains of the included GTFs, as well as about their rearrangements upon promoter melting86,89. 
Owing to the modular composition of the GTFs, however, several flexible regions are missing 
from the models. Whereas most of these are non-essential, also the C-terminal half of 
TFIIEα/Tfa1, which presumably recruits TFIIH94,100, has not been localized yet. Its stabilization 
may depend on the presence of TFIIH in the complex, consistent with the observed “context-
dependent folding transitions”47 of the other GTFs upon their incorporation into the PIC. A 
precise comparison of the available structures from the human and yeast systems indicates an 
overall striking similarity and suggests a well-conserved initiation complex architecture and a 
generally unified DNA opening mechanism, although minor, species-specific discrepancies may 
exist47,48. 
Several cryo-EM studies of initiation complexes exceeding the cPIC subunit composition 
have been reported but resulted in reconstructions of significantly lower quality and resolution. 
Analyses of complete PICs including TFIIH were performed with reconstituted complexes from 
yeast and H. sapiens and ultimately inferred an apparently conserved position of TFIIH on the 
cPIC and on downstream DNA85-87,101. However, as TFIIH is highly flexible, neither global 
reconstructions nor TFIIH-focused strategies revealed SSEs within TFIIH or details about its 
interactions with the cPIC. Consequently, previously obtained structures or homology models of 
TFIIH subunits were assigned with low orientational confidence86, resulting in a merely 
topological model of the TFIIH segments in the PIC. In a different approach a minimal yeast cITC 
was reconstituted with cMed, and the complex architecture was derived at a resolution of 9.7 Å. 
The cryo-EM density permitted fitting of atomic structures of Pol II, the GTFs and the Mediator 
head module and implied three contact interfaces between the head module, Pol II and TFIIB, as 
well as a movement of the Pol II stalk upon Mediator binding. Due to the lack of a complete 
reference model, however, it did not implicate details of the Mediator middle module and its 
interaction with the head88. The to date largest in vitro reconstituted initiation complex included 
Mediator, Pol II and all GTFs except for the TAFs of TFIID, which are usually omitted from 
structural studies due to their poor biochemical stability. Its cryo-EM reconstruction comprised 
two unaccounted additional density regions, which were attributed to the tail of Mediator and the 
TFIIH kinase and established their position in the initiation machinery101. The tail module was 
located at the base of Mediator as suggested246,252, and the TFIIH kinase module appeared to 
reside in close proximity to Mediator and the putative position of Rad3/XPD101. However, while 
this analysis provided an overview of the completely assembled initiation machinery and 
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confirmed previous findings of the cPIC and cITC-cMed structures86,89, it revealed only the 
general complex topology owing to limited resolution.  
In summary, while the core of the transcription initiation complex has been studied at 
atomic resolution in multiple states and in distinct organisms, similar information on the complete 
initiation machinery is still lacking, as the size and flexibility of components like TFIIH and 
Mediator pose major challenges to their structural characterization.  
 
 
2.8 Aims and scope of this work 
 
In eukaryotes, Pol II mediated transcription is a key process in the coordination of gene 
expression. Transcriptional regulation, and in particular events governing the stage of initiation, 
have thus been at the focus of research for decades. Although a plethora of biochemical and 
functional studies have investigated the mechanisms underlying initiation complex assembly, 
promoter opening and promoter escape, the comprehensive interpretation of the acquired data 
relies on their complementation with three-dimensional structural information. In the past, 
numerous detailed models of isolated components, subcomplexes and submodules of the initiation 
machinery have been obtained. In addition, the analysis of reconstituted PICs86,87,89 and ITCs88 
was facilitated by recent developments in cryo-EM techniques258, which permitted the structural 
dissection of respectively large macromolecular assemblies. Despite these efforts, however, high-
resolution information is limited to the core elements of the initiation complex to date. 
Incorporation of the global co-activator Mediator88,101 or the basal transcription factor 
TFIIH86,87,101 into cPICs was attempted but their architecture could be assessed merely on a 
topological level. Owing to its pivotal roles in promoter opening and escape145,147,148, in particular 
the structure of TFIIH will be relevant for the elucidation of the molecular basis of initiation and 
its analysis is thus of utmost priority. Detailed studies of TFIIH are impeded by its distinct 
flexibility but also by the lack of highly pure protein samples, since commonly derived 
endogenous TFIIH is of low abundance and frequently of heterogeneous quality. Therefore, to 
arrive at a well-resolved three-dimensional model for TFIIH or its complexes in transcription, a 
preceding optimization of the existing protocols for TFIIH preparation is required. 
This work aimed to establish methods for the routine large-scale recombinant production 
of TFIIH from the yeast S. cerevisiae and to determine its subunit structure at high resolution. 
Extensive screening of expression constructs and diverse purification approaches ultimately 
resulted in strategies for the preparation of stable TFIIH core- and kinase modules, as well as of 
derivatives of core-TFIIH that lacked one or both of its ATPases, respectively. Complete 10-
subunit TFIIH was reconstituted and isolated in a sucrose gradient. When crystallographic 
analyses of TFIIH subcomplexes were futile and 10-subunit TFIIH became available, the focus of 
this work was shifted. It subsequently aimed at the incorporation of purified TFIIH into an 
initiation – co-activator complex and at the extension of previously performed structural studies of 
cPIC89 and cMed247 to the cryo-EM analysis of the yeast PIC-cMed complex. This 
macromolecular assembly has a molecular mass of ~2 MDa and comprises 46 peptides that were, 
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with the exception of the Pol II subunits, produced recombinantly. During EM data processing, 
particle classes with diverse occupancy of cMed and TFIIH were detected and reconstructions of 
the yeast PIC and the PIC-cMed complex at resolutions of 4.7 Å and 5.8 Å, respectively, were 
obtained. The reconstruction of cryo-EM maps that revealed continuous secondary structure 
throughout the inherently flexible PIC and PIC-cMed complexes was facilitated by WarpCraft, a 
novel computational tool developed by D. Tegunov260. Modeling was performed based on 
available atomic structures and homology models of the cPIC and cMed, which were fitted and 
subsequently adapted and extended to the PIC-cMed complex. The resulting structure indicated 
details about the interfaces between Pol II, Mediator and TFIIB as well as rearrangements in the 
stalk region of Pol II and in the cMed middle module. The PIC and PIC-cMed structures 
furthermore revealed the exact subunit assignment and the modular architecture of TFIIH, as well 
as its interactions with Pol II, TFIIE, promoter DNA and cMed. To facilitate TFIIH model 
building, EDC-based crosslinking experiments were conducted, which in particular aided to the 
assignment of its interactions with TFIIE. In an elaborate homology and ab initio modeling 
approach, structures for most regions of core-TFIIH were derived and placed in the EM map 
together with published atomic models for single domains from yeast. Respective intra-/ and 
inter-subunit linkers were subsequently traced in the density. In addition, the TFIIH kinase 
module was located in proximity to cMed in the PIC-cMed reconstruction. The obtained 
structures explain a multitude of functional data on the recruitment of TFIIH, its interaction with 
the initiation machinery and its stimulation by Mediator, and provide further guidance on how 
TFIIH may engage in promoter opening, CTD phosphorylation and the facilitation of promoter 
escape. In conclusion, the presented work is a further advance towards the complete 
understanding of the intricate mechanisms that coordinate the successive stages of initiation and 
provides an accurate basis for their further biochemical and functional characterization. 
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3 Materials 
 
3.1  Bacterial strains 
 
Table 3.1 | Bacterial strains used in this study. 
Species Strain Genotype Supplier 
E. coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1              lac [F’ proAB lacIqZ∆M15 Tn10 (Tetr)] Agilent 
E. coli BL21-Codon Plus(DE3)-RIL 
E. coli B F- ompT hsdS(rB- mB-) dcm+ Tetr E. coli gal λ 
(DE3) endA Hte [argU ileY leuW Camr] Agilent 
E. coli Rosetta B834(DE3) E. coli B F- ompT hsdS(rB- mB-) dcm+ metB (DE3) Novagen 
E. coli DH10EMBacY 
F- mcrA ∆(mrr-hsdRMS-mcrBC) ϕ80dlacZ∆M15 ∆lacX74 
endA1 recA1 deoR ∆(ara, leu)7697 araD139  galU galK 
λ- rpsL nupG / bMON14272‡ yfp+/ pMON7124  
Geneva 
Biotech 
 
‡ Modified version of bMON14272 baculovirus shuttle vector (bacmid) containing a YFP reporter gene and gene deletions 
(chiA and v-cath). For more detailed explanations refer to section 4.2. 
  
3.2 Yeast strains 
 
Table 3.2 | Yeast strains used in this study. 
Species Strain Genotype Supplier 
S. cerevisiae 
BJ5464 
Rpb3-His6-Bio 
MATa; ura3-52 trp1 leu2D1 his3D200 pep4::HIS3 
prb1D1.6R can1 GAL; 
insertion of 6×His-biotin tag 5’ of Rpb3 gene     
(selection marker URA3) 
M. Kashlev260  
 
3.3 Eukaryotic cell lines 
 
Table 3.3 | Eukaryotic (insect) cell lines used in this study. 
Species Cell line Origin Supplier 
Spodoptera 
frugiperda 
Sf21 
(IPLB-Sf21-AE) 
immortalized pupal ovarian tissue cells261 Thermo Fisher Scientific 
Spodoptera 
frugiperda Sf9 
immortalized pupal ovarian tissue cells, 
 clonal isolate of parental cell line IPLB-Sf21-AE261 
Thermo Fisher 
Scientific 
Trichoplusia ni 
Hi5 (High Five) 
(BTI-TN-5B1-4) 
immortalized pupal ovarian tissue cells262 Expression Systems 
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3.4 Plasmids and Oligonucleotides 
 
Table 3.4 | Plasmids used in this study. A detailed list of precursor plasmids obtained during generation of the 
final Series-438-based constructs (438-A/C) can be provided upon request. Complete sequences of primers used 
for generation and validation of plasmids described in this study can be provided upon request. 
Gene Residue range Affinity tag 
Vector 
backbone Resistance Source 
ScTBP 1-240 6×His (Cterm) pOPINE Amp 
C. 
Plaschka89 
ScToa1† 
ScToa2† 
1-94, 210-286 
1-122 
untagged 
6×His (Cterm) 
pOPINE Amp C. Plaschka89 
ScTfg1† 
ScTfg2 
1-735 
1-400 
10×His-8×Arg-SUMO-3C (Nterm) 
untagged 
pAHS3C Amp C. Plaschka89 
ScTFIIB 1-345 6×His (Cterm) pOPINE Amp 
S. 
Sainsbury 
ScTfa2 
ScTfa1 
1-482 
1-328 
untagged 
6×His (Cterm) 
pET21 Amp C. Plaschka89 
ScTfb1 1-642 6×His-SUMO (Nterm) pET-MCN Kan this study 
ScTfb1 165-642 6×His-SUMO (Nterm) pET-MCN Kan this study 
ScSsl1 1-461 6×His-SUMO (Nterm) pET-MCN Amp this study 
Sc Tfb2 1-513 untagged pET-MCN Kan this study 
ScSsl1 
ScTfb4 
1-461 
1-338 
6×His-SUMO (Nterm) 
untagged 
pET-MCN 
(multi-ORF) 
Amp this study 
ScTfb4 1-338 6×His-SUMO (Nterm) pET-MCN Amp this study 
ScTfb2 
ScTfb5 
1-513 
1-72 
6×His-SUMO (Nterm) 
untagged 
pET-MCN 
(multi-ORF) 
Amp this study 
ScSsl1 
ScTfb2 
ScTfb4 
ScTfb5 
1-461 
1-513 
1-338 
1-72 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
pET-MCN 
(multi-ORF) 
Amp this study 
ScSsl1 
ScTfb2 
ScTfb4 
ScTfb5 
92-461 
1-513 
18-322 
1-72 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
pET-MCN 
(multi-ORF) 
Amp this study 
ScTfb1 
ScSsl1 
ScTfb4 
ScTfb5 
ScTfb2 
ScRad3 
1-642 
1-461 
1-338 
1-72 
1-513 
1-778 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
6×His-MBP-10×Arg-TEV (Nterm) 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
untagged 
438-A 
(multi-ORF) 
Amp 
Gen 
this study 
 
† The genes were codon optimized for protein expression in E. coli. 
Amp, ampicillin; Kan, kanamycin; Gen, gentamycin; Strep, streptomycin; ORF, open reading frame; TEV, tobacco etch virus 
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Gene Residue range Affinity tag 
Vector 
backbone Resistance Source 
ScTfb1 
ScSsl1 
ScTfb4 
ScTfb5 
ScTfb2 
ScSsl2 
1-642 
1-461 
1-338 
1-72 
1-513 
1-778 
untagged 
MBP-3C (Nterm) 
untagged 
untagged 
untagged 
6×His-MBP-10×Arg-TEV (Nterm) 
438-A 
(multi-ORF) 
Amp 
Gen 
this study 
ScTfb1 
ScSsl1 
ScTfb4 
ScTfb5 
ScTfb2 
ScRad3+ 
ScSsl2+ 
1-642 
1-461 
1-338 
1-72 
1-513 
1-778 
1-843 
6×His-SUMO (Nterm) 
6×His-SUMO (Nterm) 
6×His-MBP-10×Arg-TEV (Nterm) 
6×His-3C (Nterm) 
6×His-3C (Nterm) 
untagged 
untagged 
438-A 
(multi-ORF) 
Amp 
Gen 
this study 
ScKin28 
ScCcl1 
ScTfb3 
1-306 
1-393 
1-321 
6×His-MBP-10×Arg-TEV (Nterm) 
6×His-SUMO (Nterm) 
6×His-3C (Nterm) 
438-C 
(multi-ORF) 
Amp 
Gen 
this study 
ScMed1 
ScMed4 
ScMed9 
1-566 
1-284 
1-149 
10×His-8×Arg-SUMO-3C (Nterm) 
untagged 
untagged 
pCDFDuet Strep C. Plaschka89 
ScMed17 
ScMed22 
ScMed11 
ScMed6 
ScMed8 
ScMed20 
ScMed18 
1-687 
1-121 
1-115 
1-295 
1-223 
1-210 
1-307 
untagged 
untagged 
untagged 
untagged 
untagged 
untagged 
untagged 
pCOLADuet Kan C. Plaschka88 
ScMed31 
ScMed10 
ScMed7 
ScMed21 
1-127 
1-157 
1-222 
1-140 
untagged 
untagged 
untagged  
untagged 
pCDFDuet Strep C. Plaschka89 
ScMed19 
ScMed14 
1-220 
1-745 
untagged 
10×His (Nterm) 
pETDuet Amp C. Plaschka88 
 
+ The genes were codon optimized for protein expression in S. frugiperda. 
Amp, ampicillin; Kan, kanamycin; Gen, gentamycin; Strep, streptomycin; ORF, open reading frame; TEV, tobacco etch virus 
 
Table 3.5 | Oligonucleotides used for assembly of the PIC-cMed complex. 
Type Sequence (5’-3’) Length [nt] 
template DNA 
TGA CAC AGC GCA GTT GTG CTA TGA TAT TTT TAT GTA TGT 
ACA ACA CAC ATC GGA GGT GAA TCG AAC GTT CCA TAG 
CTA TTA TAT ACA CAG CGT GCT ACT GTT CTC G 
106 
non-template 
DNA 
CGA GAA CAG TAG CAC GCT GTG TAT ATA ATA GCT ATG 
GAA CGT TCG ATT CAC CTC CGA TGT GTG TTG TAC ATA CAT 
AAA AAT ATC ATA GCA CAA CTG CGC TGT GTC A 
106 
 
nt: nucleotides 
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Table 3.6 | General design of primers used for ligation-independent-cloning into Series-438 vectors. 
Ligation-independent-cloning (LIC) compatible overhangs (‘tags’) are indicated. Complete sequences of primers 
used for generation and validation of plasmids described in this study can be provided upon request. 
Tag Sequence (5’-3’) Vector backbone 
ORF 
directionality 
5’ ATG in 
ORF 
required 
3’ stop codon 
in ORF 
required 
vBac F TAC TTC CAA TCC AAT CG — 5’-ORF 438-A 5’-3’ (fw) yes - 
v1 rv TTA TCC ACT TCC AAT GTT ATT A — 3’-ORF 
438-A 
438-C 
3’-5’ (rv) - yes 
v1 F TAC TTC CAA TCC AAT GCA — 5’-ORF 438-C 5’-3’ (fw) 
no - 
 
F, forward; fw, forward; rv, reverse; ORF, open reading frame 
 
3.5 Thermal cycler programs 
 
Table 3.7 | Overview of thermal cycler programs. 
PCR type Program parameters Application 
standard PCR 98ºC, 60 s; (98ºC, 10 s; MT-4ºC, 30 s; 72ºC, 1-3 min) x30; 72ºC, 10 min; 4ºC, ∞ 
cloning,    
colony PCR  
Round-The-Horn PCR 98ºC, 60 s; (98ºC, 30 s; MT-4ºC, 30 s; 72ºC, 8-10 min) x20; 10ºC, 1 min; 4ºC, ∞ cloning 
QuikChange PCR 98ºC, 30 s; (95ºC, 20 s; MT-4ºC, 30 s; 72ºC, 8-10 min) x15; 72ºC, 10 min; 4ºC, ∞ cloning 
 
PCR, polymerase chain reaction; MT, melting temperature of PCR primers (reference for setting: primer with lowest MT) 
 
3.6 Antibodies 
 
Table 3.8 | Antibodies used in this study. 
Antibody Specificity Dilution Source organism Supplier / ID 
α-Rpb3 Rpb3 subunit of Pol II 1 : 1000 mouse Neoclone / WP012 
α-Tyr1-P phosphorylated Tyr1 residues of Rpb1-CTD of Pol II 1 : 7 rat D. Eick / 3D12
263  
α-Ser2-P  phosphorylated Ser2 residues of Rpb1-CTD of Pol II 1 : 60 rat D. Eick / 3E10
264 
α-Ser5-P phosphorylated Ser5 residues of Rpb1-CTD of Pol II 1 : 60 rat D. Eick / 3E8
264 
α-Ser7-P phosphorylated Ser7 residues of Rpb1-CTD of Pol II 1 : 10 rat D. Eick / 4E12
264 
α-GST-HRP GST 1 : 5000 - GE Healthcare / RPN1236 
α-mouse-IgG-HRP mouse IgG 1 : 3000 goat Abcam / ab5870 
α-rat-IgG-HRP rat IgG 1 : 5000 goat Sigma-Aldrich (A9037) 
 
CTD, C-terminal domain; GST, glutathione S-transferase; IgG, immunoglobulin G; HRP, horseradish peroxidase; P, phospho 
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3.7 Growth media and additives 
 
Table 3.9 | Growth media for E. coli, S. cerevisiae and insect cell culture. 
Media Application Composition / Supplier 
LB E. coli culture / plates 
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 
0.5% (w/v) NaCl                                    
(1.5% (w/v) agar for solid plates) 
ZY E. coli auto-induction culture 2% (w/v) peptone, 1.0% (w/v) yeast extract 
YPD S. cerevisiae culture 
2% (w/v) peptone, 2% (w/v) glucose, 1.5% 
(w/v) yeast extract                                  
(1.8% (w/v) agar for solid plates) 
Gibco®    
Sf-900™ III 
SFM 
Sf9 / Sf21 culture (growth and maintenance of 
suspension and monolayer cultures; 
baculovirus production and propagation)  
low-hydrolysate, serum-free, protein-free, 
animal origin-free insect cell culture 
medium / Thermo Fisher Scientific 
ESF921™ 
Hi5 culture (growth and maintenance of 
suspension cultures; large scale protein 
expression)  
serum-free, protein-free insect cell culture 
media, supplemented with L-glutamine and 
Kolliphor® P188 / Expression Systems 
 
Table 3.10 | Additives for E. coli, S. cerevisiae and insect cell culture. 
Additive Application Stock  Effective applied concentration 
ampicillin antibiotic                           
(E. coli culture / plates) 
100 mg/mL in ddH2O 100 µg/mL 
kanamycin antibiotic                           (E. coli culture / plates) 50 mg/mL in ddH2O 50 µg/mL 
chloramphenicol antibiotic                           (E. coli culture / plates) 30 mg/mL in 96% EtOH 30 µg/mL 
gentamycin antibiotic                           (E. coli culture / plates) 10 mg/mL in ddH2O 10 µg/mL 
streptomycin antibiotic                           (E. coli culture / plates) 30 mg/mL in ddH2O 30 µg/mL 
tetracycline antibiotic                           (E. coli culture / plates) 10 mg/mL in ddH2O 10 µg/mL 
IPTG  expression induction /                     blue-white selection) 1 M in ddH2O 0.25 – 0.7 mM / 1 mM 
X-Gal blue-white selection            (E. coli plates) 150 mg/mL in DMSO 150 µg/mL 
20x NPS auto-induction additive                     (E. coli culture) 
0.5 M (NH4)2SO4, 1 M 
KH2PO4, 1 M Na2HPO4 
25 mM (NH4)2SO4, 50 mM 
KH2PO4, 50 mM Na2HPO4 
50x 5052 auto-induction additive                     (E. coli culture) 
20% (w/v) glycerol, 2.5% 
(w/v) glucose, 10% (w/v) α-
lactose monohydrate 
0.4% (w/v) glycerol, 0.05% 
(w/v) glucose, 0.2% (w/v)  
α-lactose monohydrate 
MgSO4 
auto-induction additive                     
(E. coli culture) 0.5 M in ddH2O 1 mM 
X-tremeGENE™ 9 transfection agent        (insect cell culture) supplied in 80% ethanol 1.5 µL/mL 
 
IPTG, isopropyl-β-D-1-thiogalactopyranoside; X-Gal, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside; DMSO, dimethyl 
sulfoxide 
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3.8 Chemicals, kits and consumables 
 
Table 3.11 | Overview of suppliers for chemicals, kits, reagents, consumables and technical equipment 
used in this study. Suppliers of specific or unique reagents, materials or technical equipment are indicated in the 
text flow.  
Material type Supplier(s) 
chemicals Merck, Roth, Sigma-Aldrich  
enzymes, buffers, additives and reagents for 
molecular cloning Fermentas, New England Biolabs (NEB), Promgea 
kits for DNA preparation                               
(QIAquick and QIAprep series) QIAGEN 
laboratory materials and consumables Eppendorf, Greiner Bio-One, Merck Millipore, Rainin, Roth, Sarstedt, Thermo Fisher Scientific  
technical equipment 
Beckman Coulter, BINDER, Biometra, Bio-Rad, 
Eppendorf, General Electrics (GE), Merck Millipore, 
New Brunswick Scientific, Sartorius, Tecan, Thermo 
Fisher Scientific, VWR 
 
3.9 Buffers and solutions 
 
Table 3.12 | Standard buffers, dyes and solutions.  
Buffer Composition/Description (Supplier) Application 
4x SDS-PAGE 
loading dye 
45% (v/v) glycerol, 280 mM Tris pH 6.8 at 20°C,         
8% (w/v) SDS, 10% (v/v) β-mercaptoethanole,       
0.03% (w/v) bromophenol blue 
SDS-PAGE 
gel electrophoresis 
running buffer 
20x NuPAGE™ MES/MOPS SDS running buffer 
(Invitrogen) SDS-PAGE 
gel stain InstantBlue (Expedeon) Coomassie staining 
tris-glycine transfer 
buffer Trans-Blot® Turbo™ Transfer System buffer (Bio-Rad) western blotting 
PBS-T 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 pH 7.4, 1.76 mM KH2PO4 pH 7.4, 0.1% Tween-20 
western blotting 
PCR master mix 2x Phusion® High-Fidelity PCR Master Mix (NEB) PCR 
6x DNA loading dye Gel Loading Dye, Purple (NEB) agarose gel electrophoresis 
10x TAE 50 mM EDTA pH 8.0 at 20°C, 2.5 M Tris-acetate agarose gel electrophoresis 
NEBuffer™ 3.1 50 mM Tris-HCl pH 7.9 at 25°C, 100 mM NaCl,         10 mM MgCl2, 0.1 mg/mL BSA (NEB) 
restriction endonuclease 
digest 
CutSmart® buffer 
20 mM Tris-acetate pH 7.9 at 25°C, 50 mM potassium 
acetate, 10 mM magnesium acetate, 0.1 mg/mL BSA 
(NEB) 
restriction endonuclease 
digest 
Fast AP™ buffer 
10 mM Tris-Hcl pH 8.0 at 37°C, 5 mM MgCl2,          
100 mM KCl, 0.02% Triton X-100, 0.1 mg/mL BSA        
(Thermo Fisher Scientific) 
restriction endonuclease 
digest 
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T4 DNA Ligase 
buffer 
50 mM Tris-HCl pH 7.5 at 25°C, 10 mM MgCl2,           
1 mM ATP, 10 mM DTT (NEB) ligation 
T4 polymerase buffer 100 mM Tris-HCl pH 8.0 at 25°C, 500 mM NaCl,      100 mM MgCl2, 10 mM DTT 
LIC cloning 
P1 50 mM Tris-HCl pH 8.0 at 25°C, 10 mM EDTA,       100 µg/mL RNase A (QIAGEN) 
bacmid isolation 
P2 200 mM NaOH, 1% SDS (QIAGEN) bacmid isolation 
N3 4.2 M Gu-HCl, 0.9 M potassium acetate pH 4.8 (QIAGEN) 
bacmid isolation 
DPBS 138 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 pH 6.9, 1.47 mM KH2PO4 pH 6.9 
insect cell culture 
100x PI 
0.028 mg/mL leupeptin, 0.137 mg/mL pepstatin A,      
17 mg/mL PMSF, 33 mg/mL benzamidine (in 100% 
EtOH) 
protease inhibitor mix 
negative stain 
solution 2% (w/v) uranyl formate in dddH2O negative stain EM 
 
AP, alkaline phosphatase; ATP, adenosine triphosphate; BSA, bovine serum albumin; DTT, dithiothreitol; EDTA, 
(ethylenedinitrilo)tetraacetic acid; EM, electron microscopy; EtOH, ethanol; LIC, ligation independent cloning; MES, 2-(N-
morpholino)ethanesulfonic acid; MOPS, 3-(N-morpholino)propanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; 
PBS, phosphate buffered saline; PCR, polymerase chain reaction PMSF, phenylmethylsulfonyl fluoride; SDS, sodium 
dodecyl sulfate; TAE, tris-acetate-EDTA; Tris, tris(hydroxymethyl)aminomethane 
 
Buffers utilized for protein purifications are referenced and described in the text flow. Buffers 
required for purification of Pol II, TFIIA, TFIIB, TBP, TFIIE, TFIIF and cMed were reported 
previously76,88,89,260 and are not listed.	
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4 Methods 
 
4.1  Standard cloning 
 
Experimental procedures described in Section 4.1 were performed at 25°C unless indicated 
otherwise. 
 
Cloning strategy 
 
Owing to the intricate architecture of TFIIH, various co-expression strategies for the production 
of soluble protein were established. Vectors used for protein expression in E. coli were based on 
the pET-MCN (Multi-Cloning and expressioN)	series265,266. After initial insertion of isolated open 
reading frames (ORFs) into pET-MCN vectors, this system permits a sequential fusion of ORFs 
from distinct plasmids with a ‘cut-and-paste’ strategy. For ORF-combination, the backbones of 
‘acceptor’ pET-MCN vectors are opened by SpeI digest, whereas ‘donor’ vectors are treated with 
SpeI and XbaI, which results in excision of DNA fragments containing the previously inserted 
ORF and a ribosomal binding site (RBS). Ligation of such insert fragments with ‘acceptor’ 
vectors produces fusion constructs comprising the ‘acceptor’ backbone and genes from both 
‘donor’ and ‘acceptor’ vectors (Figure 8.2). Combination of SpeI and XbaI sites by ligation is 
unidirectional and a fused SpeI/XbaI site will not be cleaved by either enzyme, thereby preserving 
a multi-ORF vector’s capacity for further recombination. Repetition of the recombination 
procedure results in pET-MCN vectors that contain multiple ORFs within a long multi-cistronic 
coding region, which is preceded by a single inducible T7 promoter. Each gene retains a separate 
RBS. Stable pET-MCN vectors encoding ORFs of up to five genes and encompassing > 15,000 
nucleotides (nt) were generated. In addition, co-expression strategies involving two pET-MCN 
vectors with orthogonal antibiotic resistances (kanamycin and ampicillin) but encompassing fewer 
ORFs were applied to enhance the variability of the system.  
A related system was utilized for the production of vectors with multiple ORFs that could 
be inserted into a baculoviral genome and subsequently transfected into insect cells for 
heterologous protein expression. A more detailed explanation of the underlying ligation 
independent cloning (LIC) and assembly strategy is provided in section 4.2. 
 
Standard Polymerase Chain Reaction 
 
This method was used for the amplification of linear DNA fragments from various intra- and 
extra-genomic templates. The 5’ and 3’ ends of the generated Polymerase-Chain-Reaction (PCR) 
products were defined by specific PCR primers. These were designed for melting temperatures in 
the range of 58-65°C and optimally contained a 15-18 nt GC-rich region complimentary to the 
respective template gene. Overhangs of up to 30 nt length were optionally added to the 5’ ends of 
PCR primers, for example if a template was extended by Round-The-Horn PCR or to enhance 
enzymatic activity during cleavage of the PCR products with restriction endonucleases. 
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The setup for a standard PCR included ~50 ng (plasmids/PCR products) or ~250 ng 
(genomic DNA) of DNA template, forward and reverse PCR primers at concentrations of 0.4 
pmol/µL and 25 µL of the 2x Phusion® High-Fidelity PCR Master Mix (NEB). Reactions were 
adjusted to a volume of 50 µL with ddH2O. PCR programs (Table 3.7) comprised 30-40 
thermocycles and were executed in a TProfessional TRIO Thermocycler® (Biometra). Settings 
such as the primer annealing temperature and the time for primer extension were adapted to the 
PCR type and to the melting temperature of the utilized primers. Under standard conditions an 
average synthesis rate of 1,500 nt/min was assumed for Phusion® polymerase (NEB), and primer 
annealing temperatures were expected to be 4°C below their respective melting temperatures as 
determined with ApE (Section 4.4). PCR products were separated according to their length by 
agarose gel electrophoresis, excised from the gel and purified using the QIAquick PCR gel 
extraction kit according to the manufacturer’s instructions.   
 
Restriction endonuclease digest and dephosphorylation 
 
The generation of linearized DNA inserts and vectors with complimentary overhangs for their 
combination involved cleavage with respective restriction endonuclease enzymes. Digest 
reactions comprised 5 µg of template DNA, 1.5 µL of restriction enzyme(s) (NEB), and 5 µL of 
the recommended 10x reaction buffer (NEB), and were adjusted to a volume of 50 µL with 
ddH2O. Samples were incubated 4-5 h or overnight (O/N) at a temperature optimized for the used 
restriction enzyme(s), mostly 37°C or 25°C. Traditional ligation-dependent cloning methods 
additionally required the treatment of linearized vector backbones with FastAP™ (Thermo 
Scientific) alkaline phosphatase to remove the terminal phosphate groups. Digest reactions were 
supplemented with 20 µL of 10x FastAP™ buffer and 1 µL of enzyme (Thermo Scientific), 
adjusted to a reaction volume of 200 µL with ddH2O and incubated at 37°C for 1.5 h. Linearized 
insert fragments were purified via agarose gel electrophoresis and gel extraction whereas 
linearized and optionally dephosphorylated vectors were purified using the QIAquick PCR 
Purification kit according to the manufacturer’s instructions.  
 
Agarose Gel Electrophoresis  
 
Linear DNA fragments were separated according to their size by electrophoresis in 1% (w/v) 
agarose gels. For short fragments (< 500 nt) 1.5 % (w/v) agarose gels with a better resolution in 
the smaller size range were used. The respective amount of agarose was dissolved in 150 mL 1x 
TAE buffer by repeated boiling and the solution polymerized into a gel upon cooling. Addition of 
1 µL/mL of the DNA intercalating chemical SYBR™Safe DNA Gel Stain (Invitrogen) into the 
liquid agarose solution permitted subsequent visualization of DNA samples under ultraviolet 
(UV) light. Polymerized gels were covered with 1x TAE buffer. Samples were prepared by 
mixing with an appropriate amount of 6x DNA Loading Dye (NEB) and loaded onto the gel 
together with a 1 kb DNA Ladder size standard (NEB). A voltage of 120 V was applied for 30-45 
min until a sufficient separation of the fragments was observed. DNA bands were visualized with 
the GEL iX20 Imager system (Intas) for documentation.  
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Gel Extraction 
 
Agarose gels were UV-illuminated with the BST-20G-D2E BlueLED BioTransilluminator 
(Biostep) to detect the position of specific DNA fragments within the gels. Correct DNA bands 
were identified by comparison with a size standard and excised and removed from the gel with a 
scalpel. Gel pieces were transferred into tubes to determine their weight. Extraction and 
purification of DNA from gel slices was performed using the QIAquick Gel Extraction kit 
according to the manufacturer’s instructions and including optional steps. 
 
Ligation 
 
In a ligation reaction the formation of a covalent chemical bond between the terminal 5’ 
phosphate and 3’ hydroxyl groups of linear DNA fragments is catalyzed. This method was used to 
combine linearized dephosphorylated vector backbones with linearized ORF-containing DNA 
inserts or to regenerate functional plasmids from the linear products of a Round-The-Horn PCR. 
Ligase reactions were performed with 50 ng of vector DNA and, for traditional cloning methods, 
5-7x molar excess of the DNA insert. Additionally, the reactions comprised 2 µL of 10x T4 DNA 
Ligase buffer (Thermo Fisher Scientific) and 5-7 units (U) of T4 DNA Ligase (Thermo Fisher 
Scientific). They were adjusted to a volume of 20 µL with ddH2O and incubated for 1 h at 25°C. 
Subsequently, the complete reaction volume was used for transformation in chemically competent 
XL1-Blue cells without further purification. 
 
Round-The-Horn PCR-based site-directed mutagenesis† 
 
This method encompasses the PCR-based amplification of both strands of a template vector and a 
subsequent step for their re-ligation. The obtained linear PCR products are complimentary to each 
other and anneal to form a dsDNA fragment but the ligation of their 5’ and 3’ ends is required for 
the regeneration of a stable circular plasmid. The Round-The-Horn (RTH) setup permits the 
introduction of substantial modifications into a DNA template. Dependent on the sequence of the 
5’ overhangs of the PCR primers and the design of their complimentary regions, i.e. their 
annealing sites to the gene of interest, the original DNA sequence can be extended, subjected to 
site-directed multi-basepair mutagenesis or truncated. RTH primers require a 5’ phosphate group 
as a chemical modification for the ligation reaction. 
RTH-PCR reactions were performed with RTH-specific 5’-modified primers and an 
increased time for primer extension (Table 3.7) in order to permit amplification of the entire 
template vector sequence. PCR products were directly subjected to restriction endonuclease digest 
with DpnI (NEB) for 2 h at 37°C to degrade the original template, and purified by agarose gel 
electrophoresis and gel extraction. Purified DNA was ligated in a standard reaction with 70 ng 
input DNA and transformed in chemically competent XL1-Blue cells without further purification. 
 
† Based on the OpenWetWare protocol by Sean Moore. 
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Transformation in chemically competent cells, preparation of vector DNA and 
sequencing 
 
Frozen aliquots (100 µL) of chemically competent XL1-Blue-, BL21-Codon Plus(DE3)-RIL- or 
Rosetta B834(DE3) cells (Table 3.1) were thawed on ice and mixed with pre-cooled DNA 
samples comprising either 100 ng of purified plasmid, the complete volume of a ligation reaction 
or the complete volume of a LIC annealing reaction (Section 4.2). Cells were incubated with 
DNA for 25 min on ice, heat-shocked for 45 s at 42°C and recovered on ice for 2 min. Per 
reaction, 500 µL LB media (Table 3.9) were added and the transformed cells were incubated in a 
ThermoMixer® C (Eppendorf) for 1-1.5 h (37°C, 900 rpm). After short centrifugation (2 min, 
2,300g), the media supernatant was removed except for 100 µL LB, in which the cells were 
resuspended. Cells were plated on LB agar plates (Table 3.9) supplemented with the required 
antibiotic(s) (Table 3.10) and incubated O/N at 37°C.  
For the preparation of vector DNA, single cell colonies were picked from the plates and 
used to inoculate 25 mL of LB media supplemented with the respective antibiotic(s). Liquid 
cultures were incubated O/N (37°C, 160 rpm). Cells were harvested by centrifugation (3,000g, 15 
min, 25°C) and plasmids were extracted from the cell pellets using the QIAprep Spin Minprep kit 
according to the manufacturer’s instructions. Purified plasmids were eluted with ddH2O.  
DNA sequences of plasmids and inserts were verified by Sanger sequencing (Microsynth). 
Sequencing reactions contained 500 ng of DNA and the respective sequencing primers at a 
concentration of 2 pmol/µL, and were adjusted to a volume of 15 µL with ddH2O. 
 
 
4.2  Generation of baculovirus-compatible ORFs and insertion into 
baculovirus shuttle vectors 
 
Insertion of ORFs into MacroBac Series-438 vectors by ligation-independent cloning  
 
Ligation-independent cloning (LIC) provides an alternative strategy to introduce DNA fragments 
into a vector backbone. In contrast to traditional cloning methods a final ligation reaction is not 
required, owing to a specific design of the 5’ and 3’ ends of the LIC components. Instead, 
complimentary 15-18 nt ssDNA overhangs are generated and annealed, and remaining nicks or 
gaps in the DNA strands are repaired in E.coli cells after transformation. The recently described 
Series-438 MacroBac system267 uses a LIC-based scheme for the assembly of multi-gene 
baculovirus-compatible expression vectors (Fig. 8.3).  
Series-438 plasmids (modified pFastBac derivatives, Addgene #55218 and #55220) 
comprise a LIC-compatible site for the insertion of ORFs, which is exposed after cleavage with 
SspI. Vectors were digested with SspI (NEB) without subsequent phosphatase treatment and 
purified by agarose gel electrophoresis and gel extraction. To obtain and amplify ORF-containing 
insert fragments with matching 5’ end 3’ ends, standard PCRs with Series-438-derived, LIC-
compatible primers267 were performed (Tables 3.6 and 3.7). PCR products were subjected to 
agarose gel electrophoresis and gel extraction.  
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Complimentary ssDNA overhangs for annealing were generated from the blunt 5’ and 3’ 
DNA ends obtained after SspI digest or PCR by treatment with T4 DNA Polymerase (LIC-
qualified, Novagen). The T4 enzyme possesses both 5’ – 3’ polymerase and 3’ – 5’ exonuclease 
activities. In the absence of dNTPs the exonuclease creates 5’ ssDNA overhangs on a dsDNA 
template. Addition of specific dNTPs, however, restricts the 3’ – 5’ exonuclease processivity to 
the site of the first matching DNA base on the complimentary strand. At this site, further 
exonuclease cleavage is impeded and the added dNTP is incorporated by the DNA polymerase 
activity of the T4 enzyme. This mechanism permits formation of defined ssDNA overhangs on 
double-stranded vectors and inserts. In order to produce matching ssDNA overhangs, Series-438 
vectors have to be treated with T4 polymerase in combination with dGTPs whereas PCR products 
require dCTPs (Fig. 8.3). The complimentary overhangs permit the annealing of vectors and 
inserts but prevent internal annealing events. The linearized vector and insert fragments obtained 
by SspI digest and PCR were treated with T4 polymerase in separate reactions containing dGTP 
(vector samples) or dCTP (insert samples), respectively. Reactions comprised 150 ng of linearized 
DNA (vector or insert), 2.5 mM of the respective dNTP type, 5 mM DTT, 2 µL of 10x T4 DNA 
Polymerase buffer (NEB) and 2 U of T4 polymerase (Novagen), and were adjusted to a volume of 
20 µL with ddH2O. After incubation for 60 min at 25°C, T4 polymerase was heat-inactivated 
(75°C, 20 min) and reactions were stored at -20°C. For annealing after T4 polymerase treatment, 
2 µL of vector and 2 µL of insert DNA were mixed and incubated at 25°C for 30 min. Reactions 
were stopped by addition of 1.3 µL mM 25 mM EDTA and incubated for 10 min at 25°C. The 
complete reaction volume was directly transformed into XL1-Blue cells (Section 4.1). 
 
Generation of poly-promoter MacroBac Series-438 vectors containing multiple ORFs  
 
For co-expression of multiple genes, ORFs cloned into Series-438 vectors were assembled in a 
sequential manner using a Biobrick™-based system267,268. This approach ultimately yielded large 
poly-promoter fusion plasmids.  
Combination of two Series-438 vectors requires SwaI digest of an ‘acceptor’ vector and 
PmeI digest of a ‘donor’ vector. Whereas SwaI cleavage simply opens the vector at a defined site, 
PmeI cleavage results in excision of a fragment containing the ORF and its adjacent regions, 
including the associated polyhedrin (polH) promoter and the SV40 polyadenylation (polyA) 
termination sequence (Fig. 8.3). After its isolation this fragment constitutes the new insert. The 
specific LIC-compatible design of the DNA sequences flanking the SwaI and PmeI restriction 
sites permits fusion of the ‘acceptor’ vector backbone with the insert in a standard LIC reaction.  
‘Acceptor’ and ‘donor’ vectors were subjected to endonuclease cleavage with SwaI and 
PmeI (NEB), respectively, without subsequent phosphatase treatment. Both samples were purified 
by agarose gel electrophoresis and gel extraction to retrieve linearized vector and insert 
fragments. LIC-compatible ssDNA overhangs were generated by T4 polymerase treatment in 
reactions supplemented with dGTP for SwaI-treated samples (vectors) and with dCTP for PmeI-
treated samples (inserts). Vectors and inserts were annealed, resulting in fusion plasmids with the 
backbone of SwaI-digested ‘acceptor’ vectors but with a complete set of ORFs from both the 
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respective ‘acceptor’ and ‘donor’ vectors. Each ORF was preceded by a polH promoter and 
followed by a SV40 polyA termination site, permitting independent transcription of each gene. 
Repetition of this procedure with Series-438 vectors carrying two and more genes resulted 
in gradual accumulation of ORFs within one vector. This strategy ultimately permitted the 
generation of stable poly-promoter Series-438 vectors (438-A/C multi-ORF) with up to 12 
inserted ORFs and lengths of  > 30,000 nt.  
 
Strategy for the introduction of ORFs into baculovirus shuttle vectors (bacmids) 
 
ORFs for baculovirus-induced expression are not directly fused with baculovirus genomes in 
vitro. Instead they are co-transformed in E. coli cells, which feature the respective viral genome 
on a bacmid vector, and then transferred by gene transposition. The DH10EMBacY E. coli strain 
used in this study thus contains two extra-genomic pieces of DNA, which permit a regulated ORF 
transposition. The first is the transposition helper plasmid pMON7124269 that carries, among other 
elements, a tetracycline resistance marker and the bacterial Tn7 transposon. This transposon 
comprises a series of genes (TnsA-E), which are required for transposition of DNA sequences 
flanked by Tn7 recognition sites (Tn7L and Tn7R) into a specific target element, the Tn7 
transposon attachment site (attTn7)270. The second piece of DNA is a modified version of the 
baculovirus shuttle vector bMON14272271. This bacmid contains a kanamycin resistance marker, 
a LacZα gene with an inserted mini Tn7 transposon attachment site (mini-attTn7), all genomic 
regions of the Autographa californica nuclear polyhedrosis virus (AcNPV, a species of 
baculoviridae) that are important for viral DNA stability and propagation in host cells, and all 
elements that are required for replication of the bacmid in bacteria. The bMON14272‡ bacmid in 
DH10EMBacY cells was altered by disruption of two viral genes encoding a chitinase (chiA) and 
a cysteinase (v-cath), which improves the levels of protein production in infected host cells, and 
by introduction of an EYFP reporter gene under control of the polH promoter. Consequently, the 
EYFP production of host cells may be used to monitor their infection status272,273. 
Series-438 MacroBac vectors267 contain Tn7L and Tn7R sites that flank a region, which 
encompasses the respective ORF, its promoter and terminator elements and a gentamycin 
resistance marker, thereby generating a transposable element. If a Series-438 vector is 
successfully transformed into DH10EMBacY cells, the transposase (encoded on pMON7124) 
mediates transposition of the ORF and its associated elements into the mini-attTn7 site on the 
bacmid, thereby disrupting the LacZα gene by a large insertion. This mechanism permits the 
identification of positive colonies by simultaneous selection for the gentamycin resistance and 
blue-white screening on plates containing both the antibiotic and the metabolites IPTG and X-
gal274.  
 
Preparation of electrocompetent DH10EMBacY cells 
 
Cells from a commercially obtained glycerol stock of DH10EMBacY cells (Table 3.1) were 
plated on a LB agar plate (Table 3.9) supplemented with ampicillin, kanamycin and tetracycline 
(Table 3.10) and incubated O/N at 37°C to select cells with the correct bMON14272‡/ 
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pMON7124 genotype. A pre-culture supplemented with the respective antibiotics was inoculated 
with a single colony from the plate and grown O/N (37°C, 150 rpm). The pre-culture was used to 
inoculate 250 mL of pre-warmed LB media supplemented with the respective antibiotics in a 
1:250 (v/v) ratio. The main culture was grown (37°C, 160 rpm) to an optical density at 600 nm 
(OD600) of 0.6. Cells were transferred into 50 mL Falcon tubes, incubated 20 min at 4°C, 
harvested by centrifugation (10 min, 3,000g) and resuspended in 1 mL sterile pre-cooled ddH2O 
per Falcon tube. Cell pellets in each Falcon tube were washed once with 30 mL sterile pre-cooled 
ddH2O, once with 1 mL sterile pre-cooled 10% (v/v) glycerol, and finally resuspended in 1 mL of 
sterile pre-cooled 10% (v/v) glycerol. The suspension was aliquoted (50 µL) in pre-cooled 
Eppendorf tubes, flash-cooled in liquid N2 and stored at -80°C. 
 
Transformation of electrocompetent DH10EMBacY cells 
 
Frozen aliquots (50 µL) of electrocompetent DH10EMBacY cells (Table 3.1) were thawed on ice 
and incubated with 0.5-1 µL of purified, pre-cooled vector DNA (Section 4.1) for 15 min. 
DNA/cell suspensions were transferred to pre-cooled BIORAD Gene Pulser®/Micropulser™ 
electroporation cuvettes (0.1 cm gap) (BioRad). For electroporation, one pulse (25 µF, 1.8 kV) 
was applied. Transformed cells were immediately recovered in 1 mL LB media (Table 3.9) and 
incubated in 13 mL tubes (Sarstedt) at 37°C (4-5 h, 150 rpm). Small volumes of recovered cells 
(10-20 µL) were diluted to 100 µL with LB media and plated on LB agar plates (Table 3.9) 
supplemented with gentamycin, X-Gal and IPTG (Table 3.10) for blue-white selection. Plates 
were incubated until a clear distinction of white and blue colonies became possible (37°C, 1.5-2 
days). Several single white colonies were picked and restreaked on fresh LB plates with 
gentamycin, X-Gal and IPTG. If restreaked cell colonies remained white after one day of 
incubation at 37°C, the respective clones were considered to be positive for an insertion into the 
mini-attTn7 site in the bMON14272‡ bacmid and were used for the preparation of bacmid DNA. 
 
Isolation of bacmid DNA by alkaline lysis and isopropanol precipitation 
  
Cells from white colonies, which were positive for DNA transposition into bMON14272‡, were 
used to inoculate 5 mL of LB media (Table 3.9) supplemented with gentamycin (Table 3.10). 
Cultures were incubated O/N (37°C, 180 rpm). Cells were harvested (5 min, 3,000g) and cell 
pellets were resuspended in 250 µL buffer P1†. Suspensions were mixed with 250 µL alkaline 
buffer P2† for cell lysis and subsequently with 350 µL acidic buffer N3† for neutralization. Debris 
and precipitated proteins were pelleted by centrifugation (10 min, 21,000g) and the lysate 
supernatant of each sample was transferred to a fresh Eppendorf tube. The centrifugation and 
transfer steps were repeated and the remaining supernatant was mixed with 700 µL of 
isopropanol. DNA was precipitated by incubation at -20°C for 8-12 h and pelleted by 
centrifugation (4°C, 30 min, 21,000g). The supernatant was removed completely and the DNA 
pellets were washed with 500 µL of 70% (v/v) ethanol at -20°C. Ethanol was removed after 
centrifugation (4°C, 10 min, 21,000g) and DNA pellets were covered with ~30 µL of 70% (v/v) 
ethanol. Samples with precipitated bacmid DNA were stored at -20°C until used for transfection 
Methods 
 
	 37 
into insect cells (Section 4.3). To minimize the probability of failure during one of the subsequent 
insect-cell-dependent steps, bacmids were prepared in duplicates. Respectively, the isolation 
procedure was performed with cells from two distinct white colonies that had originated from the 
same transformation in DH10EMBacY cells.  
 
† Buffers P1, P2 and N3 were supplemented with the QIAprep Spin Minprep kit (Qiagen). 
  
 
4.3  Insect cell culture 
 
Insect cell culture maintenance and monitoring 
  
Insect cell lines (Table 3.3) were maintained in suspension, without light exposure, at constant 
temperature and agitation rates (27°C, 60 rpm), and in the appropriate type of medium (Table 3.9) 
unless indicated otherwise. Cells were incubated in pre-sterilized glass flasks of various sizes 
(250-3,000 mL volume) at target cell densities of 0.5-0.7×106 cells/mL. The filling volume of the 
flasks was limited to 1/10 and 1/5 of the flask size for Sf9/Sf21- and Hi5-cultures, respectively. 
Regular semi-weekly transfer of cell cultures into fresh flasks was required to counteract a 
gradual decrease in cell viability. Actions involving the opening of sterile containers such as cell 
culture flasks or bottles with media and viruses and the transfer of their contents were performed 
under a sterile laminar flow hood (Biowizard Golden Line, Kojair) after disinfection with 70% 
(v/v) ethanol and with sterile disposable materials unless indicated otherwise. 
Average values for cell density, cell viability and cell diameter were assessed with a 
CASY® Modell TT Cell Counter and Analyzer System equipped with a 150 mM capillary 
(OMNI Life Science) according to the manufacturers instructions and using 50 µL of insect cell 
culture per sample. Fluorescence measurements were performed with an Infinite® M1000 Pro 
micro-plate reader (Tecan) using excitation (25 pulses, 400 Hz) and emission wavelengths of 514 
and 527 nm, respectively. Samples were prepared from 1 mL of insect cell culture. For 
measurement, cells were pelleted by centrifugation (5 min, 250g), resuspended in 100 µL or 200 
µL DPBS (Table 3.12) for Sf9/Sf21- or Hi5-cultures, respectively, and transferred into 96-well 
plates (Greiner).  
  
Transfection of Sf9 cells with bacmid DNA and production of V0 viruses 
 
Tubes containing precipitated bacmid DNA were transferred under a sterile hood (Biowizard 
Golden Line, Kojair) and opened. Ethanol was removed and pellets were dried for 20 min. To re-
dissolve DNA, pellets were incubated with ~20 µL ddH2O for 20 min without further 
resuspension. In the meantime, a mix of 10 µL of X-tremeGENE™ 9 transfection agent (Table 
3.10) and 100 µL of Sf-900™ III SFM medium (Table 3.9) was prepared. Dissolved bacmid DNA 
was mixed with 200 µL of Sf-900™ III SFM medium and with 100 µL of the transfection agent-
containing solution by tube inversion. The resulting samples (‘bacmid-TAs’) were incubated for 1 
h with occasional agitation.  
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A culture of Sf9 cells with a density of 1.0×106 cells/mL was prepared and 3 mL of cells 
were added to five out of the six wells in sterile 6-well plates (Greiner). The remaining well of the 
plates was filled with 3 mL of sterile Sf-900™ III SFM medium. Plates were kept at 27°C until 
incubation of the bacmid-TAs was completed. Each bacmid-TA sample was split in half and 150 
µL of the mix were added dropwise to two wells with Sf9 cells, respectively. Four Sf9-containing 
wells of each 6-well plate were supplemented with bacmid-TA mix. One well with Sf-900™ III 
SFM medium and one well with Sf9 cells but without bacmid-TA mix served as controls. As 
bacmids were generally prepared in duplicates (Section 4.2), each 6-well plate ultimately 
comprised viruses originating from one generated cloning construct. 
Plates were incubated without agitation and light exposure (27°C, 60-80 h). Beginning 48 
h after transfection, Sf9 cells were analyzed for expression of EYFP with a fluorescence 
microscope (Leica) in 12 h intervals. Since DH10EMBacY-derived bacmids contain the EYFP 
gene under control of a viral promoter, appearance of fluorescent insect cells indicated successful 
transfection of bacmid DNA and production and release of viral particles by infected cells. If 
more than ten yellow-fluorescent Sf9 cells were observed in a well, the virus-containing media 
was removed with a pipet, transferred in sterile Falcon tubes and stored at 4°C without light 
exposure. These initial V0 viruses were harvested at the latest 72-80 h after transfection. 
 
Virus propagation and production of V1 viruses 
 
V0 viruses were used to infect larger numbers of cells in order to produce more virus particles 
(V1) and enhance the strength of the initial viruses but not for the purpose of protein expression. 
Sf9 cultures containing 25 mL of cells with a density of 1.0×106 cells/mL were transferred in 500 
mL flasks and supplemented with sufficient amounts of respective V0 supernatants for infection. 
Pipetted volumes varied between 0.3 mL and 5 mL and were dependent on the number of 
fluorescent cells observed during V0 production. Infected cell cultures were incubated at standard 
conditions for up to 144 h. Changes in density, viability, diameter and EYFP production of the 
cells were monitored in 24 h intervals. Cultures with cell densities exceeding the standard value 
were adjusted to 1.0×106 cells/mL by dilution, if necessary. Culture volumes were limited to 50 
mL due to flask size. Under ideal conditions, Sf9 cells approximately doubled in numbers within 
48 h after infection and reached a stationary phase thereafter. The first time point without further 
cell division was referred to as ‘day of proliferation arrest’ (DPA). Cultures were incubated and 
monitored for additional 48-96 h after DPA. Fluorescence values and cell diameter of the cultures 
gradually increased in this timespan, whereas cell viability remained constant for 24-48 h before 
dropping quickly. V1 viruses were harvested once cell viabilities of 80-85% were reached. Cells 
were transferred to sterile Falcon tubes and pelleted by centrifugation (20 min, 250g). V1-
containing supernatants were decanted into new sterile Falcon tubes and stored at 4°C without 
light exposure.  
In non-ideal cases, overly potent viruses inhibited cell division too strongly, resulting in a 
<1.5x increase in total cell numbers after 48 h, or ineffective viruses failed to infect cells and 
neither proliferation arrest nor an increase in cell diameter was observed. To generate V1 viruses 
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of consistently high quality, the initial titers of such V0 viruses were adapted or fresh V0 viruses 
were prepared before experiments for V1 production were repeated. Sf9 cells were occasionally 
replaced by Sf21 cells, which had an increased doubling rate and required shorter time spans for 
V1 production.  
 
 
4.4  Protein biochemistry and molecular biology 
 
Strategies for protein expression, purification and storage 
 
S. cerevisiae proteins were either produced by recombinant over-expression in E. coli and insect 
cells or prepared endogenously from S. cerevisiae strains carrying specific genomic tags. TFIIA, 
TBP, TFIIE, TFIIF and cMed subunits were expressed essentially as described89 in E. coli BL21-
Codon Plus(DE3)-RIL or Rosetta B834(DE3) strains (Table 3.1) using an IPTG-inducible system. 
The original protocol for TFIIB expression in BL21-Codon Plus(DE3)-RIL E. coli cells76 was 
slightly altered by substitution of LB media with ZY auto-induction media supplemented with 
NPS, 5052 and MgSO4 (Tables 3.9 and 3.10) and consequent omission of IPTG addition275 but 
otherwise remained unchanged. TFIIH core and kinase modules were produced in Trichoplusia ni 
High Five (Hi5) cells (Table 3.3) after baculovirus infection. Further information about the 
expression of TFIIH subunits and subcomplexes is provided below.  
Part of this study was the establishment of novel strategies for purification and assembly 
of 10-subunit TFIIH and its subcomplexes. Respective methods are described in detail in section 
4.5 and generally involved affinity chromatography, ion exchange chromatography and size 
exclusion chromatography (SEC) steps. The cMed complex and the remaining transcription 
factors used for reconstitution of the PIC-cMed complex (TFIIA, TFIIB, TBP, TFIIE, TFIIF) 
were purified according to previous reports76,88,89 with minor alterations. Pol II with a His6-Biotin-
tag on Rpb3 was prepared from the S. cerevisiae strain BJ5464 (Table 3.2) as described260. 
Purified proteins and protein complexes were aliquoted, flash-cooled in liquid nitrogen and stored 
at -80°C. 
 
Protein expression in E. coli cells 
 
TFIIH subunits and subcomplexes were initially expressed in BL21-Codon Plus(DE3)-RIL cells 
(Table 3.1) according to a standardized protocol. E. coli cells were (co-)transformed (Section 4.1) 
with the respective expression plasmids (Table 3.4). Single colonies from the transformation 
plates were used to inoculate 150 mL of LB media (Table 3.9) supplemented with the respective 
antibiotics (Table 3.10). The pre-cultures were incubated O/N (37°C, 160 rpm) and added in a 
1:100 (v/v) ratio to 12 L of LB media supplemented with the respective antibiotics. Cells were 
grown (37°C, 150 rpm) to an OD600 of 0.5 and shifted to 18°C with continued agitation. Protein 
expression was induced with 0.5-0.7 mM IPTG at an OD600 of 0.8 and carried out for 18-20 h at 
18°C. Cells were harvested by centrifugation (7,900g, 4°C, 8 min) and supernatants were 
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discarded. Pellets were resuspended in the respective lysis buffers (20 mL lysis buffer / 1 L cell 
culture), flash-cooled in liquid nitrogen and stored at -80°C. 
 
Protein expression in Hi5 insect cells 
 
TFIIH subcomplexes comprising catalytic subunits were expressed in Hi5 insect cells (Table 3.3) 
since this cell line very efficiently generated crucial post-translational modifications (PTMs) like 
phosphorylations (analyzed by S. Vos, unpublished data). Moreover, Hi5 cells were the only 
tested expression system that permitted production of Kin28, Rad3 and Ssl2 in sufficient amounts 
and with enzymatic activity. Protein expression was induced by infection of Hi5 cells with viruses 
of the V1 stage (Section 4.3) in small- and large-scale cultures. Cell cultures with volumes of 
either 50 mL (small scale) or 300 mL (large scale) were prepared at densities of 1.0×106 cells/mL 
in 500 mL or 3 L flasks. Infectious V1 supernatant was added in dilutions of 1:1500 – 1:2000 
(v/v). Applied virus titers depended on the strength and lifetime of the utilized V1 viruses and 
were experimentally determined and adapted for each respective virus. After infection, Hi5 
cultures were incubated at standard conditions (27°C, 60 rpm). Changes in density, viability, 
diameter and EYFP production of the cells were monitored in 24 h intervals. Cell densities 
surpassing the standard value were re-adjusted to 1.0×106 cells/mL by dilution with fresh media. 
If cultures exceeded the filling limit of the used flasks (100 or 600 mL, respectively) after 
dilution, surplus cells were transferred into appropriately sized fresh flasks and further incubated. 
Ideally, Hi5 cells divided once within 24 h after infection and then entered a stationary phase. As 
gene expression was controlled by the late viral polH promoter, proteins were mainly produced in 
the post-DPA phase. Therefore, cultures were incubated and monitored for an additional 48-72 h 
after DPA for optimal expression results. A gradual accumulation of protein (unpublished data) 
was accompanied by an increase in fluorescence levels and cell diameter of the infected cultures. 
Cell viability remained unchanged for ~24 h and then quickly dropped. Hi5 expression cultures 
(‘V2 cultures’) were harvested at cell viability values of 85-88%. Harvesting was performed under 
non-sterile conditions. Cells were collected by centrifugation (238g, 45 min, 4°C) and 
supernatants were discarded. Pellets were resuspended in respective lysis buffers (17 mL lysis 
buffer / 100 mL cell culture), flash-cooled in liquid nitrogen and stored at -80°C. 
 
Protein concentration and quantification 
 
Concentration of protein samples was performed to reduce the sample volume before SEC runs 
and before final storage at -80°C. Depending on the characteristics of the concentrated protein or 
complex, either AMICON® Ultra Centrifugal Filter Units (Millipore) or Vivaspin® Centrifugal 
Concentrators (GE Healthcare) with distinct sample volumes (0.5-15 mL) were used. Molecular 
weight cutoffs were generally chosen to be two-fold lower than the predicted molecular mass of 
the applied sample. Protein concentration was stopped if the target volume for injection onto SEC 
columns or the solubility limit of a sample was reached.   
Molar concentration and DNA content of protein samples were assessed by measurement 
of their absorbance at wavelengths of 280 nm (UV280) and 260 nm (UV260) with a NanoDrop-
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2000 spectrophotometer (ThermoScientific). UV260/UV280 ratios of 0.5-0.7 indicated DNA-free 
samples or tolerable low levels of DNA contamination, whereas ratios > 1 were observed only for 
DNA-bound complexes. Sample concentration c was calculated from weighted extinction 
coefficients E (i.e. absorbance of a 0.1% solution) of each analyzed protein or complex as 
determined by Expasy ProtParam276 and the measured UV280 absorbance value A (setting: 1 Abs = 
1 mg/mL) according to a simplified version of Beer’s Law ( c = A / E ).  
 
Sodium-dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE)  
 
Single components of protein samples were separated according to their molecular mass by SDS-
PAGE analysis. Samples were mixed with an appropriate amount of 4x SDS-PAGE loading dye 
(Table 3.12), incubated for 1-10 min at 95°C and loaded onto pre-cast gradient NuPAGE 4-12% 
Bis-Tris Protein Gels (Invitrogen) together with the PageRuler™ Prestained Protein Ladder 
molecular weight standard (Thermo Fisher Scientific). SDS-PAGE gels were run for 60-90 min at 
130-150 V using either 1x MOPS or 1x MES running buffer (Invitrogen) (Table 3.12). To fixate 
and visualize resolved peptide bands, gels were stained with InstantBlue™ (Expedeon) for 2 h. 
After destaining with ddH2O, gels were scanned for documentation with an Epson Perfection 
V800 flatbed scanner (Epson). If gels were used for western blot experiments, they were directly 
transferred into ddH2O without prior staining. 
 
Western blot analysis and immunostaining  
 
Targeted analysis of protein samples by western blot and antibody staining was performed to 
quickly detect specific protein subunits, domains or modifications, such as phosphorylations. 
Proteins were transferred from gels onto polyvinylidene difluoride (PVDF) membranes using the 
Trans-Blot® Turbo™ Blotting System (Bio-Rad). Unstained SDS-PAGE gels were washed in 
ddH2O for 1-2 min to remove residual SDS. Gels were stacked with ready-to-use pre-assembled 
Trans-Blot® Turbo™ Mini PVDF Transfer Packs (Bio-Rad) into blotting sandwiches according 
to the manufacturer’s instructions and placed in the blotting chamber. The pre-set transfer 
program for high molecular weight (MW) proteins (10 min, 25 V, 2.5 A) was usually selected 
since the molecular mass of several analyzed proteins exceeded 100 kDa. After transfer 
completion the membranes were blocked with 2.5% (w/v) milk powder solution in 1x PBS-T 
(Table 3.12) (2 h, 25°C, 60 r.p.m.). Subsequently the blocking solution was exchanged with 2.5% 
(w/v) milk powder / 1x PBS-T solution containing respective primary antibodies in appropriate 
dilutions (Table 3.8) and membranes were incubated (2-3 h, 25°C, 60 r.p.m. or O/N, 4°C 60 
r.p.m.). To remove residual antibodies, membranes were washed (5x, 5 min) with fresh 1x PBS-T. 
If primary antibodies were HRP-coupled (Table 3.8), membranes were analyzed directly. If 
incubation with HRP-coupled secondary antibodies was required, membranes were incubated 
with 2.5% (w/v) milk powder / PBS-T solution containing secondary antibodies in appropriate 
dilutions (Table 3.8) (2-3 h, 25°C, 60 r.p.m. or O/N, 4°C 60 r.p.m.) and the washing procedure 
with 1x PBS-T was repeated. HRP-coupled antibodies were detected and visualized on the 
membrane using the Pierce™ Enhanced Chemi-Luminescence Western Blotting Substrate kit 
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(Thermo Fisher Scientific). Membranes were imaged with the Advanced Fluorescent Imager 
(Intas) for documentation.  
 
Protein identification by mass spectrometry 
 
The presence and identity of specific proteins within a purified sample was confirmed by mass 
spectrometry. Experiments and analysis were performed by M. Raabe and A. Kühn as part of the 
facility service provided by the group of H. Urlaub (Max Planck Institute for Biophysical 
Chemistry, Göttingen). Sample components were separated on polyacrylamide gels by SDS-
PAGE and stained as described. Bands corresponding to proteins or peptides of interest were 
excised, digested in-gel with trypsin and extracted according to standard protocols277. Extracted 
peptides were enriched by SEC and analyzed on LTQ-Orbitrap Velos or Q-Exactive mass 
spectrometers (Thermo Fisher Scientific). Data sets were analyzed with Mascot278 against the 
NCBI non-redundant protein database for S. cerevisiae. Upon request, samples were initially 
enriched for phosphorylated peptides and phosphorylation sites were mapped during analysis.  
 
Pulldowns and binary interaction assays  
 
The quality of newly generated and validated expression constructs was assessed with small-scale 
bead-based pulldown assays. This method permitted fast screening of numerous samples and 
simultaneously provided information about protein expression levels, protein solubility and 
protein or complex stability during initial affinity purification steps. Pulldowns were performed 
with Ni-NTA Agarose resin (QIAGEN) or Amylose Resin (NEB). Owing to its lower capacity, 
700 µL of amylose resin were required for each pulldown, whereas 400 µL of Ni-NTA agarose 
resin were sufficient. The described protocol was applied for pulldowns with constructs expressed 
both in E. coli or insect cells. Frozen cell pellets from small-scale E. coli or insect cell expression 
cultures (1 L or 100 mL, respectively) were thawed at 25°C, supplemented with catalytic 
quantities of DNaseI (Sigma-Aldrich) and lysed with an EmulsiFlex-C5 cell disruptor (Avestin) 
(3-5 passages, 83,000 kPa). Cell lysates were cleared by centrifugation (79,000g, 60 min). The 
soluble protein-containing fractions were added to the respective amounts of Ni-NTA agarose or 
amylose resin, which had been pre-equilibrated by successive washes with ddH2O and lysis 
buffer. Bead-containing suspensions were incubated for 1 h at 4°C with agitation. Beads were 
pelleted (4°C, 30g, 3 min), transferred into empty Micro Bio-Spin™ chromatography columns 
(Bio-Rad) and washed on-column with 15 mL of lysis buffer in consecutive steps, using 1 mL of 
buffer per wash. The supernatant and wash fractions were discarded. Bound protein was eluted 
twice using 250 µL of lysis buffer supplemented with 500 mM imidazole or 50 mM maltose for 
Ni-NTA agarose or amylose resin, respectively.  
To test binary protein-protein interactions or the stability of multimeric assemblies under 
pulldown conditions, specific co-expression constructs with tags at only one or two of the target 
proteins were generated. Samples containing co-expressed protein complexes were prepared and 
subjected to bead-based pulldown assays as described and elution fractions were analyzed for the 
presence of untagged proteins that had been co-eluted as part of the complex.  
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Preparation of nucleic acid scaffolds 
 
Oligonucleotides used for the assembly of PIC-cMed complexes for EM analysis or for activity 
assays (Table 3.5) were ordered separately (IDT) and dissolved in UltraPure™ DNAse/RNAse-
Free Water (Thermo Fisher Scientific) to a concentration of 200 µM. To yield a final scaffold 
concentration if 100 µM, template and non-template strands were mixed in equimolar amounts 
(usually 15+15 µL) and annealed in a TProfessional TRIO Thermocycler® (Biometra). The 
annealing program comprised a phase of initial heating to 95°C followed by stepwise cooling of 
the sample in 1°C / 30 s increments to a temperature of 10°C. Annealed scaffolds were stored at   
-20°C and could be repeatedly re-thawed.   
 
Sucrose gradient centrifugation 
 
Centrifugation in a sucrose (or glycerol) gradient is a gentle approach for the separation of fragile 
or sensitive protein assemblies according to their molecular mass. This method was used to 
prepare the PIC-cMed complex and further PIC samples for analytical experiments and for EM.   
 Sucrose gradients were generated from a ‘sucrose light solution’, which usually comprised 
15% (v/v) sucrose, and a ‘sucrose heavy solution’, which comprised 30% or 40% (v/v) sucrose. 
Both sucrose solutions additionally contained all respective buffer components. For standard 
gradients, 4 mL Thinwall Ultra-Clear™ centrifugation tubes (Beckman Coulter) were utilized. 
Tubes were filled with sucrose light solution slightly above their middle mark (2.2-2.4 mL). 
Subsequently sucrose heavy solution was added from the bottom of the tubes such that the 
ultimate volume ratio of both solutions was 1:1. Tubes were sealed and gradients were prepared 
by mixing with a BioComp Gradient Master 108 (BioComp Instruments) according to the pre-set 
tilt and rotation parameters of a 15-30% or a 15-40% sucrose gradient program (BioComp 
Instruments). Approximately 10-15 min after gradient formation, samples were applied to the top 
of the tubes, i.e. to the least dense part of the gradient. Sample volumes of up to 300 µL could be 
loaded but required careful removal of the topmost 150-200 µL of the gradient solution. Gradient 
centrifugation was performed at 175,000g for 16 h at 4°C (SW60 Ti rotor, Beckman Coulter). 
Protein complexes sedimented in the gradient according to their molecular mass without 
perturbation by their hydrodynamic (Stokes) radii. After centrifugation, 200 µL fractions were 
collected from the top of the gradient and fractions were analyzed by SDS-PAGE. All steps were 
performed at 4°C. 
For experiments that required higher stability of the prepared sample, such as EM, a 
specific type of gradient centrifugation, ‘gradient fixation’ (‘GraFix’)279, was applied. GraFix 
combines the standard sedimentation method with simultaneous chemical sample fixation by 
crosslinking and thus requires supplementation of the high-density gradient solution with a 
crosslinking agent. For standard experiments, 0.13% (v/v) glutaraldehyde crosslinker were added 
to the sucrose heavy solution. No further alterations to the gradient centrifugation protocol were 
introduced. Following centrifugation, however, the collected 200 µL fractions were quenched 
with a mix of 10 mM aspartate and 30 mM lysine (10 min) to saturate excess crosslinker. In order 
to remove sucrose, crosslinker and quencher from the protein samples, the respective fractions 
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were dialyzed for 10 h in Slide-A-Lyzer MINI Dialysis Devices (2 ml, MWCO 20,000) (Thermo 
Fisher Scientific).  
 
Crystallization screening 
 
Initial protein crystallization screening was performed by J. Wawrzinek and T. Schulz as part of 
the facility service provided by the group of P. Cramer (Max Planck Institute for Biophysical 
Chemistry, Göttingen). Purified proteins were concentrated to 10-30 µM, centrifuged (4°C, 
21,000g, 10 min) to remove aggregates, transferred into fresh tubes and supplied to the facility on 
ice. Crystallization screens were performed at 20°C with drops of 200 nL volume (100 nL protein 
solution, 100 nL reservoir buffer solution). Screens were set up using a Crystal Gryphon robot 
(Art Robbins Instruments) on 96-well INTELLI® (Art Robbins Instruments) or MRC (Molecular 
Dimensions) sitting-drop crystallization plates. The facility offered a variety of commonly used 
commercial screens (Hampton Research, QIAGEN, Molecular Dimensions) and several 
customized screens that were produced in-house. Facility services included storage and regular 
imaging of crystallization plates in a Rock Imager 1000 (Formulatrix) within a 30-day period.  
 
Basic bioinformatics tools 
 
Gene and protein sequences were obtained from the gene database of the National Center for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/gene), the Saccharomyces 
Genome Database (SGD; http://www.yeastgenome.org) and the UniProt Database280. Analysis of 
cloning data, such as the evaluation of sequencing results or the generation of maps for newly 
assembled expression plasmids, was performed with ‘A plasmid Editor’ (ApE) 
(http://biologylabs.utah.edu/jorgensen/wayned/ape). Homologues of conserved S. cerevisiae 
proteins were identified and confirmed in various species using the NCBI BLAST suite281. 
Multiple sequence alignments (MSAs) were carried out with Clustal Omega282 and MUSCLE283. 
Secondary structure elements (SSEs) of proteins were predicted with Quick2D†, PSIPRED284, J-
Pred285 and Phyre2286. In order to visualize the level of conservation for specific SSEs during 
homology modelingø, PDB structures of confirmed homologues were mapped onto MSAs with 
ALINE287 and ESPript 3.0288. Furthermore, the HHpred program suite†289 was used to predict 
SSEs, folds and functions of specific poorly defined or conserved domains. 
 
† Quick2D and HHpred are part of the MPI Bioinformatics Toolkit290. 
ø For a detailed report about the homology modeling strategies that were applied to model structures within TFIIE and TFIIH 
refer to Section 4.5 and Tables 8.2 and 8.3.  
BLAST:  Basic Local Alignment Search Tool; PDB: Protein Data Base (http://www.rcsb.org) 
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4.5  Project-specific techniques and experimental setups 
 
This section focuses on customized methods and experimental schemes that were developed or 
specifically adapted for this study. These include particular strategies for protein expression, 
purification and assembly, for collection of EM data, for data processing and for model building, 
as well as specific functional assays. Several protocols described here have been published in: 
 
Schilbach, S., Hantsche, M., Tegunov, D., Dienemann, C., Wigge, C., Urlaub, H. & Cramer, P. 
Structures of transcription pre-initiation complex with TFIIH and Mediator. Nature 551, 204-209 
(2017). 
 
A detailed list of published text and items is provided in ‘Publications’ on page V. In addition, 
published protocols are marked with an asterisk (*) within this section. Protocol captions may 
deviate from the publication for clarity. Contributions of co-authors of the publication are 
indicated in the text flow. 
The design of expression constructs for subunits of the S. cerevisiae cPIC and cMed 
complexes, as well as methods for their preparation and assembly into subcomplexes cMed, Pol 
II, TFIIA, TFIIE and TFIIF have been reported76,88,89,260 and are not discussed.  
 
Generation of poly-promoter expression constructs for core-TFIIH and the TFIIH 
kinase module* 
 
Full-length subunits of S. cerevisiae TFIIH with the exception of Rad3 and Ssl2 were amplified 
from purified genomic DNA by PCR and transferred into modified pFastBac vectors† (derivatives 
of 438-A and 438-C; Addgene 55218 and 55220) by ligation independent cloning (LIC). The 
intron in Kin28 was removed by quick-change mutagenesis PCR after initial vector assembly. 
DNA sequences encoding full-length Rad3 and Ssl2 were obtained as Spodoptera frugiperda 
codon-optimized constructs from GeneArt (ThermoFisher Scientific), amplified from the vectors 
by PCR, and transferred into modified pFastBac vectors† by LIC. Within the vectors of the 438-
series, the TFIIH subunits contain either N-terminal 6×His- or 6×His-MBP-tags or remain 
untagged. N-terminal 6×His-tags are followed by cleavage sites for either Ulp1 or the rhinovirus 
protease (3C) whereas the N-terminal 6×His-MBP-tags are followed by a modified cleavage site 
for tobacco etch virus (TEV) protease. After separate transfer of each gene into a 438-vector, the 
single vectors were combined by successive rounds of LIC to generate a 7-subunit construct 
encoding the genes for core-TFIIH (Rad3, Ssl1, Ssl2, Tfb1, Tfb2, Tfb4 and Tfb5) and a 3-subunit 
construct encoding the genes for the TFIIH kinase module (Ccl1, Kin28 and Tfb3). Each subunit 
is preceded by a PolH promoter and followed by a SV40 termination site. Within these constructs, 
the 6×His-MBP-tags are placed on Tfb4 and Kin28. Plasmid sequences are available upon 
request. Preparation of bacmids, production of insect cell virus of the V0 and V1 stage and protein 
expression in insect cells were performed essentially as described291ø. 
 
† ‘Modified pFastBac vectors’ correspond to Series-438 vectors described in Section 4.2. 
ø A detailed protocol is also provided in Sections 4.3 and 4.4. 
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Generation of poly-promoter expression constructs for further TFIIH subcomplexes  
 
Combination of single-gene Series-438 vectors by successive rounds of LIC (Section 4.2, Fig. 
8.3) was also performed to generate 6-subunit constructs encoding full-length genes for two 
‘reduced’ core-TFIIH variants (Ssl1, Tfb1, Tfb2, Tfb4, Tfb5 and Rad3 or Ssl2), which lacked one 
of the ATPases, respectively (Table 3.4). In contrast to the core-TFIIH expression plasmid, 
however, the Rad3 and Ssl2 sequences in ‘reduced’ core-TFIIH vectors correspond to 
conventional genomic sequences of S. cerevisiae. Codon-optimized sequences for Rad3 and Ssl2 
were introduced to increase expression yields only for core-TFIIH. As described in the previous 
paragraph, each subunit in the resulting poly-promoter, multi-ORF plasmids is preceded by a 
PolH promoter and followed by a SV40 termination site to minimize effects of the respective gene 
order on protein expression levels. Within the ‘reduced’ core-TFIIH vectors, the primarily used 
(6×His-)MBP-tags were ultimately placed on Ssl1 and Tfb4, whereas intermediates and various 
test constructs were also tagged on Rad3, Tfb1, Tfb2 and Ssl2 according to different strategies. 
Although various additional test vectors with up to 12 distinct genes were produced using the 
LIC-based assembly system, these were ultimately not of relevance for this study. 
Multi-gene vectors of the pET-MCN series were prepared similarly to Series-438 vectors, 
with the following exceptions. After amplification of genes from purified genomic DNA by 
standard PCR they were inserted into pet-MCN plasmids by conventional restriction endonuclease 
cleavage and ligation methods (Section 4.1). Genes containing restriction sites targeted by SpeI 
and XbaI were modified by RTH PCR-based mutagenesis. Within the pET-MCN vectors, the 
TFIIH subunits contain either N-terminal 6×His-tags followed by Ulp1 cleavage sites (‘SUMO’) 
or remain untagged (Table 3.4). After separate transfer of each gene into pET-MCN plasmids, up 
to five distinct genes of minimal core-TFIIH (Ssl1, Tfb1, Tfb2, Tfb4 and Tfb5) were assembled 
into multi-cistronic constructs by a recombination strategy based on restriction digest and ligation 
as described (Section 4.1, Fig. 8.2). In addition, pET-MCN vectors with orthogonal selective 
markers (kanamycin and ampicillin) were co-transformed in E. coli cells, further increasing the 
number and variability of proteins obtained by co-expression. While various multi-gene vectors 
with distinctly tagged and truncated versions of minimal core-TFIIH subunits were produced, 
only selected constructs are discussed in this study in detail (Table 3.4). 
Plasmid sequences and a complete list of generated expression vectors are available upon 
request. Preparation of bacmids and production of insect cell viruses of the V0 and V1 stage were 
performed as described in Section 4.3. Protein expression in E. coli and Hi5 insect cells was 
performed as described in Section 4.4.  
 
Expression and purification of S. cerevisiae minimal core-TFIIH 
 
Recombinant S. cerevisiae minimal core-TFIIH was prepared in several variants, comprising 
either full-length subunits or distinctly truncated versions of Ssl1, Tfb1 and Tfb4 in diverse 
combinations. The applied purification scheme, however, remained essentially unchanged.  
The complexes were expressed in E. coli according to the standard protocol (Section 4.4) 
and subjected to affinity, ion exchange and size exclusion chromatography steps. All purification 
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procedures were performed at 4°C unless stated otherwise. Resuspended (700 mM NaCl, 25 mM 
Na-HEPES pH 7.5, 10% (v/v) glycerol, 20 mM imidazole, 2 mM TCEP, 1x PI), frozen E. coli 
pellets were thawed at 25°C and supplemented with catalytic amounts of DNaseI (Sigma-
Aldrich). Cells were lysed with an EmulsiFlex-C5 cell disruptor (Avestin) (5 passages, 83,000 
kPa) and the cell lysate was cleared by centrifugation (79,000g, 1 h). The supernatant was filtered 
through 0.5 µM syringe filters (Merck Millipore) and applied to two coupled GE HisTrap HP (5 
mL) columns (GE Healthcare) with a total bed volume of 10 ml, pre-equilibrated in buffer N-700 
(700 mM NaCl, 25 mM Na-HEPES pH 7.5, 10% (v/v) glycerol, 20 mM imidazole, 5 mM β-
mercaptoethanole). The columns were washed with 12 column volumes (CV) of buffer N-700 and 
the protein was eluted with a linear gradient of 0-100% buffer NE-500 (500 mM NaCl, 25 mM 
Na-HEPES pH 7.5, 10% (v/v) glycerol, 500 mM imidazole, 5 mM β-mercaptoethanole) in 8 CV. 
Protein-containing fractions were pooled, supplemented with 1 mg 6×His-Ulp1 protease (lab 
stock, prepared by S. Schilbach, unpublished data) and dialyzed for 12 h against buffer AE-100 
(100 mM NaCl, 25 mM Na-HEPES pH 7.5, 5% (v/v) glycerol, 5 mM β-mercaptoethanole) at 4°C. 
Dialyzed sample was filtered through a 0.5 µM syringe filter (Merck Millipore) and subjected to 
anion exchange chromatography on a GE Mono Q 5/50 GL column (GE Healthcare) pre-
equilibrated in buffer AE-100. After washing the column with 5 CV buffer AE-100, the protein 
was eluted with a step to 2% buffer AE-2000 (2 M NaCl, 25 mM Na-HEPES pH 7.5, 5% (v/v) 
glycerol, 5 mM β-mercaptoethanole) followed by a linear gradient from 2–9% buffer AE-2000 in 
105 CV. Fractions containing stoichiometric minimal core-TFIIH were pooled, concentrated 
using an AMICON® Ultra, MWCO 10 kDa (Amicon) centrifugal device and applied to a GE 
Superdex200 Increase 10/300 GL SEC column (GE Healthcare) pre-equilibrated in gel filtration 
buffer (100 mM NaCl, 25 mM Na-HEPES pH 7.5, 2 mM TCEP). To remove subunits present in 
excess, peak fractions were pooled conservatively and then concentrated to ~10 mg/mL using an 
AMICON® Ultra, MWCO 10 kDa (Amicon) centrifugal device. In addition to increasing sample 
purity, the SEC step was used to alter buffer conditions by variation of the salt and buffer 
components in the gel filtration buffer or by its supplementation with 2 µM ZnCl2. Purified and 
buffer-exchanged minimal core-TFIIH variants were directly subjected to crystallization trials 
(Section 4.4) at concentrations of 5-10 mg/mL (10-30 µM). Typical yields were in the range of 
0.4-0.5 mg per liter of E. coli culture. 
 
Expression and purification of S. cerevisiae core-TFIIH* 
 
The complex was expressed in Hi5 insect cells after baculovirus infection (Section 4.4)†. Cells 
were collected by centrifugation (238g, 45 min, 4°C) and resuspended in lysis buffer (400 mM 
potassium acetate, 25 mM HEPES pH 7.5, 10% glycerol (v/v), 5 mM β-mercaptoethanole, 0.284 
µg ml−1 leupeptin, 1.37 µg ml−1 pepstatin A, 0.17 mg ml−1 PMSF, 0.33 mg ml−1 benzamidine). 
The cell suspension was flash cooled in liquid nitrogen and stored at -80°C. Recombinant S. 
cerevisiae core-TFIIH was purified by consecutive steps of affinity chromatography, ion 
exchange chromatography and size exclusion chromatography. All purification procedures were 
performed at 4°C unless stated otherwise. Frozen insect cell pellets were thawed at 25°C, 
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supplemented with catalytic amounts of DNaseI and lysed with an EmulsiFlex-C5 cell disruptor 
(Avestin) (3 passages, 83,000 kPa). The cell lysate was cleared by centrifugation (79,000g; 60 
min) and the protein-containing soluble fraction was filtered through 0.8 µM syringe filters 
(Merck Millipore). The supernatant was then applied to a GE XK 16-20 column (GE Healthcare) 
containing a bed volume of 25 ml amylose resin (New England Biolabs) and pre-equilibrated in 
buffer M-300 (300 mM potassium acetate, 25 mM K-HEPES, pH 7.5, 10% glycerol (v/v), 5 mM 
β-mercaptoethanole). After application of core-TFIIH-containing lysate supernatant, the column 
was washed with 3 column volumes (CV) of buffer M-300 and the protein was eluted with 2 CV 
ME buffer (350 mM potassium acetate, 25 mM K-HEPES, pH 7.5, 10% glycerol (v/v), 50 mM 
maltose and 5 mM β-mercaptoethanole) onto a GE HiTrap Heparin HP (5 ml) column pre-
equilibrated in buffer M-350 (350 mM KOAc, 25 mM K-HEPES pH 7.5, 10% glycerol (v/v), 5 
mM β-mercaptoethanole). The column was washed with 3 CV of buffer M-350 and the protein 
was eluted with a linear gradient of 0-30% buffer M-2000 (2 M potassium acetate, 25 mM K-
HEPES, pH 7.5, 10% glycerol (v/v), 5 mM β-mercaptoethanole) in 20 CV. Peak fractions were 
pooled, supplemented with 1 mg 6×His-TEV protease, 0.5 mg 6×His-3C protease and 0.5 mg 
6×His-Ulp1 protease and kept at 4°C for 6 h. The cleaved sample was subjected to anion 
exchange chromatography using a GE HiTrap Q HP (1 ml) column pre-equilibrated in buffer A-
400 (400 mM potassium acetate, 25 mM K-HEPES, pH 7.5, 5% glycerol (v/v), 5 mM β-
mercaptoethanole). After sample application the column was washed with 10 CV buffer A-400 
and the protein was eluted with a linear gradient from 0-30% buffer A-2000 (2 M potassium 
acetate, 25 mM K-HEPES, pH 7.5, 5% glycerol (v/v), 5 mM β-mercaptoethanole) in 80 CV. 
Fractions containing stoichiometric 7-subunit core-TFIIH were pooled, concentrated using a 
Vivaspin 6 MWCO 50 000 (GE Healthcare) centrifugal device and applied to a GE Superose12 
10/300 GL size exclusion column pre-equilibrated in gel filtration buffer (600 mM potassium 
acetate, 25 mM K-HEPES, pH 7.5, 5% glycerol (v/v), 2 mM TCEP). Peak fractions were pooled, 
concentrated to 4 mg ml−1 using a Vivaspin 500 MWCO 50,000 (GE Healthcare) centrifugal 
device, aliquoted, flash-cooled in liquid nitrogen and stored at -80 °C. Typical yields were in the 
range of 0.3-0.4 mg per liter of insect cell culture. 
 
† This sentence was added to the published protocol for clarity of the text flow. 
 
Expression and purification of S. cerevisiae ‘reduced’ core-TFIIH 
 
Recombinant S. cerevisiae core-TFIIH was prepared in three variants, comprising either seven or 
six full-length subunits. The 6-subunit ‘reduced’ core-TFIIH versions lacked either Rad3 or Ssl2 
and were differently tagged (Table 3.4). However, as both constructs contained at least one MBP-
tag derivative, the expression and purification scheme applied for core-TFIIH remained 
essentially unchanged for their preparation. As an exception, core-TFIIHΔRad3 was stable in low 
salt conditions (300 mM potassium acetate, 25 mM K-HEPES, pH 7.5, 5% glycerol (v/v), 2 mM 
TCEP) during the final SEC step. 
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Expression and purification of the S. cerevisiae TFIIH kinase module* 
 
Recombinant TFIIH kinase module was expressed in Hi5 insect cells after baculovirus infection 
(Section 4.4) and subjected to consecutive affinity, ion exchange and size exclusion 
chromatography steps. All purification procedures were performed at 4°C unless stated otherwise. 
Resuspended (400 mM potassium acetate, 25 mM HEPES pH 7.5, 10% glycerol (v/v), 5 mM β-
mercaptoethanole, 0.284 µg ml−1 leupeptin, 1.37 µg ml−1 pepstatin A, 0.17 mg ml−1 PMSF, 0.33 
mg ml−1 benzamidine), frozen insect cell pellets were thawed at 25°C, supplemented with 
catalytic amounts of DNaseI (Sigma-Aldrich) and lysed with an EmulsiFlex-C5 cell disruptor 
(Avestin) (3 passages, 83,000 kPa). The cell lysate was cleared by centrifugation (79,000g, 60 
min) and the supernatant was filtered through 0.8 µM syringe filters (Merck Millipore)†. After cell 
lysis and lysate clearance, the sample was loaded onto a GE XK 16-20 column containing a bed 
volume of 25 ml amylose resin pre-equilibrated in buffer M-200 (200 mM potassium acetate, 25 
mM K-HEPES pH 7.5, 5% glycerol (v/v), 5 mM β-mercaptoethanole). The column was washed 
with 3 CV buffer M-200 and the protein was eluted with 2 CV buffer ME (200 mM potassium 
acetate, 25 mM K-HEPES, pH 7.5, 5% glycerol (v/v), 50 mM maltose and 5 mM β-
mercaptoethanole). Peak fractions were pooled, supplemented with 1 mg 6×His-TEV protease 
and 0.5 mg 6×His-3C protease and kept at 4°C for 6 h. The cleaved protein sample was subjected 
to anion exchange chromatography using a GE HiTrap Q HP (1 ml) column pre-equilibrated in 
buffer M-200. After sample application the column was washed with 10 CV of buffer M-200 and 
the protein was eluted with a linear gradient from 0-30% buffer A-2000 (2 M potassium acetate, 
25 mM K-HEPES, pH 7.5, 5% glycerol (v/v), 5 mM β-mercaptoethanole) in 80 CV. Fractions 
containing stoichiometric kinase trimer were pooled, concentrated using a Vivaspin 6 MWCO 
10,000 (GE Healthcare) centrifugal device and applied to a GE Superdex200 10/300 GL size 
exclusion column pre-equilibrated in gel filtration buffer (150 mM potassium acetate, 25 mM K-
HEPES, pH 7.5, 5% glycerol (v/v), 2 mM TCEP). Peak fractions were concentrated to 7 mg ml−1 
using a Vivaspin 500 MWCO 10,000 (GE Healthcare) centrifugal device, aliquoted, flash-cooled 
in liquid nitrogen and stored at -80 °C. Typical yields were in the range of 1.0 mg per 500 ml of 
insect cell culture. 
 
† The preceding text passage replaced the sentence “The TFIIH kinase module was prepared similarly.”292. 
 
ATPase assay 
 
In order to test the ATPase activities of core-TFIIH in separation, the 6-subunit ‘reduced’ core-
TFIIH variants were subjected to a regenerative coupled ATPase assay that provided stable levels 
of ATP. In this system, hydrolyzed ATP is continuously regenerated by pyruvate kinase (PK), 
which in turn converts phosphoenolpyruvate (PEP) into pyruvate. Pyruvate on the other hand is 
converted into lactate by L-lactate dehydrogenase (LDH), which simultaneously oxidizes NADH 
into NAD+. Thus, ATP hydrolysis is ultimately directly proportional to the oxidation of NADH. 
To quantify levels of NADH oxidation, absorption of the samples at 340 nm (A340) was 
monitored. Whereas both NADH and NAD+ absorb at 260 nm, only NADH absorbs at 340 nm 
and values for A340 gradually decrease upon its oxidation. Although this setup in principle permits 
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quantification of the ATP-hydrolysis rate and thus the ATPase activity of a tested enzyme, in this 
study a simplified version of the assay was utilized. To determine whether ATP hydrolysis had 
occurred, merely the initial and final levels of NADH were compared. 
ATPase assay mastermixes containing ssDNA or dsDNA (Table 3.5, Section 4.4) 
substrates (0.05-2 µM), MgCl2 (4 mM), NADH (0.25 mM), PEP (2 mM), 2.0 U LDH (Sigma-
Aldrich) and 1.5 U PK (Sigma-Aldrich) in buffer AA (150 mM potassium acetate, 25 mM K-
HEPES pH 7.5, 2.5% (v/v) glycerol, 2 mM magnesium acetate, 5 mM β-mercaptoethanole) were 
prepared and 50 µL aliquots were transferred into wells of 384-well micro-plates (Greiner). 
Catalytic amounts of 6-subunit ‘reduced’ core-TFIIH complexes (0.1 µM) were added and 
samples were pre-incubated for 2 min at 30°C. Reactions were initiated by addition of ATP (2 
mM). Using an Infinite® M1000 Pro micro-plate reader (Tecan), A340 of the samples was 
monitored during incubation (1 h, 30°C) at allocated time points, usually every 60 s. Data of the 
single measurements were not used for quantification but to visualize and confirm the gradual 
decrease of NADH concentration in the samples. Wells without ATP, substrate or enzyme 
components were prepared as negative controls. 
 
CTD phosphorylation assay 
 
A simplified in vitro Pol II CTD phosphorylation assay was performed to test the activity and 
specificity of recombinant TFIIH kinase module. To produce completely dephosphorylated 
substrate for the assay, Pol II was treated for 1 h at 4°C with λ-phosphatase (lab stock, prepared 
by S. Vos, unpublished data) prior to the final SEC step during Pol II purification260.  
CTD-phosphorylation reactions containing dephosphorylated Pol II (8.8 µM) and MgCl2 
(4 mM) in buffer P (150 mM potassium acetate, 25 mM K-HEPES pH 7.5, 2.5% (v/v) glycerol, 2 
mM magnesium acetate, 5 mM β-mercaptoethanole) were prepared. Catalytic amounts of the 
TFIIH kinase trimer (0.04 µM) were added and samples were pre-incubated for 2 min at 25°C. 
Reactions were started by addition of 4 mM ATP (Thermo Fisher Scientific) and monitored for 3 
h at allocated time points. At each time point, 2 µL samples were retrieved. Samples were 
analyzed in 1:10 dilution by SDS-PAGE and western blot with primary α-Tyr1-P, α-Ser2-P, α-
Ser5-P and α-Ser7-P antibodies and secondary α-rat-IgG-HRP antibodies (Table 3.8) as described 
(Section 4.4).  
 
Reconstitution and analysis of 10-subunit TFIIH 
Complete 10-subunit TFIIH was reconstituted from the 7-subunit core and 3-subunit kinase 
modules. Prior to assembly, core-TFIIH was diluted with ddH2O to lower the salt content to 500 
mM potassium acetate. Diluted protein was then mixed with 1.3x molar excess of kinase trimer 
and incubated (2-3 h, 5-10°C). The sample was centrifuged (21,000g, 10 min) to remove potential 
aggregates and subjected to sucrose-gradient centrifugation (Section 4.4.). The sucrose gradient 
was generated from a 10% sucrose light solution (10% (w/v) sucrose, 250 mM potassium acetate, 
2 mM magnesium acetate, 25 mM K-HEPES pH 7.5, 2.5% (v/v) glycerol, 0.75 mM AMP-PNP, 1 
mM TCEP) and a 25% sucrose heavy solution (25% (w/v) sucrose, 250 mM potassium acetate, 2 
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mM magnesium acetate, 25 mM K-HEPES pH 7.5, 2.5% (v/v) glycerol, 0.75 mM AMP-PNP, 1 
mM TCEP). After gradient centrifugation, 200 µL fractions were collected from the top of the 
gradient and samples were analyzed by SDS-PAGE (Section 4.4). 
 
Reconstitution and analysis of PIC variants 
 
The cPIC, cPIC-cMed and PIC-cMed complexes, as well as a PIC devoid of Rad3 and kinase 
trimer (‘PIC∆Rad3∆3mer’), were reconstituted and subjected to sucrose-gradient centrifugation 
for initial analytical experiments and for negative stain EM analysis. Whereas the following 
scheme recapitulates the complete PIC-cMed assembly, redundant steps, such as incubation with 
TFIIH or cMed, were omitted if the respective proteins were not included in the final complex. 
Also, AMP-PNP was added only if complete 10-subunit TFIIH was present in a sample although 
all samples were diluted accordingly with buffer S. Unless stated otherwise, all incubation steps 
were performed at 25 °C.  
10-subunit TFIIH was reconstituted from equimolar amounts of the 7-subunit core and the 
3-subunit kinase modules (4°C, 10 min), prior to formation of the respective initiation complexes. 
PICs were assembled according to Table 8.1†, starting with preparation of Pol II-TFIIF and DNA-
TFIIA-TBP-TFIIB complexes (25°C, 10 min), which were combined to generate a Pol II/IIA–
IIB–TBP–IIF–DNA assembly (cPIC). The cPIC sample was kept at 25°C for 5 min. TFIIE was 
added to previously reconstituted 10-subunit TFIIH and incubated for 5 min. Subsequently, the 
TFIIE-TFIIH complex was mixed with the cPIC. After incubation for 5 min, cMed and buffer S 
(2 mM magnesium acetate, 25 mM K-HEPES pH 7.5, 2.5% (v/v) glycerol, 1 mM TCEP), which 
optionally included an appropriate amount of AMP-PNP for a final concentration of 0.75 mM in 
the sample, were added. Since buffer S also lowered salt concentration of the sample and thus 
facilitated complex formation, it was also provided if no AMP-PNP was required. Reconstituted 
complexes were incubated for 120 min with slight agitation.  
Samples were centrifuged (21,000g, 10 min) to remove potential aggregates and subjected 
to sucrose-gradient centrifugation (Section 4.4). Standard gradients were generated from a 15% 
sucrose light solution (15% (w/v) sucrose, 150 mM potassium acetate, 2 mM magnesium acetate, 
25 mM K-HEPES pH 7.5, 2.5% (v/v) glycerol, 1 mM TCEP, optionally 0.75 mM AMP-PNP) and 
a 40%, sucrose heavy solution (40% (w/v) sucrose, 150 mM potassium acetate, 2 mM magnesium 
acetate, 25 mM K-HEPES pH 7.5, 2.5% (v/v) glycerol, 1 mM TCEP, optionally 0.75 mM AMP-
PNP). Several complexes, such as the PIC∆Rad3∆3mer, were isolated in a gradient generated 
from 15% and 30% (30% (w/v) sucrose, 150 mM potassium acetate, 2 mM magnesium acetate, 25 
mM K-HEPES pH 7.5, 2.5% (v/v) glycerol, 1 mM TCEP, optionally 0.75 mM AMP-PNP) 
sucrose solutions. For reconstitution of samples that were subsequently analyzed by negative stain 
EM, the sucrose heavy solution was supplemented with 0.13% (v/v) glutaraldehyde, whereas no 
crosslinker was added for analytical trials. After centrifugation, 200 µL fractions were collected 
from the top and complex formation was assessed by SDS-PAGE. Crosslinked complexes were 
quenched and dialyzed (150 mM potassium acetate, 2 mM magnesium acetate, 25 mM K-HEPES 
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pH 7.5, 1 mM TCEP) as described (Section 4.4). Dialyzed samples were applied to negative stain 
EM grids. 
 
† Table 8.1 also indicates molar ratios of PIC-cMed complex components for assembly. 
 
Preparation of the PIC-cMed complex for cryo-EM* 
 
Closed PIC-cMed complex was prepared according to a protocol adapted from the previously 
reported assembly scheme88, but with a slightly altered nucleic acid scaffold. The 106 nucleotide 
scaffold is based on the HIS4-promoter sequence (templateø: 5′-TGACACAGCG 
CAGTTGTGCTATGATATTTTTATGTATGTACAACACACATCGGAGGTGAATCGAACGT
TCCATAGCTATTATATACACAGCGTGCTACTGTTCTCG-3′; nontemplateø: 5′-CGAGAAC 
AGTAGCACGCTGTGTATATAATAGCTATGGAACGTTCGATTCACCTCCGATGTGTGTT
GTACATACATAAAAATATCATAGCACAACTGCGCTGTGTCA-3′) and contains additional 
downstream DNA. Complete 10-subunit TFIIH was reconstituted from the 7-subunit core and the 
kinase trimer at 4°C before formation of the PIC-cMed complex. The PIC-cMed complex was 
assembled for cryo-EM according to the order in Table 8.1†. Beginning with the formation of a 
Pol II-IIF complex, the other initiation factors were added to generate a Pol II/IIA-IIB-TBP-IIF-
DNA complex. TFIIE was incubated with previously assembled 10-subunit TFIIH for several 
minutes before being added to the Pol II-containing complex. After incubation for 5 min, buffer S 
(25 mM K-HEPES, pH 7.5, 2 mM magnesium acetate, 2.5% glycerol (v/v), 1 mM TCEP), with an 
appropriate amount of AMP-PNP to reach a final concentration of 0.75 mM, and cMed were 
added. The PIC-cMed complex was incubated for another 120 min shaking gently at 400 r.p.m. 
Unless stated otherwise, all incubation steps were performed at 25°C. 
The PIC-cMed sample was centrifuged at 21,000g for 10 min and subjected to sucrose-
gradient centrifugation in a 5 ml centrifugation tube. The gradient was generated from a 15% 
sucrose light solution (15% (w/v) sucrose, 150 mM potassium acetate, 25 mM K-HEPES, pH 7.5, 
2 mM magnesium acetate, 2.5% glycerol (v/v), 1 mM TCEP, 0.75 mM AMP-PNP) and a 40% 
sucrose heavy solution (40% (w/v) sucrose, 150 mM potassium acetate, 25 mM K-HEPES pH 
7.5, 2 mM magnesium acetate, 2.5% glycerol (v/v), 1 mM TCEP, 0.75 mM AMP-PNP) 
containing 0.13% (v/v) glutaraldehyde crosslinker with a BioComp Gradient Master 108 
(BioComp Instruments). Centrifugation was performed at 175,000g for 16 h at 4°C. Subsequently, 
200 µl fractions were collected and quenched with a mix of 10 mM aspartate and 30 mM lysine 
for 10 min. Fractions containing crosslinked PIC-cMed complex were dialysed for 10 h in dialysis 
buffer (150 mM potassium acetate, 25 mM K-HEPES, pH 7.5, 2 mM magnesium acetate, 1 mM 
TCEP) in Slide-A-Lyzer MINI Dialysis Devices (2 ml, 20,000 MWCO) (ThermoFisher 
Scientific) to remove sucrose and glycerol. The dialyzed sample was concentrated to 0.7 mg ml−1 
using a Vivaspin 500 MWCO 100,000 (GE Healthcare) centrifugal device and applied to cryo-
EM grids. 
 
ø Sequences of template and non-template strands are also listed in Table 3.5. Scaffold formation from single nucleic acid 
strands is described in Section 4.4. 
† Table 8.1 also indicates molar ratios of PIC-cMed complex components for assembly.  
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Chemical crosslinking and crosslink analysis by mass spectrometry*† 
 
PIC-cMed sample was crosslinked with a final concentration of 200 mM EDC (ThermoFisher 
Scientifc) in the sucrose heavy solution during gradient centrifugation. Fractions from the sucrose 
gradient were quenched with 50 mM ammonium bicarbonate. Fractions were dialyzed as before 
to remove sucrose and pooled for precipitation. Precipitated sample was dissolved in 50 µl buffer 
containing 8 M urea and 50 mM ammonium bicarbonate. Crosslinked sample was digested 1:20 
(w/w) with trypsin and peptides were enriched by peptide size-exclusion chromatography and 
analysed in duplicate on an Dionex UltiMate 3000 RSLCnano HPLC system (Thermo Fisher 
Scientific) coupled to an Orbitrap Fusion Tribrid Mass Spectrometer (Thermo Fisher Scientific). 
MS acquisition was performed as described293 with the exception that peptides were separated on 
the analytical column using a 63-min linear gradient. The data sets were analyzed with pLink 
1.23294 against a database containing the sequences of the protein components in the complex. 
Database search parameters included mass accuracies of MS1 < 10 p.p.m. and MS2 < 20 p.p.m., 
carbamidomethylation on cysteine as a fixed modification and oxidation on methionine as a 
variable modification. The number of residues of each peptide on a cross-link pair was set 
between 5 and 40 amino acids. A maximum of two trypsin-missed cleavage sites was allowed. An 
initial false discovery rate (FDR) cutoff of 1% was set. For simplicity, the crosslink score was 
represented as a negative logarithm value of the original pLink score and identified spectra with a 
score larger than three were considered. Results were visualized using the xiNET online server295 
and the XLink Analyzer Plugin296 for UCSF Chimera297. New crosslinks are summarized in Fig. 
5.12. 
 
† Experiments were performed in collaboration with M. Hantsche, C.-T. Lee and I. Parfentev. 
 
Negative stain EM data collection and analysis 
Negative stain data were acquired to initially assess the quality of a protein sample on EM grids. 
Data collection was performed on carbon coated copper mesh grids (S160-4; Plano). Grids were 
glow-discharged (45 s, 25 mA, 0.39 mbar) with a PELCO easiGlow™ System (Ted Pella) before 
3-5 µL sample were applied. After incubation for 60-90 s, excess sample was removed with filer 
paper (Whatman) and grids were washed twice for 30 s by floating them on the surface of 1 mL 
drops of dddH2O. Grids were stained by floating them on 20 µL drops of freshly prepared 2% 
(w/v) uranyl formate solution for 30 s. The staining procedure was performed thrice with different 
drops of staining solution. Excess uranyl formate was removed with filter paper and grids were 
stored on filter paper without light exposure.  
Negative stain EM data were acquired on a CM200 transmission electron microscope 
(Phillips) operated at 200 kV and equipped with a field emission gun (FEG) and a 2k x 2k CCD 
camera (TVIPS). Images were collected with an in-house TCL-based software in spot-scanning 
mode, at a nominal magnification of 88,000x (2.51 Å / pixel) and with a defocus range from -0.5 
to -2.5 µm. Average datasets comprised 200-300 images with 15,000-20,000 particles. Particle 
coordinates were determined with the e2boxer.py tool implemented in EMAN2298. CTF correction 
and subsequent image processing, such as particle picking, reference-free 2D- or template-guided 
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3D-classification, were performed with the RELION 2.0.4 package299,300.  
 
Cryo-EM data collection* 
 
Cryo-EM data collection was performed on R1.2/1.3 gold grids (Quantifoil). Grids were glow-
discharged† for 45 s before application of 5 µl concentrated PIC-cMed sample, blotted for 5 s and 
vitrified by plunging into liquid ethane with a Vitrobot Mark IV (FEI) operated at 4°C and 100% 
humidity. Cryo-EM data were acquired on a FEI Titan Krios G2 transmission electron microscope 
(FEI) operated in EFTEM mode at 300 kV and equipped with a K2 Summit direct detector 
(Gatan). Automated data acquisition was carried out using the FEI EPU software package at a 
nominal magnification of 105,000x (1.37 Å per pixel). A total of 14,000 image stacks were 
collected at a defocus range from -0.5 µm to -5.0 µm. Each stack contained 40 frames that were 
acquired over a 10 s exposure time window in the counting mode of the camera. A dose rate of 
4.2 e- Å−2 was applied, resulting in a total dose of 42 e- Å−2. 
 
† Glow discharging (45 s, 15 mA, 0.39 mbar) was performed with a PELCO easiGlow™ System (Ted Pella). 
 
Image processing* 
 
Cryo-EM image frames were stacked and processed with MotionCor2301 and CTF parameter 
estimation was performed with Gctf302. CTF correction and subsequent image processing were 
performed with the RELION 2.0.4 package299,300 unless indicated otherwise. Post-processing of 
refined models was performed with automatic B-factor determination in RELION and resolution 
was reported based on the gold-standard Fourier shell correlation (FSC) (0.143 criterion) as 
described303 unless indicated otherwise. Local resolution estimates were determined using a 
sliding window of 403 voxels as described 89. 
To obtain an initial particle set, coordinates of approximately 15,000 particles were 
determined semi-automatically with the e2boxer.py tool implemented in EMAN2298. The 
coordinates were imported into RELION and the respective particles were extracted with a 3802 
pixel box and normalized. Reference-free 2D class-averages were calculated and 20 
representative 2D classes were selected. These were low-pass filtered to 20 Å and used as 
templates for automated particle picking on the first 700 micrographs, resulting in approximately 
200,000 particles. Particles were extracted with a 3802 pixel box size, normalized and screened by 
a combination of manual inspection and iterative rounds of reference-free 2D-classification. From 
the obtained improved 2D class-averages, 20 representative 2D classes were selected, low-pass 
filtered to 20 Å and used as templates for automated picking on the remaining micrographs with 
RELION. Initially, around 1.6 million particle images were obtained. Particles were extracted 
with a box size of 3502 pixel, normalized and screened using a combination of iterative rounds of 
reference-free 2D- and template-guided 3D-classification with image alignment combined with 
manual inspection of the images in specific classes. An initial reference (ModelI) for the 
screening 3D-classifications had been obtained by performing one pre-3D-classification with the 
initial 200,000 particles using a 60 Å low-pass filtered EM map of the cPIC-cMed complex 
(EMDB accession EMD-2786)88 as reference. Calculation of five 3D classes resulted in one class 
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with the complete PIC-cMed complex. This class was used as ‘Model I’ for the screening 3D-
classifications after low-pass filtering to 60 Å. During the screening process, approximately 60% 
of the initial 1.6 million particles were discarded, resulting in 650,000 input particles. Using 
‘Model I’ as the initial reference, iterative rounds of hierarchical 3D-classification with image 
alignment were performed as outlined in Fig. 5.10. After the first round of classification, classes 
with clearly visible density for cMed were selected. The same procedure was applied for classes 
with clear TFIIH density but no density for cMed, resulting in a separation of the classification 
tree in one branch for the PIC-cMed particles and one branch for PIC particles that lacked cMed. 
Before the second round of 3D-classification, new reference models (‘Model PIC’ and ‘Model 
PIC-cMed’) were generated from the best classes of the first round of 3D-classification and low-
pass filtered to 60 Å. The second round of template-guided 3D-classification for the PIC-cMed 
branch was consequently performed with ‘Model PIC-cMed’ as a reference, whereas for the PIC 
branch ‘Model PIC’ served as reference. Subjecting the best 3D class of the PIC branch to a 
focused 3D-refinement with a local mask encompassing only TFIIH resulted in a reconstruction† 
with a resolution of 7.4 Å (after post-processing) from 32,000 particles. 
 
† Not deposited. 
 
Flexible Refinement (‘WarpCraft’) 
 
The flexible refinement tool WarpCraft was developed and applied by D. Tegunov as reported292. 
Flexible refinement combined with local filtering of classes with apparently highly resolved PIC 
and PIC-cMed particles resulted in reconstructions with a nominal resolution of 4.7 Å from 
58,000 particles for the PIC and a nominal resolution of 5.8 Å from 16,000 particles for the PIC-
cMed complex (Fig. 5.10). 
 
Structural Modeling* 
 
For structural modeling we used both the continuous EM maps obtained by WarpCraft and EM 
maps with focus on specific regions in TFIIH. Model placement and docking of rigid bodies into 
the EM maps was performed with UCSF Chimera297. The I-TASSER304,305, SWISS-Model306,307 
and Rosetta308,309 tools were used for the generation of homology models of various PIC-cMed 
components as indicated in Tables 8.2 and 8.3. Manual modification of models and de-novo 
model building procedures were performed with COOT310. The model of the S. cerevisiae cPIC89 
was placed into the EM map and the Pol II clamp and stalk regions, as well as TFIIA, TFIIF† and 
peripheral regions in Rpb3, Rpb6, Rpb8, Rpb9 and Rpb12 were adjusted as rigid bodies. The 
model of TFIIB was extended in the B-linker and B-reader regions based on the Pol II-TFIIB 
crystal structureø76 (PDB code 4BBR). Homology models for TFIIE subunits Tfa1 and Tfa2 were 
generated based on the H. sapiens crystal structures of TFIIE311  (PDB code 5GPY) and flexibly 
fitted into the TFIIE density, replacing the previous TFIIE modelø. The S. cerevisiae cMed 
homology model was adapted from the previously generated homology model of the S. pombe 
cMed crystal structure247 (PDB code 5N9J). To improve the fit to the EM map, cMed was divided 
into seven rigid bodies (head module, knob, hook-connector, plank, beam RWD1-UBC1, beam 
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RWD2 and beam UBC2) that were placed in the density individually†. Downstream DNA was 
generated by placing three pieces of ideal B-DNA into the density, connecting these in COOT and 
performing alternating rounds of real space refinement with secondary structure restraints and 
geometry optimization in PHENIX312. For a summary on structural modeling of proteins, see 
Tables 8.2 and 8.3.  
We generated a conservative model of S. cerevisiae TFIIH with the use of available 
structural information. Models of domains were first derived based on structures of TFIIH 
homologues from different species and on other structures with regions of partially related 
sequences. Homology models were generated for the Tfb1 BSD1 and BSD2 domains, for the 
three Tfb2 helix-turn-helix motifs, for the Tfb3 RING-finger, for the Tfb4 vWA-fold, for the 
eZnF domains in Tfb4 and Ssl1, and for the Ssl1 RING-finger. These models were derived from 
the H. sapiens NMR structure of the BSD1 domain (PDB code 2DII), the Staphylococcus aureus 
CadC crystal structure313 (PDB code 1U2W), the H. sapiens MUS81 NMR structure314 (PDB code 
2MC3), the Pyrococcus furiosus TrmBL2 crystal structure315 (PDB code 5BOX), the NMR 
structure of the H. sapiens Mat1 RING-finger210 (PDB code 1G25), the crystal structure of the H. 
sapiens p34 vWA-fold181 (PDB code 4PN7), the crystal structure of a H. sapiens E3 ubiquitin 
ligase (PDB code 3LRQ), the crystal structure of P. furiosus rubrerythrin316 (PDB code 1NNQ) 
and the NMR structure of the H. sapiens p44 RING-finger182 (PDB code 1Z60), respectively. In 
addition, two 3-helix bundle domains, one located at the C-terminus of Tfb1 (residues 543-639) 
and one located C-terminally of the Tfb3 RING-finger (residues 71-145) were modeled ab initio 
using the QUARK server317. Together with the crystal and NMR structures of the Tfb1 PHD183 
(PDB code 1Y5O), the Tfb2-Tfb5 dimerization domains192 (PDB code 3DGP) and the vWA-fold 
of Ssl1179 (PDB code 4WFQ), the homology and ab initio models listed above were placed into 
the density and rigid-body adjusted. If the correct position of models could not be deduced from 
the electron density directly, placement was performed on the basis of BS3- and SBAT-derived 
crosslinks that had been published101,190,201 or EDC-derived crosslinks obtained in this study (Fig. 
8.12).  
Several homology models were subjected to conservative modifications, in particular 
minor truncations, short α-helical extensions and positional corrections, to improve their fit to the 
electron density manually. The S. cerevisiae crystal and NMR structures exhibited a good fit to 
the electron density and did not require modification with the exception of the Tfb1 PHD that was 
C-terminally extended (residues 115-121). Homology models for the ATPases Rad3 and Ssl2 
were generated from crystal structures of their Thermoplasma acidophilum208 (PDB code 2VSF), 
Archaeglobus fulgidis107 (PDB code 2FWR) and H. sapiens209 (PDB code 4ERN) homologues. 
The models were split into their domains (Rad3: lobe 1, FeS-cluster, ARCH and lobe 2; Ssl2: lobe 
1 and lobe 2) and placed individually into the electron density. Lobe 1 and lobe 2 of Rad3 did not 
require further adaptation. The FeS-cluster was placed by superpositioning the T. acidophilum 
Rad3 structure onto the TFIIH model in COOT and extracting the coordinates of the Fe and S 
atoms. A backbone model of the ARCH domain was generated with Gorgon318,319 and used as an 
additional input to calculate a second homology model, which then was adjusted to the density. It 
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accounted for an evolutionary difference between S. cerevisiae and T. acidophilum that had 
resulted in an extension of two α-helices and an insertion of one α-helix and a loop (residues 255-
347). In the Ssl2 homology model an additional α-helix (residues 468-481) was placed into well-
defined density substituting for an initially unstructured stretch of residues. Two loops (residues 
426-451, 692-702) with significant deviation from the EM density were manually adjusted. The 
location of four Tfb1 α-helices (residues 308-330, 369-394, 465-483 and 495-519) and two TFIIE 
α-helices (residues 267-289 and 349-373) was confirmed by XL-MS analysis as described above 
and the respective α-helices were placed into the corresponding density. The TFIIE acidic region 
(residues 407-417) interacting with the PHD of Tfb1 was modeled based on the NMR structure of 
the H. sapiens TFIIE C-terminal region bound by the PHD of p62102 (PDB code 2RNR). 
Additionally, a few linkers and α-helical regions within TFIIH subunits Tfb1 (residues 219-251, 
295-307, 331-353 and 484-494), Tfb2 (residues 3-40, 113-159, 195-214, 380-419 and 433-450), 
Tfb4 (residues 89-97, 103-114 and 257-273), and Ssl1 (residues 308-324 and 373-386) which 
could be clearly traced in the EM maps and assigned respectively were built de novo. Lastly, one 
of the clutch domains, consisting of four β-strands and one α-helix, was built de novo. Owing to 
the limited resolution of the EM maps in this region, however, the secondary structure elements in 
the domain could not be assigned to the two adjacent TFIIH subunits Tfb2 and Ssl2 with 
confidence‡. To address these concerns the modeled clutch domain was assigned to a newly 
introduced and unrelated chain Z. Residues with any probability to deviate from the indicated 
sequence register, i.e. all residues in the de-novo built elements, were denoted as UNK in the 
deposited PDB model.  
The model fit to the EM maps was further optimized by iterative rounds of flexible fitting 
with vmd320 and MDFF321. Each flexible fitting procedure was divided in three simulation steps, 
starting with a simulation at room temperature, followed by a cooling step to 0 K and a third step 
in which the simulation was performed at 0 K. Flexible fitting was performed without domain 
restraints for small units and with domain restraints once models had been combined into larger 
entities. 
Density-adjusted PIC and PIC-cMed models were refined using the geometry 
minimization routine in PHENIX312 with applied secondary structure and rotamer restraints. A 
brief overview of EM data collection, data processing and model statistics for the final PIC and 
PIC-cMed models is provided in Table 8.4. Figures were generated using UCSF Chimera297. 
 
† Modeling was performed by M. Hantsche. 
ø Modeling was performed by C. Dienemann. 
‡ The possibility of a domain swap by a β-strand exchange between Tfb2 and Ssl2 could not be excluded. 
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5 Results 
 
5.1 Preparation and assembly of recombinant TFIIH 
 
Since the discovery of the TFIIH complex more than two decades ago193 its preparation has 
remained a tedious and inefficient process despite a plethora of biochemical and biophysical 
studies145,148 aiming to elucidate its structural and functional properties. To date, TFIIH is 
obtained primarily from endogenous sources, such as HeLA and yeast cells, and purified by 
affinity and immuno-affinity chromatography techniques85,165. These standard approaches require 
large quantities of input cell material and yield comparatively little and partially inhomogeneous 
protein. Although efforts to express H. sapiens TFIIH recombinantly in insect cells were 
successful in principle203,204, large-scale production schemes, which would permit further 
extension of the structural and in-vitro analyses of the complex, have not been established. As a 
consequence, the first step towards a more profound, high-resolution structural characterization of 
TFIIH and its assemblies, like the transcription initiation machinery, must be the development of 
an efficient strategy for the recombinant production of high-quality TFIIH samples. 
 
5.1.1 Dissection of the protein network in core-TFIIH 
 
Initial experiments were focused on the analysis of interactions within TFIIH and on the 
identification of targets for crystallization experiments, whereas the assembly of complete 10-
subunit TFIIH and its incorporation into the initiation complex was defined as a future goal.  
The recombinant expression of TFIIH subunits and small subcomplexes was first tested in 
E. coli after transformation with the respective pET-MCN plasmids (Methods, Table 3.4). 
Experiments revealed that all subunits except for those with enzymatic function (Kin28, Rad3, 
Ssl2) could be produced in bacteria. With the exception of Tfb1, the proteins were obtained in 
soluble form either untagged or after introduction of N-terminal Ulp1-cleavable 6×His-tags 
(6×His-SUMO). The solubility of Tfb1 was dependent on the presence of Ssl1, confirming the 
intimate physical interaction between these subunits155,322 (Fig. 5.1 a). Pairwise co-expression 
coupled with subsequent pulldown interaction assays further confirmed the previously 
characterized interactions between Ssl1 and Tfb1, and between Tfb2 and Tfb5192,322. In addition, 
the formation of a predicted Ssl1-Tfb4 dimer323 was observed and Tfb2 was newly identified as a 
direct binding partner of Ssl1 and Tfb4 (Fig. 5.1 a, b). These findings provided better insight into 
the protein network within core-TFIIH and, in combination with prior analyses121,165,198,203,205, 
suggested a strategy for reconstitution of the holo-complex. While ‘minimal core-TFIIH’, 
encompassing Ssl1, Tfb1, Tfb2, Tfb4 and Tfb5, was to be co-expressed in E. coli cells and 
purified as one complex, the catalytic subunits Rad3 and Ssl2 would be produced in a different 
expression system, purified separately and assembled with minimal core-TFIIH into full, 7-
subunit core-TFIIH. The TFIIH kinase module was to be prepared as an isolated complex based 
on previously reported strategies324. 
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Figure 5.1 | Dimeric complexes within core-TFIIH. a, Ssl1 co-expression enhances solubility of Tfb1. Comparison of 
protein levels during expression and pulldown of 6×His-SUMO-Tfb1 in isolation (left) and in complex with Ssl1 (right) by 
SDS-PAGE analysis. Tfb1 is detected only in presence of Ssl1. Pulldowns were performed with Ni-NTA agarose resin. 
Sample fractions are indicated (P, pellet; SN, supernatant; E, elution) and a molecular weight standard is depicted on the left. 
b, Binary interaction assays identify prominent dimers within core-TFIIH. Various pairs of TFIIH subunits comprising one 
6×His-SUMO-tagged and one untagged subunit were co-expressed. Dimer complexes obtained by affinity pulldown with Ni-
NTA agarose resin are marked with dashed red outlines. Protein levels were analyzed by SDS-PAGE and protein identity 
was confirmed by mass spectrometry (MS). Labels as described in a. S, 6×His-SUMO. 
 
5.1.2 Preparation of recombinant minimal core-TFIIH and initial crystallization trials 
 
In addition to its proposed role for the assembly of 7-subunit core-TFIIH, minimal core-TFIIH 
appeared to be a reasonable target for crystallization. The pentameric complex was ultimately 
produced from E. coli cells that had been co-transformed with a pET-MCN vector comprising the 
genes for Ssl1, Tfb2, Tfb4, and Tfb5 and a second pET-MCN vector carrying the Tfb1 gene 
(Table 3.4). Incorporation of the Tfb1 gene in the multi-cistronic construct and co-expression of 
all five proteins from one plasmid had resulted in poor yields for Tfb1, regardless of its position 
within the transcript. All proteins were expressed as SUMO-tagged versions with enhanced 
solubility. A three-step purification scheme for preparation of minimal core-TFIIH was 
established. The purified complex was stable during size exclusion chromatography (SEC) in low-
salt conditions and contained all subunits in apparently stoichiometric amounts (Methods, Fig. 
5.2). Truncations of minimal core-TFIIH were generated based on reported domain assign-
ments190,280, the prediction of secondary structure elements (SSEs) and on limited proteolysis 
experiments. These suggested the removal of N- and C-terminal stretches in Ssl1, Tfb1 and Tfb4 
as well as deletion of internal loops in Ssl1, Tfb1, Tfb4 and Tfb2. The most truncated minimal 
core-TFIIH version to retain complex stability during purification and final SEC encompassed 
Ssl1∆1-91, Tfb1∆1-164, Tfb2, Tfb4∆1-17∆323-338 and Tfb5 (Methods, Fig. 5.2). 
Extensive crystallization trials (Methods) remained unsuccessful despite testing of 
distinctly truncated core-TFIIH variants in various buffer conditions (TRIS, HEPES, pH range 
6.8-8.5) and with different salt (NaCl, KCl, KOAc) concentrations (50-300 mM). Although initial 
crystals were yielded in rare cases, these were irreproducible or identified as salt crystals during 
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in-situ diffraction screening on a PX scanner (Rigaku). Additional internal loop deletions were 
attempted but never experimentally executed as the project’s focus was shifted to the production 
of complete 10-subunit TFIIH and its incorporation into the transcription initiation complex. 
 
 
 
Figure 5.2 | Preparation of recombinant minimal 
core-TFIIH. Analysis of purified minimal core-TFIIH 
complexes by SEC and SDS-PAGE revealed formation 
of homogeneous complexes with apparently 
stoichiometric subunits. An impurity in the full-length 
complex (top), which was identified as an N-terminal 
degradation product of Tfb1 by MS, is indicated by an 
asterisk. The most truncated stable minimal core-TFIIH 
version (bottom, truncations abbreviated as ∆N or ∆C) 
contains highly pure subunits. Protein identity was 
confirmed by MS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1.3 Preparation of Rad3 and Ssl2 
 
In addition to minimal core-TFIIH, which had been obtained successfully, the ATPases Ssl2 and 
Rad3 were required for the assembly of 7-subunit core-TFIIH. Previous studies involving their 
archaeal and H. sapiens homologues107,175,204,208,209 suggested that recombinant production of the 
S. cerevisiae proteins in insect cells was feasible. Multiple Series-438-based Ssl2- and Rad3-
constructs were generated and proteins were expressed in Hi5 cells after baculovirus infection. 
Various tags and solubility enhancers, such as 6/8×His-3C/SUMO/TEV-, 6×His-MBP- or GST-
tags, as well as N- and C-terminal tag positions were tested. However, although most variants 
were well expressed, the isolated proteins remained essentially insoluble or were present in 
solution only in form of multivariate aggregates despite the usage of S. frugiperda codon-
optimized constructs and the performance of extensive buffer screens. These results indicated that 
Rad3 and Ssl2 required their natural binding partners as chaperones for solubility in yeast. 
Consequently, complete 7-subunit core-TFIIH had to be obtained as a singe complex by co-
expression in insect cells, thereby rendering the production of minimal core-TFIIH in E. coli cells 
obsolete.  
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5.1.4 Preparation of recombinant core-TFIIH complexes  
   
The basic trials for baculovirus-mediated expression of TFIIH subcomplexes in insect cells 
were performed with constructs for a 6-subunit ‘reduced’ core-TFIIH assembly, which 
comprised Ssl1, Ssl2, Tfb1, Tfb2, Tfb4 and Tfb5 but lacked Rad3 (‘core-TFIIHΔRad3’). This 
subunit was initially excluded to decrease the number of respectively co-expressed subunits 
and thus the variables for construct generation. Moreover, a strong affinity of Rad3 for the 
TFIIH kinase module had been reported105,164 and it remained elusive whether the absence of 
this interaction in core-TFIIH would affect recombinant protein production or complex 
solubility. Co-expression vectors were compiled using a parallelized semi-high-throughput 
LIC-based cloning strategy (Methods). Literature165, SSE predictions and previous results 
suggested the placement of affinity tags on Ssl1, Tfb1 or Tfb4. Series-438 plasmids, which 
contained 3C- and SUMO-tags or TEV-cleavable (6×His-)MBP- and 6×His-tags on the genes 
for these subunits, were analyzed by co-expression tests in Hi5 insect cells and subsequent 
pulldown and interaction assays (Methods). In these experiments intact though partially 
heterogeneous complexes were obtained, indicating that core-TFIIHΔRad3 formed a stable 
assembly.  
 
Figure 5.3 | Beneficial effects of 6×His-MBP-tags on 
core-TFIIHΔRad3 expression and purity. a, Addition 
of a 6×His-MBP-tag enhances Ssl2 expression. 
Comparison of Ssl2 expression levels of core-
TFIIHΔRad3 constructs comprising 6×His-MBP-tags on 
either Tfb1 (left lane) or on Tfb1 and Ssl2 (right lane). 
A significantly larger amount of Ssl2 was produced if it 
was additionally tagged. Whole-cell-extract (WCE) 
samples were analyzed by SDS-PAGE. A molecular 
weight standard is provided on the left. b, Use of MBP-
tags in affinity pulldowns yields near-pure protein 
sample. Affinity assays with a core-TFIIHΔRad3 
construct comprising a 6×His-MBP-tag on Ssl2 were 
performed with equal input sample (SN) but utilizing 
either Ni-NTA agarose (Ni; lanes 3+4) or amylose 
(MBP; lanes 5+6) resin. A small amount of near-pure core-TFIIHΔRad3 complex was obtained after elution from amylose 
resin. Proteins in the Ni-NTA agarose elution fraction were more abundant but the core-TFIIHΔRad3 complex was 
significantly contaminated. Overall low yields of the assay indicate poor accessibility of the affinity tag on Ssl2. Protein 
levels were analyzed by SDS-PAGE. Labels as described in Fig. 5.1. 
 
As Ssl2 was produced in significantly smaller amounts than other components of core-
TFIIHΔRad3, the expression ratio between Ssl2 and the remaining subunits was optimized by 
introduction of a 6×His-MBP-tag (Fig. 5.3 a), which additionally enhanced protein solubility. 
Although the use of MBP-tags yielded almost pure protein in one affinity step, the 6×His-
MBP-tag on Ssl2 was not sufficient to retain the complex efficiently in affinity assays, 
possibly due to poor accessibility of the maltose-binding site (Fig. 5.3 b). Thus, ultimately a 
co-expression construct comprising (6×His-)MBP-tags on the Ssl1 and Ssl2 genes was 
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selected for large-scale preparation (Fig 5.4 a, Table 3.4). Proteins were purified by a four-
step strategy, yielding an apparently stoichiometric 6-subunit complex that was stable during 
SEC in low-salt conditions (Methods, Fig. 5.4 b). 
Figure 5.4 | Preparation of recombinant 6-subunit core-
TFIIH complexes. a, Initial affinity assays of core-
TFIIHΔRad3 and core-TFIIHΔSsl2 constructs, which were 
subsequently used for large-scale purification. A complete 
set of subunits was detected in the respective elution 
fractions. Affinity assays were performed with amylose 
resin for core-TFIIHΔRad3 due to the lack of a well-
accessible 6×His-tag, and Ni-NTA agarose resin for core-
TFIIHΔSsl2. Samples were analyzed by SDS-PAGE. Elution 
fractions were treated with Ulp1 (15 min, 4°C) before analysis, resulting in cleavage of residual 6×His-SUMO tags. Labels as 
described in Fig. 5.1. b, Purified core-TFIIHΔRad3 and core-TFIIHΔSsl2 complexes. Analysis of recombinant TFIIH assemblies 
by SEC and SDS-PAGE revealed formation of pure and homogeneous complexes with apparently stoichiometric subunits. 
Protein identity was confirmed by MS. 
 
Initial constructs for the preparation of 7-subunit core-TFIIH were generated based on the core-
TFIIHΔRad3 expression vector, which was extended by addition of 6×His-MBP-Rad3 by LIC 
(Methods). However, application of the established protocols resulted in poor expression and low 
yields of core-TFIIH (< 20 µg / 1 L cell culture), suggesting adverse effects of the MBP-tags on 
Rad3, Ssl1 or Ssl2 in context of the 7-subunit complex. Consequently, the semi-high-throughput 
screening approach, which had permitted identification of an optimized core-TFIIHΔRad3 
expression plasmid, was also applied to evaluate prospective 7-subunit core-TFIIH constructs. 
The analyses revealed that the 6×His-MBP-tag on Rad3 was poorly accessible and, more 
importantly, partially resistant to removal by TEV-cleavage. These observations indicated 
unanticipated co-/ or mis-folding events between MBP and Rad3. Indeed, the removal of tags 
from both Rad3 and Ssl2 ultimately proved to be a key step for the production of high-quality 
core-TFIIH. Moreover, tags on the Ssl1 subunit appeared to be incompatible with presence of 
Rad3 in the 7-subunit complex, possibly as a side effect of the intricate association between the 
ATPase and Ssl1173. Thus, the finally selected co-expression vector comprised a single 6×His-
MBP-tag on Tfb4. In addition, S. frugiperda codon-optimized versions of the Rad3 and Ssl2 
genes were introduced, which provided increased expression rates of the ATPases with respect to 
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the affinity-tagged subunit (Table 3.4). The components of core-TFIIH were co-expressed and 
purified as described for core-TFIIHΔRad3 (Methods) and the 7-subunit complex was stable during 
SEC in buffers containing 5% glycerol (Fig. 5.5). 
To obtain a counterpart to core-TFIIHΔRad3 for activity tests, a construct for ‘core-
TFIIHΔSsl2’, a 6-subunit complex which lacked Ssl2, was generated. This co-expression vector 
was identical to the one assembled for core-TFIIH but lacked the Ssl2 gene (Fig 5.4 a, Table 3.4). 
The complex was prepared according to previously established strategies. During purification, 
core-TFIIHΔSsl2 displayed characteristics that resembled 7-subunit core-TFIIH more than core-
TFIIHΔRad3 (Fig 5.4 b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 | Preparation of recombinant TFIIH. Analysis of purified TFIIH core and kinase modules by size-exclusion 
chromatography and SDS-PAGE revealed high purity and homogeneity of the complexes with apparently stoichiometric 
subunits. SDS-PAGE analysis of fractions 1-13 of a sucrose gradient centrifugation after reconstitution of TFIIH from 
purified core and kinase modules. A shift in the bands originating from the subunits of the kinase module (Ccl1, Kin28 and 
Tfb3) by four fractions was detected, indicating formation of complete TFIIH. This experiment was repeated three times with 
equivalent results. Figure 5.5 and the corresponding figure legend are excerpts from Schilbach et al.292, as indicated on page 
VI. 
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In addition to core-TFIIH, which had been successfully retrieved, the TFIIH kinase module was 
required for the assembly of 10-subunit TFIIH. According to literature324, co-expression of the 
three subunits Ccl1, Kin28 and Tfb3 was a well-established process. Since the catalytic subunit 
was likely to be a limiting factor during preparation, the Kin28 gene was fused with a 6×His-
MBP-tag when expression vectors were generated by LIC (Methods). Applying the previously 
described screening approach, distinctly tagged versions of Tfb3 and Ccl1 were co-expressed with 
6×His-MBP-Kin28 and assessed in pulldown interaction assays. The construct for large-scale 
production was selected based on the final ratio between kinase, cyclin and the accessory factor 
Tfb3. It comprised cleavable 6×His-(3C/SUMO)-tags on Tfb3 and Ccl1, which, however, were 
not used during purification. The applied purification scheme was adapted from the four-step 
strategy for core-TFIIH preparation and yielded a stoichiometric complex that was stable during 
SEC in very low salt conditions (Methods, Fig. 5.5).   
10-subunit holo-TFIIH was reconstituted from the 7-subunit core and the 3-subunit kinase 
modules and isolated in a sucrose gradient (Methods, Fig. 5.5). Similar approaches involving size 
exclusion chromatography were ineffective. A 1.3x excess of kinase module was sufficient for 
TFIIH complex formation. 
 
5.1.5 Activity assays 
 
To test the catalytic activity of the recombinant TFIIH core and kinase modules, enzymatic assays 
were performed. A CTD-phosphorylation assay (Methods) with a dephosphorylated Pol II 
substrate was applied to test the functionality and specificity of the isolated kinase module (Fig. 
5.6). An increase in phosphorylation was detected for all analyzed residues (Tyr1, Ser2, Ser5 and 
Ser7) of the Pol II CTD, indicating enzymatic activity of the trimeric complex. In addition, the 
kinase module exhibited substrate specificity and phosphorylated primarily Ser5- and, to a lesser 
extent, Ser7 residues. Ser2 and Tyr1 residues displayed an unexpected, albeit significantly 
weaker, increase in phosphorylation levels, which may be attributed to unspecific phosphorylation 
events or antibody cross-reactivity. Although a direct comparison between phosphorylation levels 
of different residues is problematic since no quantification was performed, the obtained results 
appear to be generally consistent with literature19. However, it cannot be excluded that the 
specificity of the kinase module is altered in context of 10-subunit TFIIH or the complete 
initiation machinery. 
The ATPase activities of Ssl2 and Rad3 were separately assayed utilizing the core-
TFIIHΔRad3 and core-TFIIHΔSsl2 constructs (Methods). Reflecting their distinct substrate 
specificities, dsDNA and ssDNA substrates were provided for core-TFIIHΔRad3 and core-
TFIIHΔSsl2, respectively. Consistent with literature, both constructs exhibited enzymatic activity 
and hydrolyzed ATP109,325, suggesting a correct fold of the ATPases within the 6-subunit 
complexes. ATP hydrolysis rates were not determined. 
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Figure 5.6 | Recombinant TFIIH kinase module is 
catalytically active and selectively phosphorylates the Pol II 
CTD. Analysis of the Pol II CTD phosphorylation state by 
western blot. Specific antibodies against the Tyr1, Ser2, Ser5 
and Ser7 residues in the CTD of the Pol II subunit Rpb1 were 
utilized to monitor relative levels of CTD phosphorylation over 
a 180 min period. Although phosphorylation levels gradually 
increased for each analyzed residue, the TFIIH kinase module 
preferentially targeted Ser5- and Ser7 residues. The Pol II 
subunit Rpb3 was loaded as a control.  
 
 
 
 
 
5.2 Optimization of initiation complex assembly and initial negative stain 
EM analysis 
 
Once protocols for the preparation of recombinant TFIIH were being established and the complex 
was becoming available for structural investigation, appropriate targets and techniques for its 
analysis were specified. Although originally defined as a long-term goal, ultimately the 
incorporation of 10-subunit TFIIH into the transcription initiation machinery was attempted. To 
this effect a cMed-containing pre-initiation (PIC-cMed) complex was to be formed and its 
structure was to be determined by cryo-EM. Related transcription initiation complexes had been 
subjected to cryo-EM previously86,88,89,101, thereby providing initial guidance on sample 
preparation. Due to the complexity and sheer size of such an assembly, however, the existing 
reconstitution approaches had to be re-evaluated and optimized. 
 
5.2.1 Complex preparation by gradient centrifugation with optimized TFIIE excess 
 
Owing to the fragility and sensitivity of macromolecular initiation complexes, an altered protocol 
for their assembly and isolation, which involved their sedimentation in a sucrose gradient, was 
established (Methods)†. Using this technique, stable and apparently perfectly stoichiometric 
samples were reproducibly obtained. In addition, this method permitted a significant reduction of 
the molar excess of TFIIE over the limiting factor Pol II during initiation complex reconstitution, 
which was demonstrated for the cPIC-cMed complex (Fig. 5.7). Instead of a 10x molar excess of 
TFIIE, as claimed in the original SEC-based approach89, only a 2x molar excess was required for 
assembly of a stoichiometric cPIC-cMed complex in a 15-30% sucrose gradient. Since TFIIH is 
recruited to the PIC primarily by TFIIE100 equimolar amounts of TFIIH were found to be 
sufficient as input for formation of the PIC-cMed complex, thus greatly facilitating sample 
preparation.  
 
† Initial trials of sucrose gradient centrifugation with cPIC complexes were performed by C. Dienemann. 
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Figure 5.7 | Reconstitution of cPIC-cMed complexes with 10x and 2x molar excess of TFIIE. SDS-PAGE analysis of 
fractions 1-18 of 15-30% sucrose gradient centrifugations. Stoichiometric cPIC-cMed complexes were successfully 
assembled with 10x (top) and 2x (bottom) molar excess of TFIIE. Other cPIC-cMed components were added as described 
(Table 8.1). TFIIE subunits (Tfa1, Tfa2) are highlighted. Tfa1 and Tfa2 are present in apparently identical amounts in both 
reconstituted cPIC-cMed complexes. 
 
5.2.2 Initial analysis of a PIC-cMed complex variant by negative stain EM 
 
The optimized sucrose gradient protocol was initially tested with a TFIIH-containing sample 
during assembly of an incomplete PIC-cMed complex that comprised core-TFIIHΔRad3, the first 
recombinant construct to become available. The components were reconstituted according to the 
scheme that was designed for formation of the complete PIC-cMed complex (Table 8.1) but a 15-
30% sucrose gradient was applied for sedimentation. The obtained ‘PICΔRad3ΔTrimer’ complex 
contained subunits in stoichiometric amounts except for core-TFIIHΔRad3, which appeared to be 
present in excess (Fig. 5.8 a), possibly owing to unspecific interactions with DNA. To determine 
whether the TFIIH subcomplex remained stably associated with cPIC-cMed, the sample was 
subjected to negative stain EM (Methods). The collected micrographs revealed well-distributed 
particles with distinct shapes, indicating a large variety of orientations and a good angular 
distribution (Fig. 5.8 b). A small dataset was collected and processed, resulting in a 3D-
reconstruction of the complex at ~30 Å resolution. Comparison with the cryo-EM map of the 
cPIC-cMed complex (EMDB accession EMD-2786)88 revealed the presence of additional density 
that presumably corresponded to a monomer of the 320 kDa core-TFIIHΔRad3 complex (Fig. 5.8 c) 
with several flexible regions. Based on these positive results, the reconstitution of the complete 
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PIC-cMed complex and its structural analysis by cryo-EM were performed immediately upon 
retrieval of the recombinant TFIIH core and kinase modules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 | Negative stain EM analysis of the PICΔRad3ΔTrimer complex. a, Complex formation. SDS-PAGE analysis 
of fractions 1-19 of a 15-30% sucrose gradient centrifugation after reconstitution of the PICΔRad3ΔTrimer complex. The gel 
indicates successful assembly of a largely stoichiometric complex, containing 1.5-2x excess core-TFIIHΔRad3. TFIIH subunits 
(Ssl1, Ssl2, Tfb1, Tfb2, Tfb4, Tfb5) are highlighted. b, Representative negative stain EM micrograph. A scale bar is 
provided. c, 3D-reconstruction of the PICΔRad3ΔTrimer complex. Comparison of the obtained EM density (grey) with the 
cryo-EM map of the cPIC-cMed complex (green, filtered to 30 Å) reveals additional density. Complexes are viewed from the 
front255. 
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5.3 Reconstitution and structural characterization of transcription pre-
initiation complexes with TFIIH and Mediator 
 
The results presented in this section were published in: 
 
Schilbach, S., Hantsche, M., Tegunov, D., Dienemann, C., Wigge, C., Urlaub, H. & Cramer, P. 
Structures of transcription pre-initiation complex with TFIIH and Mediator. Nature 551, 204-209 
(2017). 
 
The following text, as well as figures and figure legends reflect the contents of the publication in 
unaltered form with the exception of literature references, figure and table numbers and their 
respective references. These elements have been adapted to the format of this work.  
Extended Data Fig. 1 Panel a) of the publication was re-assigned to Section 5.1, Fig. 5.5 for 
clarity of the text flow, as indicated. This item is therefore missing from Section 5.3. Extended 
Data Fig. 1 Panel b-d) of the publication were re-assigned to Fig. 5.9 a-c. 
A detailed list of published items is also provided on page V. 
 
References to supplementary videos and supplementary data were removed, as the respective files 
are not available with the printed version of this work.  
 
5.3.1 Structures of the PIC and PIC-cMed complex 
 
Thus far, TFIIH was purified in small quantities from natural sources. To overcome this 
limitation, we prepared both TFIIH modules in recombinant form after co-expressing their 
subunits (Methods, Fig. 5.5). The two modules contained TFIIH subunits in apparently 
stoichiometric amounts and could be assembled into the complete 10-subunit TFIIH. 
Reconstituted TFIIH formed a stable complex with cPIC and cMed. The resulting 46-subunit PIC-
cMed complex was subjected to cryo-EM data collection (Methods, Fig. 5.9 a, b). Unsupervised 
particle sorting led to cryo-EM reconstructions of the PIC and PIC-cMed complex at nominal 
resolutions of 4.7 Å and 5.8 Å, respectively (Fig. 5.10 a-d). 
Secondary structure was visible in maps obtained with RELION299 after focused 
refinement on cPIC, TFIIH or cMed. To reconstruct continuous cryo-EM maps from particles 
with such flexible regions, we developed a computational tool, ‘WarpCraft’ (Methods). 
WarpCraft represents maps as pseudo-atomic models and simulates restrained motions between 
flexible map regions. This avoids the spatial divergence of separate focused refinements, and can 
make the construction of composite maps obsolete. Thus we obtained cryo-EM maps that 
revealed highly defined secondary structure throughout the PIC and PIC-cMed complex.  
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Figure 5.9 | Preparation of the PIC-cMed complex. a, Assembly of complexes. SDS-PAGE analysis of fractions 1-19 of 
15-40% sucrose gradient centrifugations (Methods). Labeling of protein subunits according to the color scheme in Figs 5.11 
and 5.13. The analysis demonstrates successful formation of the cPIC, cPIC-cMed and PIC-cMed complexes (top to bottom). 
Bands originating from Pol II, cMed and TFIIH are shifted by several fractions, indicating formation of higher-order 
complexes. Subunits are present in apparently stoichiometric amounts. This experiment was repeated three times with 
equivalent results. b, Representative cryo-EM micrograph of the PIC-cMed complex. A scale bar is provided. c, 2D-class 
averages reveal 2D reconstructions from particles with clear signal for TFIIH and/or cMed adjacent to the centrally located 
Pol II density. A scale bar is provided. 
Results 
 
	 70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 | Cryo-EM data processing and quality of reconstructions. a, Particle sorting and classification tree used for 
3D reconstruction of the PIC and PIC-cMed complex at nominal resolutions of 4.7 Å and 5.8 Å, respectively. The distinct 
branches of the classification tree (Methods) are highlighted in pink (PIC) and blue (PIC-cMed). In a conventional focused 
refinement approach in RELION299,300, the best-resolved PIC class was reconstructed with a local TFIIH mask, resulting in a 
focused map with a nominal resolution of 7.4 Å (green branch) that was not deposited. b, Two views of the final 
reconstructions of PIC and PIC-cMed colored according to local resolution89. The colour scheme is indicated. c, Fourier shell 
correlation (FSC) between half maps of the final reconstructions of PIC and PIC-cMed. Resolutions for the gold-standard 
FSC 0.143 criterion are listed. For comparison of distinct regions within PIC and PIC-cMed reconstructions, FSC 0.143 was 
additionally calculated using local masks. d. Angular distribution plot for all particles in the final reconstructions of PIC and 
PIC-cMed. Color shading from blue to yellow correlates with the number of particles at a specific orientation as indicated. 
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To solve the PIC structure (Fig. 5.11), we first fitted our cPIC structure89 to the density and made 
minor adjustments to TFIIB, the TFIIE subunits Tfa1 and Tfa2, and the Pol II clamp. The PIC 
adopts the open promoter state with unwound DNA in the active center as before89. Structures and 
models for 22 TFIIH domains were unambiguously fitted to the remaining density (Table 8.2). 
Eleven connections within and between TFIIH domains were traced and the obtained model was 
refined by flexible real space fitting (Methods). The TFIIH structure is consistent with 153 known 
protein-protein crosslinks obtained with bis(sulfosuccinimidyl) suberate (BS3) and 1,1′-
(suberoyldioxy)bisazabenzotriazol) (SBAT)101,190,201, and with additional 55 crosslinks obtained 
with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) (Fig. 5.12 a-d, Tables 
8.5, 8.6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11 | Structure of the Pol II PIC. Two views255 of the yeast PIC cryo-EM structure. The DNA template and non-
template strands are in dark and light blue, respectively. Positions of TFIIH subunits are indicated. Dashed lines represent 
flexible linkers in TFIIE and TFIIF. The color code is used throughout. 
 
 
Results 
 
	 72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 | EDC crosslinking analysis of PIC-cMed. a, EDC-derived inter-subunit crosslinks between selected subunits 
in the PIC-cMed complex. Observed crosslinks are consistent with the structure of the cPIC and with positions of previously 
reported BS3- and SBAT-crosslinks. Color code as indicated. b, EDC-crosslinks observed in TFIIH and between TFIIH and 
cPIC. Intra- and inter-subunit crosslinks are depicted as blue and black lines, respectively. Crosslinks between the TFIIE 
Tfa1 C-terminal region and Tfb1, Tfb2 and Ssl1 confirm interactions between TFIIE elements and TFIIH. c, Crosslinking 
hub of the Tfb1 N-terminal region. Ribbon representation of Tfb1 (residues 1-353, 369-394 and 544-639) and the 
surrounding domains of Rad3, Ssl1 and Tfb4. BS3-/SBAT- and EDC-derived crosslinks are depicted in red and black, 
respectively. The displayed crosslinks aided modeling of the Tfb1 PHD, BSD1, BSD2 and Rad3 anchor domains into the 
cryo-EM density. d, Statistical analysis of EDC-derived crosslinks. Most observed crosslinks are within a cutoff Cα distance 
of 16 Å. Cα distances of up to 21 Å may be attributed to flexibility of the involved residues and the coordinate error of the 
model. Some outliers with Cα distances of 22-30 Å were observed for the well-defined cPIC and Rad3 structures and may 
have originated from over-crosslinking of particles. 
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To solve the PIC-cMed structure (Fig. 5.13), we placed the generated PIC model into the PIC–
cMed cryo-EM map. We then fitted the remaining density with the S. cerevisiae cMed model 
obtained from the S. pombe crystal structure247. We obtained a model for the PIC-cMed complex 
after flexible real space fitting of seven rigid bodies in cMed and manual adjustments (Methods, 
Table 8.3). The DNA path is virtually identical in both new structures, highly similar in the yeast 
open cPIC89, and similar in the human open PIC86. The obtained PIC and PIC-cMed structures 
consist of atomic models where high-resolution structures were available (76% and 73%, 
respectively), and of backbone models for other parts of TFIIH and cMed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13 | Structure of the PIC-cMed complex. Two views of the PIC-cMed cryo-EM structure. The first view is 
rotated by 180° compared to the top view in Fig. 5.11. The second view is obtained by a 120° rotation around a horizontal 
axis. Mediator submodules within the head (blue) and middle (cyan) modules are indicated. 
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5.3.2 TFIIH structure 
 
The PIC structure reveals that the TFIIH core forms a crescent-shaped complex spanning from 
Ssl2 to Rad3 (Fig. 5.14 a, b, Fig. 5.15 a-k). Ssl2 binds downstream DNA as previously 
observed86,87,109, consistent with its role in DNA opening103. Rad3 is located approximately 40 Å 
away from DNA, in agreement with its ATPase activity being dispensable for transcription105. 
The TFIIH subunits Tfb5, Tfb2, Tfb4 and Ssl1 are arrayed in between the two ATPases. The Tfb1 
subunit meanders along Tfb4, Ssl1 and Rad3 and its plekstrin homology domain (PHD) protrudes 
from the crescent towards the Pol II clamp.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14 | Structure of TFIIH. a, Domain organization of yeast TFIIH subunits except Kin28 and Ccl1. Names of 
corresponding human subunits are in parentheses. Residue numbers are given for domain borders. Color saturation scales 
with the percentage of residues modeled as atomic or backbone structures (solid and dashed black bars, respectively). The 
highlighted RED motif is essential and strictly conserved throughout the XPB family. DRD, damage recognition domain; 
HTH, helix-turn-helix; NTE, N-terminal extension. b, TFIIH structure in cylindrical representation viewed from the side 
(Fig. 5.11). The DNA register with respect to the putative TSS +1 is indicated. 
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Figure 5.15 | TFIIH structure and quality of the cryo-EM density. See next page for legend. 
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Figure 5.15 | TFIIH structure and quality of the cryo-EM density. a, Schematic of TFIIH subunit and domain 
architecture with bound double-stranded DNA (dsDNA) using the top view. Flexible linkers are depicted as black lines. 
Prominent helices within the folds of the tethering subunit Tfb1 and in Tfb2 are highlighted. b, Top view of the TFIIH 
structure in cylindrical representation. Prominent domains are labeled. The DNA register with respect to the putative 
transcription start site +1 is indicated. c, Overall fit of PIC structure into final WarpCraft PIC reconstruction. Observed 
density for a few remaining regions that could be clearly assigned but were not modeled are highlighted as indicated in Table 
8.2. d, Fit of cPIC structure into final WarpCraft PIC reconstruction at a higher contour level than in c shows the high 
resolution of the map in this region. e, Fit of TFIIH model into final WarpCraft PIC reconstruction. EM map reveals 
secondary structure throughout. Observed density for regions that could be clearly assigned but were not modeled are 
highlighted (compare with Table 8.2). f-k, EM density (black mesh) for domains and subunits of TFIIH reveals secondary 
structure throughout. Loops and linkers were traced when continuous density between unambiguously placed models was 
observed. Depicted density is part of either the WarpCraft PIC reconstruction or a focused reconstruction with a local mask 
on TFIIH core unless indicated otherwise. l, Cryo-EM reconstruction of the PIC reveals side-chain density in well-ordered 
regions. Depicted are helical regions in the large Pol II subunit Rpb1. m, Fit of the PIC-cMed model into the final WarpCraft 
PIC-cMed reconstruction. Structures of cMed head and middle modules account for density within this region.  
 
 
The TFIIH core structure shows that the bilobal Ssl2 ATPase contains a C-terminal extension in 
lobe 2 that contacts Tfb5 in the Tfb2-Tfb5 dimerization module192. Ssl2 and Tfb2 interact via 
newly observed and partially modeled ‘clutch’ domains. Tfb2 further contains a region with three 
helix-turn-helix subdomains that binds Tfb4, which comprises a van Willebrandt (vWA) domain 
with an insertion and an extended zinc-finger (eZnF) domain. Like Tfb4, Ssl1 contains vWA and 
eZnF domains, and an additional RING domain. Tfb4 and Ssl1 interact intimately and form the 
backbone of TFIIH. Ssl1 also binds Rad3, a bilobal ATPase with two insertions in lobe 1, an iron-
sulfur (FeS) cluster, and an ARCH domain. Whereas the FeS cluster resembles that in 
homologous archaeal structures174,175,208, the ARCH domain contains an additional helix and two 
helix extensions. Tfb1 comprises an N-terminal PHD, two BTF2-like, synapse-associated and 
DOS2-like (BSD) domains326, helical regions that anchor Rad3 and Tfb4 (Rad3 anchor and Tfb4 
anchor, respectively), and a C-terminal 3-helix bundle that binds the two eZnF domains.  
Our TFIIH structure defines the orientation of eight domains in TFIIH subunits that were 
inferred by previous studies of the PIC86,87,101. It also reveals 15 additional domains, numerous 
connections, and details of domain interactions. Regions in TFIIH subunits that are essential for 
cell viability in yeast216 tend to be ordered in our structure (Fig. 5.16 a). The TFIIH structure also 
suggests the effect of mutations in human TFIIH subunits p8, XPB and XPD that are associated 
with the human diseases xeroderma pigmentosum, trichothiodystrophy and Cockayne 
syndrome148,160,161. Many of the mutated sites are predicted to destabilize the TFIIH core structure 
(Fig. 5.16 b). 
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Figure 5.16 | Location of essential regions in TFIIH and sites mutated in disease. See next page for legend. 
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 Figure 5.16 | Location of essential regions in TFIIH and sites mutated in disease. a, TFIIH regions essential for cell 
viability in yeast. Mapping of TFIIH regions identified to be essential in S. cerevisiae by in vivo deletion analysis216 on the 
PIC structure revealed that they are generally forming well-ordered regions of the TFIIH core. Structures are viewed from the 
top (Fig. 5.11) with regions colored in magenta or yellow if their removal caused cell lethality or growth defects, 
respectively. Affected TFIIH subunits and ranges of deleted residues are highlighted in colors according to Fig. 5.14. For 
deletions exceeding the modeled residue range, the last modeled residue is indicated in parentheses. b, Mapping of human 
disease mutations onto the structures of Rad3 (human XPD) and Tfb5 (human p8). Reported mutations in xeroderma 
pigmentosum, trichothiodystrophy or Cockayne syndrome148,160,161 were included. The sites of point mutations are depicted 
as red spheres, and Tfb5 truncations are colored in black. Color coding of TFIIH subunits as in Fig. 5.14. A list of yeast 
residues highlighted in the PIC structure is provided together with the corresponding human mutations in parentheses. 
Mutation sites are conserved. Rad3 mutations apparently interfere either with the stability and/or the function of the ATPase 
core or with the Rad3-Ssl1 interaction. Only few mutations target the FeS cluster or ARCH domain. Newly available data on 
the Rad3 anchor in Tfb1 suggest close proximity to at least four mutation sites that may affect the Rad3-Tfb1 interaction in 
this region. Tfb5 mutations either abolish Ssl2 binding or the formation of the dimerization domain with the Tfb2 C-
terminus, resulting in destabilization of the Ssl2/Tfb2 region. If the clutch domains remain intact, however, a complete 
disruption of the Ssl2/Tfb2 interaction seems unlikely. We omitted Ssl2 from analysis as our structure does not cover the 
region in which reported mutations occur. 
 
 
5.3.3 TFIIH interactions with cPIC 
 
The PIC structure reveals four sites of interaction between TFIIH and cPIC (Fig. 5.17 a, b). First, 
the TFIIH kinase module subunit Tfb3 bridges between the Pol II stalk subcomplex Rpb4-Rpb7, 
TFIIE and Rad3 (Fig. 5.18 a). In particular, the Tfb3 RING domain binds between the Rpb7 OB 
domain and the TFIIE E-linker helices, and the Tfb3 ‘ARCH anchor’ contacts the Rad3 ARCH 
domain. This is consistent with the known interaction between the TFIIH kinase module and 
Rad3105,164 and the initiation function of Rpb4-Rpb7327, which also binds TFIIE89 and cMed88. The 
Tfb3 contact with Pol II further explains why the PIC recruits TFIIH that contains the kinase 
module, rather than only core TFIIH166.  
 
 
Figure 5.17 | Interactions of TFIIH with 
cPIC. a, Domain organization of TFIIE subunit 
Tfa1 (human TFIIEα) including the previously 
unassigned helices α7 (E-dock), α8 (E-bridge) 
and α9 (E-floater). Solid or dashed bars refer to 
protein residues modeled as atomic or backbone 
structures, respectively.  
b, TFIIH-cPIC interactions. PIC is viewed from 
the top (Fig. 5.11). Regions involved in the 
formation of the four interfaces are encircled. 
The color code of cPIC and TFIIH subunits 
highlights components that participate in the 
interaction. 
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Figure 5.18 | TFIIE-TFIIH interactions. See next page for legend. 
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Figure 5.18 | TFIIE-TFIIH interactions. a, Tfb3-Pol II interaction. The TFIIH kinase module subunit Tfb3 (human MAT1) 
tethers Pol II and the TFIIH core together. Ribbon representation of the Tfb3 N-terminal RING-finger binding in a groove 
between the Pol II stalk subunit Rpb7 and the TFIIE E-linker helices. The RING-finger is linked to the ARCH anchor which 
binds the ARCH domain of Rad3. b, Secondary structure and conservation of TFIIE subunit Tfa1 as determined with 
CONSURF329. Regions observed in the PIC and PIC-cMed structures are exceptionally well conserved throughout evolution. 
C-terminal residues with used crosslinks are indicated. c, E-dock. The predicted Tfa1 helix α7 is wedged between the TFIIE 
extended winged helix (eWH) domain situated on the Pol II clamp and the PHD of Tfb1 in the TFIIH core. α7 was not 
modeled owing to weak density at the interface of the two major mobile parts of the PIC structure (cPIC and TFIIH) and 
owing to the absence of crosslinks (Methods). The Tfb1 PHD is additionally contacted by the Tfa1 C-terminal acidic region. 
The identity and directionality of this acidic peptide were unambiguously established by crosslinking (Methods). d, e, E-
bridge. This helix (α8) extends from the Tfb1 BSD2 domain at the center of the TFIIH crescent to the central β-sheet of the 
Ssl2 ATPase lobe 2. The C-terminal anchor peptide (dashed line) was not modeled into the density due to limited resolution. 
The identity and directionality of the E-bridge was unambiguously established by independent crosslinking experiments 
(Methods). f, g, E-floater. The Tfa1 helix α9 is positioned by the BSD1 domain of Tfb1 and located adjacent to the 3-helix 
bundle at the center of the TFIIH crescent. The identity and directionality of the E-floater was unambiguously established by 
independent crosslinking experiments (Methods). 
 
A role for Tfb3 in TFIIH recruitment can also explain why the kinase module is required for 
transcription initiation in a reconstituted system119 although its kinase activity is not328. The C-
terminal part of Tfb3 is disordered and connects to the kinase-cyclin pair, which is also mobile in 
the PIC structure.  
The three additional interactions between TFIIH and cPIC involve the mobile C-terminal 
region of TFIIE subunit Tfa1 (human TFIIEα). This TFIIE region forms three previously 
unobserved helices that are flexibly connected and named here E-dock (α7), E-bridge (α8) and E-
floater (α9) (Fig. 5.18 b). The E-dock apparently enables docking of the Tfb1 PHD to the TFIIE 
extended winged helix domain that is located on the Pol II clamp (Fig. 5.18 c). The E-bridge 
extends from Tfb1 domain BSD2 to the Ssl2 lobe 2 (Fig. 5.18 d, e). The E-floater binds the BSD1 
domain in Tfb1 (Fig. 5.18 f, g). Taken together, these contact sites explain why TFIIE is required 
for TFIIH recruitment to the PIC100. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Results 
 
	 81 
5.3.4 TFIIH and DNA opening 
 
The PIC structure shows that the Ssl2 ATPase engages with promoter DNA approximately 25-30 
base pairs (bp) downstream of the putative transcription start site (TSS) +1 (Fig. 5.19 a, b, Fig. 
5.20 a, b, f). This location is consistent with crosslinking data96 and previous cryo-EM studies86,87, 
and with the translocase model for ATP-dependent DNA opening108,109. According to this model, 
Ssl2 uses ATP hydrolysis to translocate on DNA away from Pol II. If the Ssl2 location is fixed, 
Ssl2 action results in a reeling of DNA into the active center. The PIC structure supports a fixed 
location of Ssl2 and the proposed directionality of translocation. The two ATPase lobes bind the 
DNA backbones on both sides of the minor groove, similar to the ATPase in the chromatin 
remodeling enzyme Chd1291. Comparisons with Chd1 and with ATPase structures of NS3 and 
Rad3 (Fig. 5.20 d, e) indicate that Ssl2 tracks along the DNA template strand in the 3′-5′ direction, 
consistent with biochemical studies111,172,330. One study suggested that tracking occurs on the non-
template strand in 5′-3′ direction109, but this would result in the same overall movement.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19 | TFIIH and DNA opening. a, Schematic cross-section of the PIC with open and closed DNA viewed from the 
side. PIC elements involved in DNA opening are depicted. Color coding as in Fig. 5.11 except for Ssl2 lobe 1 (pink) and lobe 
2 (burgundy). The Ssl2 ATPase translocates to the right and DNA moves to the left during DNA opening. b, Putative 
ratcheting of lobe 2 in the Ssl2 ATPase with respect to lobe 1. The PIC structure reveals the pre-translocation state (no ATP 
bound). The post-translocation state of lobe 2 was modeled by superposition of Chd1 (PDB code 5O9G). Helicase motifs are 
indicated (Fig. 5.20). 
 
The PIC structure also suggests how TFIIE may stimulate the ATPase activity of TFIIH110. 
According to the current model for ATPase translocation291,331, ATP binding induces a ratcheting 
movement of lobe 2 with respect to lobe 1, and a DNA translocation by one base pair. In our 
structure, we trapped the pre-translocation state of Ssl2 with an empty ATPase active site (Fig. 
5.19 b). The C-terminal end of the TFIIE E-bridge contacts the Ssl2 lobe 2, suggesting that the E-
bridge can influence the conformational ratcheting in the Ssl2 ATPase that occurs during DNA 
translocation. 
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Figure 5.20 | Detailed analysis of Ssl2 ATPase conformation and implications for translocase activity. See next page for 
legend.   
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 Figure 5.20 | Detailed analysis of Ssl2 ATPase conformation and implications for translocase activity. a, Overview of 
PIC complex with highlighted Ssl2 (human XPB) ATPase lobes 1 and 2 (in pink and burgundy, respectively) and interacting 
domains of Tfb2, Tfb5 and Tfa1. b, Detailed view on Ssl2 positioned on dsDNA in the presumed pre-translocation state. The 
ATP analogue AMP-PNP was present in the buffer but was not observed in the active site of the Ssl2 ATPase, supporting the 
model that we trapped the structure in the pre-translocation state. Register of covered nucleotides with respect to the putative 
TSS +1 is indicated. Highlighted helicase motifs were identified and assigned as described171. Yellow colored motifs are 
involved in the DNA interaction, purple motifs participate in NTP binding and hydrolysis, and green motifs are involved in 
coupling of ATP hydrolysis to DNA binding. Both lobes of the ATPase contact both nucleic acid strands. c, Chd1 and Ssl2 
ATPases are closely related on a structural level and share the same fold. The presumed post-translocation state of Ssl2 was 
modeled by separate alignment of ATPase lobe 1 and 2 to the respective lobes in the structure of Chd1 bound to an ATP 
analogue (PDB code 5O9G); the presumed pre-translocation state was modeled vice versa using the Ssl2 structure as 
reference model. In both states the structures overlap to a high degree. d, The Ssl2-DNA arrangement observed in the PIC 
structure resembles that of 3′-5′-directed rather than 5′-3′-directed members of the SF2 family. Superposition of the Ssl2-
dsDNA structure with models of the NS3 (PDB code 3KQK)332 and T. acidophilum (Tac) Rad3 (PDB code 5H8W)175 
ATPase domains reveals a closer resemblance of Ssl2 to the 3′-5′-helicase NS3. Additionally, the bound single-stranded (ss) 
DNA fragment in the NS3 model aligned well to the dsDNA in the Ssl2 structure whereas the bound fragment in the 
TacRad3 structure was positioned differently and did not exhibit a minor groove twist as observed for NS3 and Ssl2 in the 
respective position. e, Superposition of structures of TacRad3 and ScRad3 ATPase domains indicates very high level of 
structural homology. ATPase lobes 1 and 2 were superimposed separately to account for the absence of bound DNA in the 
ScRad3 structure. f, Putative movement of E-bridge and the Tfb2-Tfb5 dimerization domain upon Ssl2 transition from the 
presumed pre- to the presumed post-translocation state (grey and color, respectively). Upon movement of lobe 2, the E-
bridge may undergo a rotation-translation movement towards Pol II and against its own trajectory onto the central β-ribbon of 
the Ssl2 ATPase lobe 2. The flexible Tfb2-Tfb5 dimerization domain would swing towards Pol II. 
 
5.3.5 TFIIH and Pol II phosphorylation 
 
The PIC-cMed structure provides details on the previously described PIC-Mediator interfaces88, 
and suggests conformational changes in Mediator upon PIC binding (Fig. 5.21 a, b, Fig. 5.22 a-e). 
The Mediator head module is largely unchanged248, but the conformation of the middle module 
differs from that in the cMed structure247 (Fig. 5.22 c). The submodules in the middle module 
apparently undergo concerted movements. Whereas the plank rotates to bind the Pol II foot, the 
hook and knob undergo swinging motions and the beam moves towards the head module jaws. 
Comparison with the cMed cryo-EM structure234 also suggests conformational changes in 
Mediator upon PIC binding. 
The PIC-cMed structure further reveals an additional density for the Kin28-Ccl1 kinase-
cyclin pair on the outer surface of cMed (Fig. 5.21 a, b). This density is located above one of two 
openings that flank the knob at the Mediator head-middle interface. The kinase-cyclin pair resides 
between the Mediator hook, knob and shoulder, roughly consistent with its previously reported 
position101. The density for Kin28-Ccl1 is weaker than the density for cMed or TFIIH, indicating 
that the kinase-cyclin pair retains some mobility.  
How the TFIIH kinase reaches its phosphorylation substrate, the Pol II CTD, was unclear. 
The linker to the mobile CTD extends from Pol II towards the inner surface of Mediator that lines 
a previously described cradle formed between Mediator and Pol II88 (Fig. 5.21 a, b). To reach the 
kinase, the CTD may exit the cradle and extend around Mediator or through Mediator101. 
However, the CTD crosslinks to the inner surface of the cradle247, suggesting that it resides in the 
cradle, where it can be accommodated if it adopts a compact globular shape255.  
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Figure 5.21 | TFIIH and phosphorylation of Pol II. a, PIC-cMed structure as in Fig. 5.13 but with additional cryo-EM 
density for the mobile TFIIH Kin28-Ccl1 kinase-cyclin pair (orange, filtered to 15 Å). An orange sphere depicts the last 
modeled residue in the Tfb3 linker to the kinase-cyclin pair (Met145). A black sphere depicts the last ordered residue in the 
Rpb1 linker to the CTD (Lys1452). Red spheres depict Med19 residues that crosslink to the CTD C-terminal end. Filled red 
circles indicate two openings at the Mediator head-middle interface. b, The same structure viewed from the front into the 
cradle between Pol II and Mediator (red outline). A model for the kinase-cyclin pair is shown for size comparison in an 
arbitrary position. 
 
The TFIIH kinase may access the CTD through the openings at the head-middle interface. 
Phosphorylation of CTD regions would then lead to repulsion between accumulating negative 
charges, expansion of the CTD globule in the cradle, a weakening of the Pol II-Mediator 
interaction and Mediator dissociation. Loss of Mediator destabilizes the PIC and would facilitate 
Pol II escape from the promoter. 
Results 
 
	 85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.22 | Structure and conformational changes of cMed. See next page for legend. 
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Figure 5.22 | Structure and conformational changes of cMed. a, Schematic representation of cMed subunits. Regions 
contributing to submodules are colored as in the S. pombe cMed crystal structure247. Solid and dashed black lines refer to 
protein regions that were modeled as atomic or backbone models, respectively. b, Ribbon model of cMed colored by type of 
structural model used for interpreting the cryo-EM density. Regions with backbone models based on the S. pombe cMed 
structure247, regions with atomic models inclusive of the PDB code, and de novo modeled regions are indicated in grey, 
orange and blue, respectively. c, Repositioning of the cMed middle module upon PIC binding. The structures of unbound 
cMed (khaki, PDB code 5N9J) and PIC-cMed complex (blue, this study) were superimposed on the cMed head module. The 
positions of the cMed middle module domains hook, knob, connector, plank and beam apparently undergo conformational 
changes upon PIC binding, as indicated by arrows. This may cause or enlarge two observed openings at the head-middle 
interface. d, PIC-cMed interactions. Structure of the PIC-cMed complex in two views. The three previously identified 
interfaces88 between cPIC and cMed are indicated. In interface A, the Mediator movable jaw (light blue) contacts the Pol II 
Rpb3-Rpb11 heterodimer (red/yellow), the dock domain (beige) and the TFIIB β-ribbon (green). In interface B, the Mediator 
spine domain (green) contacts helix H* of the Pol II stalk subunit Rpb4 (blue) with its Med22 helix H1, and the Mediator arm 
domain (violet) contacts Rpb4 with its Med8 helices H1 and H2. In interface C, the Mediator plank domain (pink) contacts 
the Pol II foot region (cyan) with its Med9 helix H2. Two newly observed EDC-crosslinks between Med9 helix H2 and the 
Pol II foot domain are indicated by black spheres. e. Mediator head-middle module interfaces. In the unbound S. pombe 
cMed X-ray structure, four interfaces (I–IV) were observed between the head and middle modules247. Owing to stretching of 
the beam, interfaces I and II are altered in the PIC-bound cMed structure. In the new conformation, the Med4 C-terminal 
region in the Mediator knob is flexible and does not contact the spine region (interface III). Interface IV between the shoulder 
and hook domains is lost. Mediator domains are colored as in a. 
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6          Conclusion 
  
This section was published in: 
 
Schilbach, S., Hantsche, M., Tegunov, D., Dienemann, C., Wigge, C., Urlaub, H. & Cramer, P. 
Structures of transcription pre-initiation complex with TFIIH and Mediator. Nature 551, 204-209 
(2017). 
 
The following text reflects the contents of the publication in unaltered form with the exception of 
literature references. These elements have been adapted to the format of this work. A detailed list 
of published items is also provided on page V. 
 
 
We have been aiming to achieve detailed structures of the yeast Pol II PIC and its complex with 
Mediator ever since the structure of the core Pol II enzyme was determined255. Important steps 
towards this goal included the Pol II-TFIIB crystal structure, which led to minimal models of the 
closed and open promoter complexes75, and our recent structures of cPIC89 and cMed247. The 
crucial step reported here was to prepare recombinant TFIIH, to derive its structure, and to arrive 
at structures of the PIC and the PIC-cMed complex. The PIC-cMed complex lacks TFIID and the 
Mediator tail module, but their location on the PIC is known from work by others in the human58 
and yeast101 systems, respectively. 
The structures presented here define interactions of TFIIH within the PIC and interactions 
of cMed with the PIC, and provide unexpected insights. First, anchoring of TFIIH to the cPIC 
involves a subunit of the TFIIH kinase module, ensuring that complete TFIIH is incorporated into 
the PIC. Second, a mobile extension of TFIIE tethers several parts of TFIIH, including the Ssl2 
ATPase. Third, the TFIIH kinase is mobile in the PIC, but adopts a preferred location on Mediator 
when cMed binds the PIC. Finally, PIC-bound Mediator contains two openings at its head-middle 
interface that may allow access of the TFIIH kinase to the Pol II CTD residing in the cradle. The 
structures thus provide the basis for future mechanistic studies of TFIIE-stimulated and TFIIH-
dependent promoter opening, Mediator-stimulated CTD phosphorylation and promoter escape, 
and gene regulation during transcription initiation. 
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7          Discussion and Outlook 
  
7.1 A paradigm for the structural dissection of macromolecular multi-subunit 
assemblies 
 
Ultimately, a comprehensive approach, which included sophisticated techniques in the fields of 
biochemistry, biophysics and bioinformatics, was pivotal for the determination of the PIC and 
PIC-cMed structures at high resolution. Recent advances in routine cryo-EM analysis and the 
respective processing and reconstruction software258,300-302 were successfully exploited in 
combination with an optimized sample preparation strategy and powerful modeling suites, which 
also permitted identification of genetically distant homologues in template searches. Limitations 
such as the intrinsic flexibility between the TFIIH and cPIC entities in the complex were 
overcome by the development of innovative computational tools like WarpCraft to obtain a well-
resolved EM map for TFIIH. Other challenges such as the derivation and correct positioning of 
models for single domains within TFIIH, however, would not have been met without the 
availability of existing structural or crosslink data. In addition, structural information on many 
regions of the cPIC and cMed complex had been compiled by numerous studies in the preceding 
years (exemplary in85-87,101,247,248. The present work now provided the architecture of the PIC-
cMed complex as an ultimate framework, in which this previously gathered information was 
coalesced and extended with novel findings to generate the complete model of a transcription 
complex that comprises all proteins essential for productive initiation in an in-vitro system25,94,135 
and its most prevalent co-activator.  
The versatile strategy applied to generate the PIC and PIC-cMed structures may serve as a 
paradigm for the implementation of future projects that involve similar, highly intricate samples. 
In addition, quickly evolving cryo-electron tomography (cryo-ET) techniques may further extend 
the system to study the respective macromolecular complexes in their native cellular environment. 
Indeed, related schemes were used to arrive at models for many distinct multi-subunit assemblies 
involved in transcription and transcriptional regulation, as isolated structures of polymerases and 
numerous accessory factors are widely available. Future application targets in the field of Pol II 
encompass not only further complexes that govern initiation, pausing, elongation or termination 
but also co-transcriptional events such as transcription-coupled repair (TCR) or co-transcriptional 
splicing, possibly even in the context of chromatin.  
 
 
7.2 Comparison of free and PIC-bound TFIIH and implications of structural 
rearrangements upon PIC-association 
 
While the obtained structures of the PIC and PIC-cMed complex were the first to reveal details on 
TFIIH in the context of the transcription initiation machinery, simultaneously also a high-
resolution cryo-EM structure of TFIIH in its free conformation was reported333. Although the 
models derived in the studies describe TFIIH complexes originating from yeast and H. sapiens, 
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respectively, TFIIH subunits are sufficiently well conserved between these organisms to permit 
their comparison. Owing to the previous lack of detailed structural information, these models 
provide the first opportunity for a discussion of putative conformational changes in TFIIH during 
the transition between its free and its cPIC-associated state. 
Whereas the global shape of TFIIH deviates significantly in the two models, direct 
superposition of isolated subunits indicates a high degree of overlap within most regions (Fig. 7.1 
a). Minor discrepancies, such as slight displacements or divergent lengths of SSEs and variable 
linker regions, are presumably a result of species-specific differences. The general domain- and 
module conformations, however, appear to be well conserved. Consistently, all subunits that were 
confidently assigned were positioned and oriented equally in both studies, which additionally 
reflects the high quality of the independently generated TFIIH models. The ATPase lobes of 
Rad3/XPD and Ssl2/XPB, as well as the Rad3/XPD FeS-cluster and ARCH domains are 
analogously arranged with respect to each other, in pronounced contrast to the folds observed in 
the crystal structures of their archaeal homologues174,175,207,208. Seemingly, incorporation of the 
ATPases into TFIIH in the adopted conformations is favored or even exclusive, probably due to 
their requirement for correct assembly and stability of the holo-complex. In comparison to their 
pre-translocated state in the PIC model, the ATPase lobes of Ssl2/XPB are differently positioned 
in the absence of DNA in free TFIIH (Fig. 7.1 b). They apparently undergo a closure upon 
binding to DNA, which is likely to affect the conformation of the ATP binding pocket and the 
active center of Ssl2/XPB. The unengaged state therefore may represent a relaxed Ssl2/XPB 
conformation that is less active and less competent for ATP-binding, consistent with the observed 
stimulation of the Ssl2/XPB ATPase in presence of dsDNA substrates109.  
The scaffolding factors Ssl1/p44, Tfb2/p52 and Tfb4/p34, which constitute the backbone 
of core-TFIIH and form the middle of its crescent-like shape, contain the same vWA (Ssl1/p44, 
Tfb4/p34) and HTH/α-helical solenoid motifs (Tfb2/p52) in yeast and H. sapiens TFIIH. 
However, the free TFIIH model lacks several regions of these subunits, such as parts of the eZnF- 
and RING-finger domains in Tfb4/p34 and Ssl1/p44 (Fig 7.2). They appear to be more robust and 
better defined within the PIC architecture and could therefore be assigned with confidence in the 
PIC and PIC-cMed models. Their flexibility in the free TFIIH structure is possibly a secondary 
effect of missing sequestration of the Tfb1/p62 PHD by the dock helix in Tfa1/TFIIEα. In the 
PIC, this interaction seems to have a stabilizing effect on the adjacent BSD1, BSD2 and the 3-
helical bundle of Tfb1/p62, which in turn binds to the eZnF domains of Ssl1/p44 and Tfb4/p34, 
and consequently results in higher rigidity of the entire region. Consistently, also the Tfb1/p62 
PHD and BSD1, which in addition lacks its contact with the E-floater helix of Tfa1/TFIIEα, were 
not detected in the cryo-EM map of free TFIIH. The Tfb1/p62 BSD2 and 3-helical bundle were, 
albeit observed and partially modeled, not confidently assigned to Tfb1/p62 due to this missing 
information333. In summary, the mapping and model building for large segments of Tfb1/p62 and 
adjacent small domains of Ssl1/p44 and Tfb4/p34 was feasible for cPIC-bound TFIIH but not for 
the free conformation owing to a strongly increased flexibility in these peripheral regions (Fig. 
7.2). The HTH/α-helical motifs in Tfb2/p52 in the structure of free TFIIH were modeled 
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incompletely without β-turns and were thus interpreted as a purely solenoid-like arrangement333 
although the corresponding EM-map indicates a similar HTH-fold as observed for the cPIC-
associated state. In contrast, the H. sapiens p52/p8 dimerization domain, which was modeled 
based on the yeast crystal structure192, overlaps well with the template. The EM-maps of free and 
cPIC-bound TFIIH suggest that the clutch domains of Ssl2/XPB and Tfb2/p52 mediate the 
primary interaction between these proteins and adopt a fold that resembles the Tfb2/Tfb5 
dimerization domain, involving two opposing β-sheets. Due to low resolution in this map region, 
however, the structure of cPIC-bound yeast TFIIH includes only part of the clutch domains and 
lacks the N-terminal portion and the DRD-domain of Ssl2, which were modeled, although not 
completely assigned, for XPB in free TFIIH333. Seemingly, cPIC-bound TFIIH misses stabilizing 
contacts between the Ssl2- and Rad3-halves of the core-TFIIH crescent after its incorporation into 
the initiation complex (Fig 7.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 | Superposition of subunits within free and PIC-bound TFIIH. a, Subunits of TFIH from H. sapiens (PDB 
code 5OF4) and yeast exhibit highly conserved domain folds. Exemplary superposition of the TFIIH subunit Rad3/XPD and 
the vWA domain of Ssl1/p44 reveal close resemblance. Structural elements and local folds appear highly similar in both 
species. Minor species-specific differences between structures are primarily observed in loops or peripheral regions, for 
example in parts of the Rad3 FeS cluster. Individual folds and domains do not undergo rearrangements during transition from 
the free to the PIC-bound state of TFIIH. The color code is indicated. b, Comparison of the Ssl2/XPB ATPase domains in the 
free and DNA-engaged state. Structure of XPB (not DNA-associated) in free TFIIH (PDB code 5OF4) was superimposed on 
Ssl2 in the pre-translocation state using ATPase lobe 1 as reference. ATPase lobe 2 of XPB is positioned at greater distance 
from the DNA than lobe 2 of Ssl2, which interacts with both DNA strands (Figs. 5.19 and 5.20). Structural shifts between the 
open and closed state of lobe 2 transmit to the Ssl2/XPB ATP-binding pocket situated between lobes 1 and 2. The color code 
is indicated. Views as in Figs. 5.19 and 5.20. 
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The kinase module of TFIIH appears to be the most mobile segment in free and cPIC-bound 
TFIIH and was not observed in 3D-reconstructions of human TFIIH and the yeast PIC. However, 
while 2D-classifications of free TFIIH define an approximate positional range for the kinase-
cyclin pair333, indicating an intrinsic stabilization, its location in the PIC structure is revealed only 
in presence of cMed. This suggests that Mediator, albeit without detected direct interactions, 
prompts the TFIIH kinase module to adopt a position in close proximity to the initiation complex, 
in agreement with a stimulation of its CTD kinase activity133,240,241 and other PIC-Med studies101. 
Mediator may direct partial immobilization of the kinase module without the involvement of rigid 
and structured elements but instead by tethering via flexible linkers or low-affinity interactions. 
Such a scenario would explain the observed EM-density, which seems to correspond rather to a 
preferred, not exclusive, location of the kinase-cyclin pair and indicates that the sub-complex 
retains some mobility. Nevertheless, the elucidation of the underlying mechanisms for TFIIH 
kinase module recruitment and stimulation will ultimately require very highly resolved structures 
of PIC-cMed or PIC-Med complexes in combination with biochemical mapping and mutational 
analyses.  
The decreased flexibility of the kinase module in free TFIIH is directly associated with a 
marked discrepancy between free and cPIC-bound TFIIH. Although structures of both models 
correlate strongly on the subunit level (Fig. 7.1 a, b), the global crescent- or horseshoe-like shape 
of core-TFIIH apparently undergoes a major rearrangement upon its incorporation into the 
initiation machinery (Fig. 7.2). While TFIIH adopts a rather open conformation in the cPIC-bound 
state, in which the ATPases Ssl2 and Rad3 are located at the terminal and most distant points of 
the core-TFIIH crescent, free TFIIH is much more compacted and the ATPases XPB and XPD are 
in direct contact with each other. Although species-specific differences may contribute to this 
contraction, it appears to primarily result from a robust linkage of both ATPases by a long α-helix 
in MAT1 (Fig. 7.2). This α-helix extends from the H. sapiens equivalent of the Tfb3 Rad3-anchor, 
which interacts with XPD, to the DRD domain of XPB, which is associated with ATPase lobe 
1333. Whereas its existence is strongly predicted by various SSE identification tools for S. 
cerevisiae as well, a respective Tfb3 α-helix was not observed in the yeast PIC structure. Thus, 
the N-terminal segment of XPB/Ssl2 lacks its stabilizing effect, which provides an explanation for 
the decreased resolution of the PIC’s EM-map in this region. In the PIC, the contact between a 
putative Tfb3/MAT1 α-helix and the Ssl2/XPB DRD may not be established due to the more 
expanded shape of core-TFIIH. The α-helix may simply be unable to traverse the correspondingly 
increased gap between Rad3/XPD and Ssl2/XPB. Intriguingly, the Tfb3/MAT1 α-helix also 
represents the only reported physical connection between the kinase-cyclin pair and core-TFIIH 
since it is embedded between the Rad3/XPD-anchor of Tfb3/MAT1 and its C-terminus, which 
anchors Kin28/CDK7 and Ccl1/CycH214. Thus, while the α-helix is engaged between the 
ATPases, the kinase-cyclin pair is kept in relative proximity to core-TFIIH, separated only by 
small spacer region between the C-terminal end of the α-helix and the C-terminus of Tfb3/MAT1. 
Accordingly, the kinase-cyclin pair is observed as a blurry shape in 2D-classifications of free 
TFIIH333. However, if the MAT1 α-helix is conserved between H. sapiens and yeast, it appears to 
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become a mobile element, tethered only to the Rad3/XPD-anchor of Tfb3/MAT1, upon 
recruitment of TFIIH into the PIC, as demonstrated in this study. In consequence, the length and 
flexibility of the ‘spacer’ that connects the kinase-cyclin pair with core-TFIIH is significantly 
enhanced, which implies a sudden increase of the activity range of the TFIIH kinase and would 
permit the phosphorylation of distant targets. Moreover, it remains uncertain whether the MAT1 
α-helix will retain its conformation after dissociation from the DRD of Ssl2/XPB or will become a 
disordered linker. The described putative rearrangements of the kinase module subunits would 
explain why the kinase-cyclin pair was not observed in 2D-classes of the yeast PIC but of H. 
sapiens TFIIH. Cryo-EM analyses of the human PIC seem to confirm such a theory86,333 although 
the obtained EM-maps have to be interpreted cautiously owing to the low resolution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 | Comparison of free and PIC-bound TFIIH. TFIIH adopts very distinct conformations in the free and PIC-
associated states. Structures are viewed from the side (adapted from Fig 5.14). XPB and XPD in free TFIIH contact each 
other directly while Ssl2 and Rad3 are physically separated in the PIC-derived structure. Elements specifically 
observed/modeled in only one of the structures are indicated with dashed black lines, respectively. The free TFIIH model 
comprises peptides that may be part of the Tfb1/p62 Ridge domain, which were not modeled in the yeast structure owing to 
poor resolution. Alternatively they may be (partially) attributed to the eZnF or RING folds of Ssl1/p44 and Tfb4/p34. The 
αClutch-helix of Tfb2 is a yeast-specific element and not predicted in the sequence of p52 in H. sapiens. Color code as in Fig. 
5.14. The color code of free TFIIH was adapted to the subunit assignment of PIC-associated TFIIH. 
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The comparison of the two recently obtained structural studies that revealed TFIIH in its free and 
cPIC-bound state demonstrates that TFIIH undergoes major conformational changes on a global 
level during its incorporation into the initiation machinery, while most of its central modules 
retain their original local fold. However, several peripheral mobile domains in free TFIIH become 
more rigid and ordered within the PIC, presumably due to stabilizing interactions with the newly 
identified helical elements in the C-terminus of Tfa1/TFIIEα. The notable expansion of the 
crescent shape of core-TFIIH appears to be directly induced by its association with the PIC and is 
probably based on three pivotal elements. First, Rad3/XPD is fixed in one position by the N-
terminal Rad3-anchor and RING-finger of Tfb3/MAT1, which bind the ARCH domain of 
Rad3/XPD and intercalate between the stalk of Pol II and the E-linker helices, respectively. 
Correspondingly, the RING-finger of Tfb3/MAT1 was clearly assignable only within the PIC333. 
Second, Ssl2/XPB with a reported high affinity for dsDNA109 presumably shifts to engulf the 
DNA downstream of Pol II with its ATPase domains, thereby opening the core-TFIIH crescent 
and losing its contact with the Tfb3/MAT1 α-helix. The described relocation of the ATPases, and, 
consequently, the tips of the crescent, is facilitated by the newly discovered bridge helix of 
Tfa1/TFIIEα. The E-bridge is wedged between the Tfb1/p62 BSD2, which in turn is anchored to 
ATPase lobe 2 of Rad3, and ATPase lobe 2 of Ssl2/XPB (Fig 7.2). Although atomic details of the 
interactions between the E-bridge and core-TFIIH remain yet elusive, they may provide sufficient 
stability for this element to serve as a rigid spacer between the two halves of the TFIIH crescent. 
As discussed, the expansion of core-TFIIH and the presumed resulting release of the Tfb3/MAT1 
α-helix present novel implications on the location and mobility of the TFIIH kinase-cyclin pair. 
However, although the proposed hypotheses appear to be plausible, the analysis of structural 
rearrangements in TFIIH using protein complexes derived from one species and prepared by a 
uniform strategy will be an important future goal. At present, yeast TFIIH was obtained from a 
recombinant expression system whereas human TFIIH was purified endogenously. In addition, 
the introduction of mutations in distinct domains of TFIIH and the associated elements of Tfa1 
and Pol II may provide further detailed knowledge about their interaction network and its impact 
on stability and functionality of TFIIH during transcription initiation. In the past, transcription 
assays were successfully used to characterize variants of TFIIE or cMed88,89. An adapted setup or, 
as an alternative, promoter opening assays may prove suitable for the analysis of TFIIH. For such 
an approach, the recombinant production scheme established in this study would be clearly 
beneficial. Similar procedures may have to be applied to dissect the mechanism by which 
Mediator coordinates the kinase-cyclin pair. 
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7.3 Towards an atomic model of transcription initiation 
 
The structures of the PIC and PIC-cMed complex are in agreement with numerous functional data 
and offer valid explanations for previous observations like the intimate association of TFIIE and 
TFIIH100, TFIIE-dependent ATPase stimulation of TFIIH110, or the kinase module’s requirement 
for in-vitro initiation experiments119. However, as indicated before, many aspects of the 
underlying molecular mechanisms that ultimately drive transcription initiation remain yet elusive. 
A better understanding of these processes at the structural level demands a plethora of atomic 
structures that reflect the various states adopted by the entirety of the transcription initiation 
machinery during the distinct phases of initiation. While the PIC and PIC-cMed structures 
represent snapshots of the initiation stage after DNA melting and formation of an initial 
transcription bubble, their resolution is not sufficient to reveal all molecular details, particularly 
not in the newly described TFIIH and cMed regions.  
Although the current method for PIC-cMed preparation is superior to any other tested 
approach, the system is not completely optimized, as indicated by the identification of 
heterogeneous particles in the cryo-EM data. Whereas SDS-PAGE analysis indicated full 
occupancy of the cMed and TFIIH sub-modules, as well as homogeneous crosslinking of the PIC-
cMed complex, only 6% of the visualized particles contained both cMed and TFIIH and more 
than 50% contained neither of them. Moreover, many particles were discarded owing to strong 
conformational heterogeneity, which may have been caused by mechanical destabilization of the 
complex rather than by its intrinsic flexibility. Therefore, as a first step to arrive at PIC-cMed 
structures of high- or even atomic resolution, the sample preparation protocol has to be adapted to 
achieve higher occupancy rates for cMed and TFIIH while retaining a similar particle 
concentration for cryo-EM experiments. The observed partial decomposition of the cPIC-cMed 
complex is most likely attributable to concentration of the sample after crosslinking and dialysis, 
or to the plunge-freezing process. Thus, alternative methods, which increase concentration but 
exert less stress on macromolecules than conventional ultrafiltration, need to be assayed. For 
example, proteins may be dialyzed against a buffer containing high molecular weight PEGs or 
Ficoll-400 (Sigma-Aldrich) prior to application to cryo-EM grids. Another approach, frequently 
used for preparation of endogenous protein samples with low concentration, would involve 
sample adsorption to cryo-EM grids with a continuous carbon support film58,85,86,333. These grids 
would, albeit at the cost of a slightly decreased contrast and an increased DQE, permit in-situ 
sample concentration by adjustment of the incubation time and may additionally stabilize fragile 
regions of the complex and prevent decomposition during plunge freezing. Once the current 
biochemical limitations of sample preparation have been overcome and a final robust strategy for 
the assembly of the PIC-cMed complex is established, cryo-EM experiments are expected to 
result in better resolved reconstructions, simply due to the presence of a larger number of intact, 
rigid particles. Subsequently, the PIC-cMed analysis may be extended to further states of the 
initiation complex such as closed PIC-cMed or initially transcribing complexes (ITCs) with RNA.  
While the determination of the PIC-cMed structure marks a major breakthrough, the 
complex still does not represent the entire initiation machinery. The macromolecular factors 
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Mediator tail and TFIID, or more precisely its TAF subunits, are additionally required for 
completion of the canonically defined initiation complex334. The incorporation of these missing 
elements into the present model is highly anticipated but may introduce significant 
rearrangements. Except for the stalk region of Pol II, the architecture of the cPIC remained almost 
unaltered upon addition of TFIIH and cMed but both cMed and TFIIH underwent drastic 
conformational changes compared to their free states234,247,333. A future assembly with Mediator 
tail and activators may similarly affect peripheral regions in the PIC-cMed complex. The tail 
segment of Mediator comprises a similar size as cMed in yeast and associates with transcriptional 
activators at DNA enhancer elements52, thereby mediating physical long-range interactions 
between them and the cMed-bound initiation machinery. Thus, it is vital to the regulation of 
initiation complex assembly as well as to the transmission of signals to tune its activity. Taking 
the versatile nature of Mediator222,223,233 and the capability of cMed to undergo significant 
structural reorganization (Fig. 5.22 c) into account, local and global rearrangements of Mediator, 
and possibly its interaction partners, are likely a crucial component of the crosstalk between 
activators and the Pol II-associated complex52,246. Although a cryo-EM analysis of a yeast PIC-
Med complex including Mediator tail has been performed, the resolution in most parts of the 
obtained EM-map was not sufficient to distinguish conformational changes101. Consequently the 
structural impact of an association of the PIC with complete Mediator and transcriptional 
activators remains elusive. Moreover, structural cooperativity between Mediator and TFIID, the 
largest general transcription factor with a molecular mass of 1.2 MDa in yeast42, during promoter 
recruitment has been reported335. TFIID recognizes core promoter sequences and further 
modulates promoter-enhancer interactions by binding to multiple transcriptional activators as well 
as acetylated nucleosomes42,58. Thus, the complex is generally considered as the second base 
component of the PIC assembly platform. The structure of a TFIIA-TFIID-promoter complex has 
been revealed at medium resolution58 and provides insights into TFIID-mediated promoter 
recognition. Moreover it offers a model for correct positioning of TBP and the priming of 
promoter DNA for PIC recruitment independently of TATA-box element availability336, To date, 
however, the structure of a PIC-(cMed)-TFIID complex has not yet been obtained. Superposition 
of EM-maps and models of PIC, TFIID and cMed by using common elements suggests only 
minor clashes of TFIID with the other factors37,336 (Fig 7.3), indicating that the holo-complex may 
be stable. In addition, it has been demonstrated that TFIID, similarly to Mediator, is highly 
modular, undergoes significant rearrangements and exists in cell-type specific alternative states in 
metazoans42,58,336. Consequently, the determination of initiation complex structures containing 
canonical TFIID or conformational variants may reveal distinct subunit organizations and 
additional effects on the remainder of the initiation machinery.  
Once the discussed optimization of the PIC-cMed reconstitution strategy has reached a 
stage of routine application for cryo-EM analysis, the current complex may be extended by 
incorporation of TFIID, Mediator tail and transcriptional activators. Similarly to TFIIH, these 
factors may be produced recombinantly in insect cells, permitting variations in subunit 
composition and the introduction of mutations. In a long-term effort, it thus may not only be 
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possible to ultimately arrive at an atomic model of the canonical transcription initiation complex 
but also to structurally dissect its entirety during the various stages of initiation and track putative 
conformational changes. Based on the derived structures, additional targeted mutational analyses 
and biochemical assays may then contribute to the elucidation of further key determinants and 
molecular mechanisms that govern the initial phase of transcription.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 | Composite topological model of a TFIID-containing Pol II initiation complex. Cryo-EM density of TFIID 
(brown) (analysis of a TFIIA-TFIID-promoter complex, EMDB accession EMD-3305)58 was superposed on the structure of 
the PIC-cMed complex using the common elements of the upstream promoter assembly. Only the TAF subunits of TFIID are 
depicted. Overlaps and clashes between the TAFs, cPIC and TFIIH are negligible. Initiation complexes are viewed from the 
side and the front (Figs. 5.11, 5.21). The color code is indicated. 
 
 
7.4 Novel concepts to transcription initiation 
 
Very recently several studies have presented novel experimental data, which, although not being 
in direct opposition to the canonical interpretation of transcription initiation events, suggest that 
an extension or revision of current, commonly accepted models may be advisable. These analyses 
especially affect the fields of promoter recruitment, promoter opening and promoter escape as 
well as the regulatory mechanisms involved in these processes. Although they provide a 
complementation to available structural information such as the models of the PIC and PIC-cMed 
complex, also new questions are being raised.  
 
For a long time, the existence of two differently regulated gene classes utilizing distinct platforms 
for PIC assembly has been implied. Genes containing promoters with poorly defined TATA box 
elements (‘TATA-less genes’) were considered to be dependent on TFIID, consistent with a 
model of TFIID serving as a ‘molecular ruler’ for correct TBP positioning58. Promoter 
recruitment to genes with canonical TATA boxes, however, was supposedly controlled by another 
transcriptional co-activator complex, SAGA, which shares several subunits with TFIID, has a 
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molecular mass of ~ 2 MDa in yeast and is a histone modifier337. Overlaps between SAGA- and 
TFIID-based regulation were assumed to be minimal, especially since genes of the respectively 
dominated classes were located in distinct chromatin environments with divergent histone 
modifications and +1 nucleosome positioning56,57. However, applying the recently advanced 
‘chromatin endogenous cleavage coupled with high throughput sequencing’ (ChEC-seq) 
technique, a genome-wide recruitment of both TFIID and SAGA to both TATA-less and TATA-
containing genes has been demonstrated in yeast338,339. Consequently, a novel model suggests co-
localization of these co-activators at essentially all promoters of Pol II-transcribed genes and thus 
a global role for SAGA in transcription initiation, similar to that of Mediator338. Although SAGA 
does not bind DNA and interactions with Pol II or the remainder of the transcription initiation 
machinery have not been reported, the existence of promoter assemblies that integrate the three 
macromolecular co-activators, Mediator, SAGA and TFIID, now seems plausible. However, it 
remains elusive whether SAGA is able to form transient or stable complexes with the other co-
activators or further PIC components. Cooperation may also occur primarily on a functional level, 
regulated by recruitment of Mediator and SAGA to specific, co-localizing transcriptional 
activators bound to adjacent enhancer DNA regions340. Thus, the characterization of promoter 
architectures containing the Med-SAGA-TFIID triad and their association with PIC assemblies 
will require an advanced set of structure-function analyses, particularly since chromatin context 
may be a determinant for complex properties, composition and activity. Nevertheless, if the 
biochemical reconstitution or isolation of a SAGA-containing transcription initiation complex 
would be realized, the canonical model of the initiation machinery334 would have to be extended 
by an additional macromolecular factor. As such a ~5 MDa complex would likely also have to be 
positioned in the correct chromatin environment, its analysis may be one of the greatest 
challenges for structural biology in the near future. 
 
Despite extensive biochemical and in-vivo studies, the exact mechanism by which unwinding of 
promoter DNA occurs in the Pol II system has remained enigmatic. In contrast to other multi-
subunit RNA polymerases, Pol II requires the presence of ATP and activity of the TFIIH subunit 
Ssl2/XPB for formation of an open promoter complex90,104,106. The presented PIC and PIC-cMed 
structures visualized the ATPase lobes of Ssl2 bound to DNA, consistent with models implying 
an involvement of Ssl2 in promoter opening103,105,176. They unambiguously demonstrate that Ssl2 
binds distant from the site of initial DNA opening and confirm that it does not act as a 
conventional DNA-helicase85-87,96,98,108,109. Ssl2 rather functions as a dsDNA translocase that is 
directed away from the cPIC, thereby feeding promoter DNA into the active center cleft of Pol II 
and inducing promoter unwinding through a right-handed screwing rotation of the DNA.  
The reports of ‘spontaneous’, Ssl2/TFIIH-independent DNA opening and transcription 
events in structural and functional analyses89,112 have challenged the concept of Ssl2/XPB as an 
indispensable factor for the ‘mechanical’ promoter opening process. Instead, a ‘built-in-block’ 
model112 was suggested, assigning a regulatory, rather suppressive role to DNA-bound, but 
inactive, Ssl2/XPB. However, also in the structures of the PIC and PIC-cMed complexes, which 
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contained TFIIH and a non-hydrolysable ATP-analogue, spontaneous DNA opening was 
observed, indicating that the expected stabilization of closed DNA by Ssl2 had not occurred. As 
spontaneous DNA unwinding would require the absence of interactions with the ATPase domains 
of Ssl2, this effect may be explained either by slow kinetics of the in-vitro PIC formation, which 
permitted DNA opening before TFIIH and Ssl2 were correctly positioned, or by inherently 
dynamic properties of the Ssl2-mediated DNA sequestration. These dynamics would imply a 
series of poor binding events permitting the DNA to ‘slip’ through the enzyme’s ATPase 
domains. Recent investigations of the activity of yeast Ssl2/TFIIH may support such a theory. E. 
Tomko and colleagues studied in-vitro promoter opening events in real-time and at single base 
pair resolution, thereby identifying an initial promoter opening intermediate encompassing 5-6 bp 
of heteroduplex DNA341. This intermediate, which was identified as a direct product of ATP-
dependent Ssl2 action, underwent both extension into a fully established 12-13 bp transcription 
bubble and collapse into a closed state. Moreover, analyzed DNA fragments apparently 
participated in multiple cycles of DNA opening and closing events. The observed reversibility of 
the transition between closed DNA and the 5-6 bp intermediate bubble suggested that the Ssl2 
enzyme might not constantly remain tightly bound to DNA but dissociate and re-associate, 
thereby allowing DNA to ‘slip’ and initial bubbles to collapse. This mechanism may have 
contributed to the unexpected spontaneous opening of DNA in the PIC and PIC-cMed complexes 
but without further information, kinetic effects cannot be completely excluded as an underlying 
cause. Thus the proposed explanation remains speculative.  
The identification of a Ssl2-generated 5-6 bp promoter opening intermediate341 moreover 
implies that DNA unwinding is dependent on further processes in addition to the ATP-consuming 
action of Ssl2/TFIIH, since a fully established transcription bubble encompasses 12-13 bp86,341. 
The idea of a corresponding two-step mechanism, which potentially limits ATP-expense per 
opening event, was first introduced more than two decades ago. Holstege et al. demonstrated 
TFIIH-independence of a second phase of promoter opening in-vitro by using 5-9 bp-comprising 
heteroduplex scaffolds as minimal initial templates104. Their observations may relate to the 
processes underlying the spontaneous opening of promoter DNA that have been described lately. 
Remarkably, structural evidence for spontaneous opening was reported only for HIS4 promoter 
DNA sequences89, which require little energy input for DNA strand separation. In-vitro 
transcription experiments have demonstrated that specific promoters are more resistant to opening 
and suggested that the intrinsic biophysical properties of the DNA, especially its meltability and 
supercoiling state, as well as environmental conditions significantly affect promoter opening 
efficiency in context of the PIC94. For the AT-rich HIS4-promoter and in specific assembly 
buffers, this equilibrium may be shifted towards open DNA so severely that spontaneous opening 
occurs in-vitro when long sample incubation times apply, such as for preparation of the cPIC89 
and PIC-cMed complex. As discussed, the Ssl2-induced ‘block’ may be temporarily released, 
thereby permitting the transition of HIS4-DNA into a thermodynamically favored open state in 
TFIIH-containing assemblies as well.  
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Some of the discussed theories will likely contribute to a final explanation for spontaneous 
DNA opening observed in initially closed cPIC89, PIC and PIC-cMed complexes in absence of 
ATP. Still, it remains elusive how a proposed two-step mechanism is consolidated and regulated 
at different types of promoters inside a living cell. In order to develop a reliable model, the 
structural basis of the intermediate states of promoter opening will have to be analyzed and 
reconciled with the plethora of available biochemical data. This involves investigation of closed 
PICs comprising DNA templates with high meltability and, in particular, PIC intermediates with 
various small heteroduplex scaffolds. These may aid to recapitulate the transition from initial 
promoter unwinding, facilitated by the catalyst-like function of TFIIH, to ATP-independent 
transcription bubble extension. Deciphering the precise roles of TFIIH and factors like TFIIE and 
TFIIF, which may contact and reposition DNA during promoter melting42,47,89, will moreover 
promote the investigation of potential parallels to the ATP-independent initiation processes in the 
Pol I and III systems. After all, a unified mechanism of promoter opening in eukaryotic multi-
subunit RNA polymerases may still be in part existent. 
 
When the EM-map of the PIC-cMed complex was first derived and interpreted, it was thoroughly 
analyzed for traces of the Pol II CTD in the density. In yeast, the CTD comprises 26 hepta-peptide 
repeats of the Y1S2P3T4S5P6S7 consensus sequence, of which few are slightly degenerate. The 
CTD may be altered by introduction of various PTMs that define the universal CTD code. 
Specific patterns of phosphorylation, for example, primarily regulate the progression through the 
transcription cycle19. Thus, while fulfilling no known catalytic or structural function, the CTD is a 
pivotal component for the integration and transmission of regulatory transcriptional signals and is 
essential for the organization of the distinct transcription phases. At the onset of transcription 
initiation, the unmodified CTD presumably aids in recruitment of Pol II to promoters by serving 
as an anchor that binds the co-activator Mediator. Although high affinity of the CTD for 
endogenous Mediator and, in particular, its isolated head and middle modules has been 
demonstrated in vitro 250,342, to date only little structural evidence has been provided to elucidate 
the nature of this interaction. A single X-ray structure of a 4-heptapeptide repeat of the CTD 
bound to the Mediator head module was published343 but has been challenged by novel findings, 
which indicate potential steric clashes between the proposed path of the CTD peptide and the 
interfaces between the Mediator head and middle modules247. On the contrary, recent experiments 
suggest that the CTD in its unmodified state may not participate in defined, sequence-specific 
interactions. Instead, its incorporation into liquid droplets formed by transcription-associated 
proteins that comprise intrinsically disordered regions has been repeatedly demonstrated19. 
Indeed, owing to its repetitive character, many properties of the CTD resemble that of low-
complexity domains and favor the formation of multivalent intra- and intermolecular interactions, 
potentially resulting in liquid-liquid phase separation. Consistent with such a hypothesis, a 
defined electron density that may be attributed to the CTD was absent from the EM-
reconstruction of the PIC-cMed complex. However, EM-maps with significantly higher resolution 
will be required to confirm this observation and, possibly permit the detection of a compact, but 
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weakly ordered, hydrogel-like CTD entity in the density. As proposed, the CTD is expected to be 
enveloped and shielded by the cradle formed by Pol II, Mediator and TFIIH. The theory of a 
compacted CTD250 that assumes a molten-globule shape was formulated early on255 and may 
imply a function in CTD interaction for intrinsically disordered regions in Mediator, which are 
predicted within numerous conserved subunit segments52,344. Moreover, it agrees with reported 
crosslinks between the CTD C-terminus and Med1988,252 that face towards the inside of the cradle. 
In contrast, the model of an elongated CTD-peptide meandering along Mediator, as advocated by 
Robinson et. al.101, mis-positioned these crosslinks on the cradle outside, likely due to a lack of 
information on the detailed Mediator middle module structure247. A more global and precise 
positional analysis of the Pol II CTD may be permitted by replacement of single residues in the 
CTD sequence by artificial lysines and subsequent XL-MS experiments. Reconstituted PIC-cMed 
complexes comprising such mutant CTDs could be investigated to derive information about the 
domains of PIC-cMed subunits located adjacently to the respective heptad repeats and may reveal 
interactions of putative low-complexity regions.  
During the last step of transcription initiation, promoter escape, Mediator and most 
general transcription factors are released from Pol II, which subsequently proceeds to the 
elongation stage. Though in tandem with further processes, such as emergence of the nascent 
transcript from the mRNA exit tunnel and consecutive displacement of TFIIB42, the dissociation 
of Mediator strongly promotes the destabilization and disassembly of the initiation complex. 
Numerous studies have suggested that phosphorylation of the CTD by the TFIIH kinase 
Kin28/CDK7 is a prerequisite for promoter clearance since it weakens the affinity between the 
PIC and Mediator132-134. However, to date is has remained elusive by which mechanism the 
observed destabilization occurs or whether CTD phosphorylation by Kin28/CDK7 is sufficient to 
induce disintegration of the complete initiation machinery in vitro. Having established protocols 
for the preparation of active, recombinant TFIIH and the formation of PIC-cMed complexes, 
which constitute the majority of the initiation machinery, the required activity and pulldown 
assays can now be performed with purified factors and artificially dephosphorylated Pol II. In 
addition, such analyses may provide further data on the putative arrangement of the CTD in a 
low-complexity globular domain that resides in the central cradle of the initiation complex. CTD 
peptides lose their ability for incorporation into hydrogels upon phosphorylation19, suggesting that 
the addition of phosphate groups modifies relevant physiochemical properties of the CTD, for 
example its hydrophobicity and charge distribution. The decreased hydrophobicity of the CTD 
and the accumulation of negative charges following heavy phosphorylation at physiological 
conditions would result in internal electrostatic repulsion of diverse regions, thus disrupting 
multivalent interaction networks. Moreover, the accompanying spatial expansion of the CTD 
might infer steric clashes with the surface of the surrounding cradle and thus lead to dissociation 
of Mediator and, consequently, other PIC components. According to this theory, any kind of 
hyper-phosphorylation, independent of the identity of the modified residues and independent of 
the involved kinase, would suffice for Mediator release from the PIC. This has been demonstrated 
in previous experiments performed with endogenous Mediator, Pol II and distinct kinases241. To 
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prove that the destabilization of the initiation complex is a primarily stochastic event also in a 
larger context, the PIC-cMed complex could be subjected to corresponding time-course 
experiments with Kin28 and other kinases. Alternatively, the Mediator affinity of recombinant Pol 
II variants that mimic specific CTD phosphorylations could be analyzed.  
The promotion of the CTD from a simple platform for protein recruitment to a semi-
structural component, which may be actively involved in controlling initiation complex shape and 
the definition of micro-compartments for transcription, implies intriguing functional and 
experimental perspectives. However, the physiological relevance of the Pol II CTD’s ability to 
participate in liquid-liquid phase separation and the possible formation of transient ‘transcription 
compartments’ is currently heavily debated19. Although numerous observations agree with this 
hypothesis, there is yet too little direct evidence for a partial regulation of transcription by low-
complexity interactions between Pol II and its associated factors. Structural biology may only be 
able to provide limited information on the underlying systems, as the currently applied methods 
are not ideal for the analysis of amorphous, fluid-like domain arrangements. However, a 
fundamental explanation of the mechanisms that govern initial promoter recruitment and promoter 
escape will only be derived once the respective biological states of the Pol II CTD have been 
completely elucidated. Thus, the CTD will have to be characterized by hybrid approaches, 
involving single-molecule techniques or additional indirect biochemical experiments, as 
discussed.  
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The determination of a model for the PIC-cMed complex marks a milestone in one of the most 
ambitious projects of structural biology, which was started more than two decades ago when 
researchers sought to obtain the first structures of the upstream promoter complex. Naturally, ever 
more sophisticated methods for the reconstitution of transient macromolecular assemblies and 
their high-resolution analysis will have to be developed to permit a structural dissection of the 
complete Pol II-associated machinery throughout the various stages of transcription. The PIC-
cMed model, however, may become a crucial resource for future developments in the field of 
transcription initiation, similarly to the first structures of the cPIC. Thus, the PIC-cMed model 
may not only serve as a framework and paradigm for the expansion of structural studies to the 
architecture of the entire initiation machinery and its chromatin environment but may also provide 
a basis for the establish- and improvement of further advanced biochemical initiation assays.  
Nowadays, a wide selection of structural biology tools is available for in-vitro analyses of 
asymmetric particles ranging from small peptides345 to gigantic macromolecular machineries346 
and hybrid methods can be applied to arrive at reliable models even for flexible, highly modular 
assemblies like the PIC-cMed complex. The structural assessment of large transcription 
complexes will remain at the focus of approaches aiming to decipher the molecular details of 
processes governing the transcription cycle. However, the astute incorporation of findings from 
other fields will become essential for future research progress. As discussed, some of the 
established models describing transcription and, specifically, initiation, may require extension by 
novel unprecedented concepts. Theories such as the attribution of low-complexity liquid-like 
domain characteristics to the CTD have the potential to revolutionize the present interpretation of 
transcription mechanisms. Consequently, the current concepts of integrated structural biology will 
have to be adapted to the ever more complex and dynamic systems to be analyzed in the future. 
This will require an even more pervasive integration of complementary techniques such as cryo-
ET, super resolution microscopy or molecular dynamics simulations, but also system-wide in-vivo 
mapping or single molecule assays. Yet, in a collaborative, community-wide effort the analysis of 
fundamental processes such as transcription in both their native cellular context and on the single 
molecule level may eventually be achieved. 
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8 Supplementary Materials 
 
8.1 WarpCraft 
 
WarpCraft292 was utilized to simultaneously refine the cPIC, TFIIH and cMed regions, which 
were flexible with respect to each other in the conventionally obtained cryo-EM reconstructions. 
In particular, the resolution of the TFIIH segment was significantly improved over globally 
refined maps (Fig. 8.1 a, b). Focused 3D-refinement approaches with local masks on TFIIH or 
specific regions therein yielded reconstructions of similar resolution as the global 3D-refinement 
with WarpCraft. 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1 | Resolution improvement by WarpCraft. a, Cryo-EM maps of the PIC obtained from 58,000 particles after 
refinement in RELION (left) and with WarpCraft (right). For PIC reconstructions with WarpCraft, the previously obtained 
globally refined map was divided in 20 segments for local filtering and calculations were constrained to the first 20 normal 
modes. TFIIH and cPIC regions are indicated. b, Final EM map of the PIC, colored according to resolution improvement by 
WarpCraft. The color scheme is indicated. Maps were generously provided by D. Tegunov. 
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8.2 The pET-MCN system 
 
The pET-MCN system265,266 was utilized to generate E. coli expression vectors comprising 
multiple ORFs (Methods, Fig. 8.2). The concept is based on repeated restriction endonuclease 
cleavage and subsequent ligation reactions. Ligation of overhangs produced by two specific 
distinct endonucleases (SpeI and XbaI) results in a fused restriction site, which may not be 
cleaved by either of the originally used enzymes. Thus the capability of a pET-MCN vector to 
undergo multiple rounds of assembly is preserved. Since combined genes are under control of a 
single preceding lac operon (lacO) and T7 promoter, the order of their assembly may affect their 
expression efficiency, in particular for genes located at the 3’ end of the resulting multi-cistronic 
construct. The removal of single genes from such a vector is not possible. In this study, up to five 
genes were combined with the pET-MCN system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2 | Assembly of multi-cistronic vectors with the pET-MCN system. Schematic depiction of the combination of 
two distinct pET-MCN vectors, containing ORFs for ‘Gene 1’ and ‘Gene 2’, respectively. Genes are initially introduced into 
pET-MCN vectors by conventional restriction endonuclease cleavage and ligation utilizing a multiple cloning site (MCS). 
The multi-cistronic fusion product comprises the backbone of the original ‘acceptor’ vector and the genes of both the 
‘acceptor’ and ‘donor’ vectors. Multi-cistronic constructs may serve as templates for further steps of vector assembly. The 5’ 
and 3’ designations refer to dsDNA positions relative to the ORF, not to ssDNA strands. T7 prom, T7 promoter; lacO, lac 
operon; RBS, ribosomal binding site; Tag, affinity tag; Stop, stop codon; T7 term, T7 terminator. 
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8.3 The MacroBac system 
 
Similarly to the pET-MCN system, the MacroBac267 system was used to assemble large multi-
gene expression constructs. These were transferred into baculoviral shuttle vectors and utilized for 
subsequent infection of insect cells to induce recombinant protein expression. The assembly of 
MacroBac vectors is based on LIC methods and the Biobricks™ system (Methods). The vector 
design preserves the viral promoter and a SV40 polyA termination signal for each gene after 
vector combination. Consequently, distinct genes are expressed independently of each other and 
the order of assembly is irrelevant for protein production levels, contrary to the pET-MCN 
system. In this study, vectors comprising up to 12 inserts could be assembled by repeated rounds 
of LIC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.3 | Assembly of poly-promoter vectors with the MacroBac system. Schematic representation of the generation of 
initial MacroBac vectors and vector combination. Endonuclease cleavage with SspI exposes a LIC-compatible insertion site 
in Series-438 vector backbones. Sequences for LIC-compatible PCR primers are listed in Table 3.6. The poly-promoter 
fusion product comprises the backbone of the original ‘acceptor’ vector and the genes of both the ‘acceptor’ and ‘donor’ 
vectors. Poly-promoter constructs may serve as a template for further steps of vector assembly. LIC, ligation independent 
cloning; fw, forward; ORF, open reading frame; rv, reverse. Adapted from267. 
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8.4 Supplementary Tables 
 
8.4.1 Composition of the PIC-cMed complex 
 
Table 8.1 ⎟  Components of the PIC-cMed complex. Names of the human homologues of the yeast subunits 
are provided. For details about complex assembly and composition, see the main text and Methods. 
Component Subunit (yeast) Corresponding human subunit 
Construct residues (aa) / 
scaffold length (nt) 
Mass 
(kDa) Molarity 
Pol II 
Rpb1 RPB1 1-1733 191.6 1 
Rpb2 RPB2 1-1224 138.7 1 
Rpb3‡ RPB3 1-318 35.3 1 
Rpb4 RPB4 1-221 25.4 1 
Rpb5 RPB5 1-215 25.1 1 
Rpb6 RPB6 1-155 17.9 1 
Rpb7 RPB7 1-171 19.1 1 
Rpb8 RPB8 1-146 16.5 1 
Rpb9 RPB9 1-122 14.3 1 
Rpb10 RPB10 1-70 8.3 1 
Rpb11 RPB11 1-120 13.6 1 
Rpb12 RPB12 1-70 7.7 1 
TFIIF Tfg1
‡ RAP74 1-735 82.2 5 
Tfg2 RAP30 1-400 46.6 5 
Nucleic acid strands Template - 106 32.6 1.5 Non-template - 106 32.6 1.5 
TFIIA Toa1 TFIIAα 1-94, 210-286 19.4 10 Toa2‡ TFIIAβ 1-122 13.4 10 
TBP TBP‡ TBP 1-240 27.0 5 
TFIIB TFIIB‡ TFIIB 1-345 38.2 5 
TFIIE Tfa1
‡ TFIIEα 1-482 54.7 2.5 
Tfa2 TFIIEβ 1-328 37.0 2.5 
core-TFIIH 
Rad3 XPD 1-778 89.8 2.5 
Ssl1 p44 1-461 52.3 2.5 
Ssl2 XPB 1-843 95.3 2.5 
Tfb1 p62 1-642 72.9 2.5 
Tfb2 p52 1-513 58.5 2.5 
Tfb4 p34 1-338 37.5 2.5 
Tfb5 p8/TTDA 1-72 8.2 2.5 
TFIIH kinase 
module 
Ccl1 CycH 1-393 45.2 2.5 
Kin28 CDK7 1-306 35.2 2.5 
Tfb3 MAT1 1-321 38.1 2.5 
cMed 
Med1‡ Med1 1-566 64.2 1.5 
Med4 Med4 1-284 32.2 1.5 
Med6 Med6 1-295 32.8 1.5 
Med7 Med7 1-222 25.6 1.5 
Med8 Med8 1-223 25.3 1.5 
Med9 Med9 1-149 17.4 1.5 
Med10 Med10 1-157 17.9 1.5 
Med11 Med11 1-115 13.3 1.5 
Med14‡ Med14 1-745 84.6 1.5 
Med17 Med17 1-687 78.5 1.5 
Med18 Med18 1-307 34.3 1.5 
Med19 Med19 1-220 24.9 1.5 
Med20 Med20 1-210 22.9 1.5 
Med21 Med21 1-140 16.1 1.5 
Med22 Med22 1-121 13.8 1.5 
Med31 Med31 1-127 14.7 1.5 
Final PIC-cMed 46 subunits 16,622 aa 1948.7 - 
 
aa: amino acids, nt: nucleotides, kDa: kilodalton 
‡ constructs contain N- or C-terminal 6xHis or 10xHis tags as described 
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8.4.2 Modeling of TFIIH 
 
Table 8.2 | Modeling of yeast TFIIH subunits, domains and regions.  
For details refer to main text and Methods. 
Subunit /  
Chain ID Domain 
Residue 
range 
(yeast) 
Initial model 
PDB-
template for 
initial model 
Modeling 
algorithm 
Changes to 
initial model 
Density 
assigned in  
Figure 5.15c / 
Color 
Rad3 / 0 N-terminus 1-17 not modeled - - - yes / yellow 
Rad3 / 0 Lobe 1 
18-108, 
204-248, 
441-484 
homology-/ 
ab-initio model 2VSF:A I-Tasser 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Rad3 / 0 FeS cluster 109-203 homology-/ ab-initio model 2VSF:A I-Tasser - 
Rad3 / 0 ARCH 
249-293, 
327-425, 
429-440 
(1) de-novo 
modeling of α-
helices 
- Gorgon - 
(2) homology-/ 
ab-initio model 
α-helix PDB 
from Gorgon, 
5IVW:W, 
5IVW:A, 
5IY9:W 
I-Tasser - 
Rad3 / 0 ARCH linker 294-326 poly-alanine model - - - 
Rad3 / 0 Lobe 2 485-723 homology-/ ab-initio model 2VSF:A I-Tasser  - 
Rad3 / 0 C-terminus 724-778 not modeled - - - yes / yellow 
Tfb1 / 1 PHD 1-121 yeast NMR-structure 1Y5O:A - 
PHENIX 
geometry 
minimization 
- 
Tfb1 / 1 PH-linker 122-175 not modeled - - - no 
Tfb1 / 1 BSD1 176-218 homology-/ ab-initio model 2DII:A I-Tasser 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb1 / 1 Linker  219-251 poly-alanine model loop - - - 
Tfb1 / 1 BSD2 252-294 homology-/ ab-initio model 2DII:A I-Tasser - 
Tfb1 / 1 Linker  295-307 poly-alanine model loop - - - 
Tfb1 / 1 Rad3 anchor (α-Helix 1) 308-330 
poly-alanine model 
α-helix - - - 
Tfb1 / 1 Linker 331-353 poly-alanine model loop - - - 
Tfb1 / 1 Rad3 anchor (α-Helix 2) 369-394 
poly-alanine model 
α-helix - - - 
Tfb1 / 1 Ridge 395-464 not modeled - - - partially / purple 
Tfb1 / 1 Tfb4 anchor (α-Helix 1) 465-483 
poly-alanine model 
α-helix - - 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb1 / 1 Linker 484-494 poly-alanine model loop - - - 
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Tfb1 / 1 Tfb4 anchor  (α-Helix 2) 495-519 
poly-alanine model 
α-helix - - - 
Tfb1 / 1 Linker 520-543 not modeled - - - no 
Tfb1 / 1 3-helix bundle 544-639 
(1) ab-initio model - QUARK MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
(2) homology-/ 
ab-initio model 
PDB output 
from QUARK 
2W6D:A, 
1WRD:A, 
4M70:A, 
5F8P:A,  
I-Tasser 
Tfb1 / 1 C-terminus 640-643 not modeled - - - no 
Tfb2 / 2 N-terminus 1-2 not modeled - - - no 
Tfb2 / 2 α 3-40 poly-alanine model α-helix - - 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb2 / 2 HTH-1 41-113 homology-/ ab-initio model 1U2W:A SWISS - 
Tfb2 / 2 α 114-131 poly-alanine model loop - - - 
Tfb2 / 2 α 132-159 poly-alanine model α-helix/loop - - - 
Tfb2 / 2 HTH-2 160-194 homology-/ ab-initio model 2MC3:A SWISS - 
Tfb2 / 2 HTH-2 195-213 poly-alanine model α-helix - - - 
Tfb2 / 2 HTH-3 214-281 homology-/ ab-initio model 5BOX:A SWISS - 
Tfb2 / 2 Linker 282-336 not modeled - - - no 
Tfb2 / 2 Clutch 337-419 
poly-alanine model 
α-helix/β-sheet 
(partially) 
- - 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb2 / 2 Linker 420-432 not modeled - - - yes / blue 
Tfb2 / 2 Dimerization domain 433-450 
poly-alanine model 
α-helix - - 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb2 / 2 Dimerization domain 451-508 
yeast crystal 
structure 3DGP:A - 
PHENIX 
geometry 
minimization 
- 
Tfb2 / 2 C-terminus 509-513 not modeled - - - no 
Tfb3 / 3 N-terminus 1-7 not modeled - - - no 
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Tfb3 / 3 RING 8-70 homology-/ ab-initio model 
1G25:A, 
3M62:A I-Tasser 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
 
Tfb3 / 3 ARCH anchor 71-145 
(1) ab-initio model - QUARK 
- 
(2) homology/ 
ab-initio model 
PDB output 
from 
QUARK; 
2W6D:A, 
3NIX:A, 
5EQZ:A, 
2EWF:A 
I-Tasser 
Tfb3 / 3 C-terminus 146-321 not modeled - - - no 
Tfb4 / 4 N-terminus 1-21 not modeled - - - no 
Tfb4 / 4 vWA 22-88 homology-/ ab-initio model 
4PN7:A, 
4CRN:X, 
4PLA:A, 
4OKU:A, 
5IY9:3 
I-Tasser 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb4 / 4 vWA insertion 89-97 poly-alanine model loop - - - 
Tfb4 / 4 vWA insertion 98-102 not modeled - - - no 
Tfb4 / 4 vWA insertion 103-114 poly-alanine model loop - - 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb4 / 4 vWA 115-256 homology-/ ab-initio model 
4PN7:A, 
4CRN:X, 
4PLA:A, 
4OKU:A, 
5IY9:3 
I-Tasser - 
Tfb4 / 4 Linker 257-273 poly-alanine model loop - - - 
Tfb4 / 4 eZnF / C-terminus 274-323 
homology-/ 
ab-initio model 3LRQ:D Robetta - 
Tfb4 / 4 C-terminus 324-338 not modeled - - - no 
Tfb5 / 5 N-terminus 1 not modeled - - - no 
Tfb5 / 5 Dimerization domain 2-64 
yeast crystal 
structure 3DGP:B - 
PHENIX 
geometry 
minimization 
- 
Tfb5 / 5 C-terminus 65-68 poly-alanine model loop - - 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Tfb5 / 5 C-terminus 69-72 not modeled - - - no 
Ssl1 / 6  unstructured NTE 1-73 not modeled - - - no 
Ssl1 / 6 α 74-122 not modeled - - - yes / green 
Ssl1 / 6 vWA 123-308 yeast crystal structure 4WFQ:A - 
PHENIX 
geometry 
minimization 
- 
Ssl1 / 6 Linker 309-324 poly-alanine model loop - - 
MDFF and 
manual 
corrections, 
- 
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Ssl1 / 6 eZnF 325-372 homology-/ ab-initio model 1NNQ:A Robetta 
PHENIX 
geometry 
minimization 
- 
Ssl1 / 6 α  373-386 poly-alanine model α-helix - - - 
Ssl1 / 6 RING 387-457 homology-/ ab-initio model 
1Z60:A Robetta 
- 
1Z60:A SWISS 
Ssl1 / 6 C-terminus 458-461 not modeled - - - no 
Ssl2 / 7 NTE 1-110 - - - - no 
Ssl2 / 7 Clutch and DRD 111-362 not modeled - - - yes / pink 
Ssl2 / 7 Lobe 1 363-425 homology-/ ab-initio model 2FWR:A SWISS 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Ssl2 / 7 Lobe 1 426-451 homology model /  poly-alanine model - - - 
Ssl2 / 7 Lobe 1 452-462 homology-/ ab-initio model 2FWR:A SWISS - 
Ssl2 / 7 Lobe 1 463-481 poly-alanine model α-helix/loop - - - 
Ssl2 / 7 Lobe 1 482-548 homology-/ ab-initio model 2FWR:A SWISS - 
Ssl2 / 7 Lobe 2 549-691 homology-/ ab-initio model 4ERN:A Robetta 
MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
Ssl2 / 7 Lobe 2 692-702 poly-alanine model α-helix/loop - - - 
Ssl2 / 7 Lobe 2 703-712 homology-/ ab-initio model 4ERN:A Robetta - 
Ssl2 / 7 Extension 713-770 homology-/ ab-initio model 4ERN:A Robetta - 
Ssl2 / 7 C-Terminus 771-843 not modeled - - - no 
TFIIE / W E-bridge 259-266 poly-alanine model β-strand - - MDFF and 
manual 
corrections, 
PHENIX 
geometry 
minimization 
- 
TFIIE / W E-bridge 267-289 poly-alanine model α-helix - - - 
TFIIE / W E-floater 349-373 poly-alanine model α-helix - - - 
TFIIE / W Acidic peptide 407-417 homo sapiens NMR structure 2RNR:A - 
amino acid 
replacement 
MDFF, 
PHENIX 
geometry 
minimization 
- 
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8.4.3 Modeling of cPIC and cMed 
 
Table 8.3 | Adaptation and extension of yeast cPIC and cMed models.  
For details refer to the main text and Methods. 
Factor/Subunit 
/ 
Chain ID 
Initial 
Model 
PDB-template for 
initial model Modeling algorithm Changes to initial model 
Pol II / A-L 
yeast high 
resolution 
EM 
structure 
5FYW:A-L - 
rigid body fit of clamp region (residues 1-346 
in chain A) and peripheral regions in Rpb3 
(residues 22-44, 73-97), Rpb6 (residues 72-
154), Rpb8 (residues 2-146), Rpb9 (residues 
20-43, 55-117) and Rpb12 (residues 26-65); 
MDFF correction of stalk (chain D, G), 
PHENIX geometry minimization 
TFIIA / U-V 
yeast high 
resolution 
EM 
structure 
5FYW:U-V - rigid body fit, PHENIX geometry minimization 
TFIIB / M 
yeast high 
resolution 
EM 
structure 
5FYW:M - 
extension by residues 59-123 based on PDB 
4BBR:M; MDFF correction of this range, 
PHENIX geometry minimization 
TBP / O 
yeast high 
resolution 
EM 
structure 
5FYW:O - PHENIX geometry minimization 
TFIIE / W-X homology model 5GPY:A-B 
I-Tasser 
SWISS 
MDFF correction of homology model, PHENIX 
geometry minimization 
TFIIF / Q-R 
yeast high 
resolution 
EM 
structure 
5FYW:Q-R - 
rigid body fit of residues 329-415 in chain Q 
and residues 58-244 in chain R; extension of 
linker (residues 245-250) in chain R, PHENIX 
geometry minimization 
cMed model originates from S. cerevisiae homology model247 of PDB 5N9J and was subjected to alterations listed below; complete 
cMed model was subjected to PHENIX geometry minimization routine 
Med4 / h homology model 5N9J:H - 
extension of α-helix in residue range 118-126; 
de-novo modeling of α-helix in residue range 
130-145; MDFF correction of homology model 
Med7 / i yeast crystal structure 1YKE:A - 
extension of α-helix in residue range 206-211; 
MDFF correction of homology model 
Med14 / l homology model 5N9J:L - 
truncation of residues 341-345; MDFF 
correction of homology model 
Med21 / j yeast crystal structure 1YKE:B - 
extension of α-helix in residue range 128-138; 
MDFF correction of homology model 
Med31 / o yeast crystal structure 3FBI:B - 
truncation of residues 94-110; replacement by 
de-novo modeled α-helix (SSE predicted); 
MDFF correction of homology model 
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8.4.4 Cryo-EM data collection and model statistics 
 
Table 8.4 ⎟  Cryo-EM data collection and model statistics for the PIC and the PIC-cMed complex 
structures. For details about EM data collection, data processing and model building, see the main text and 
Methods. 
 
PIC 
(EMD-3846) 
(PDB 5OQJ) 
PIC-cMed 
(EMD-3850) 
(PDB 5OQM)  
Data collection    
          Magnification 105 000 105 000 
          Particles 58 000 16 000  
          Pixel size (Å) 1.37 1.37 
          Defocus range (µm) -0.5 to -5.0 -0.5 to -5.0 
          Voltage (kV) 300 300 
          Electron exposure (e-/Å2) 42 42 
          Symmetry imposed C1 C1 
Reconstruction   
          Map resolution (Å) 4.70 5.84 
          Map sharpening B-factor (Å2) -201 -334 
          FSC threshold 0.143 0.143 
Model composition   
          Non-hydrogen atoms 62,931 79,757 
          Protein residues 8,188 10,825 
          DNA bases 148 148 
          Ligand atoms 25 25 
Model validation   
          MolProbity Score 1.92 1.89 
          Clashscore 7.83 7.53 
          Rotamer outliers (%) 0.30 0.37 
          Cβ-deviations 0 0 
Ramachandran Plot   
          Favored (%) 91.95 92.21 
          Allowed (%) 6.66 6.45 
          Disallowed (%) 1.39 1.34 
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8.4.5 Crosslinking information 
 
Table 8.5 | Compilation of published BS3- and SBAT- crosslinking information. 
a. TFIIH crosslinks from previous studies101,190,201 utilizing BS3 and SBAT and respective Cα-distances within 
the PIC-cMed model obtained in this study. Crosslinks used to verify various TFIIH regions are indicated. For 
details also refer to the main text and Methods.  
Study Link type Protein 1 Protein 2 Residue 1 Residue 2 Distance (Å) Used for modeling Remark 
Robinson 2016 intra Rad3 Rad3 30 476 16.4 x - 
Murakami 2013, Luo 2016, 
Robinson 2016 intra Rad3 Rad3 30 481 14.8 x - 
Luo 2015 intra Rad3 Rad3 81 673 19.5 x - 
Robinson 2016 intra Rad3 Rad3 95 125 39.0 - - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Rad3 Rad3 112 125 5.9 x - 
Robinson 2016 intra Rad3 Rad3 112 132 10.7 x - 
Robinson 2016 intra Rad3 Rad3 112 142 24.0 x - 
Robinson 2016 intra Rad3 Rad3 112 180 16.0 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Rad3 Rad3 112 605 19.6 x - 
Luo 2015 intra Rad3 Rad3 122 125 8.6 x - 
Luo 2015, Robinson 2016 intra Rad3 Rad3 122 132 9.4 x - 
Luo 2015 intra Rad3 Rad3 125 588 26.2 x - 
Luo 2015 intra Rad3 Rad3 144 276 27.1 x - 
Luo 2015 intra Rad3 Rad3 144 281 18.5 x - 
Luo 2015 intra Rad3 Rad3 173 68 17.3 x - 
Robinson 2016 intra Rad3 Rad3 183 112 15.0 x - 
Robinson 2016 intra Rad3 Rad3 188 180 11.6 x - 
Luo 2015 intra Rad3 Rad3 228 68 9.7 x - 
Luo 2015, Robinson 2016 intra Rad3 Rad3 336 343 10.5 x - 
Luo 2015, Robinson 2016 intra Rad3 Rad3 347 343 6.2 x - 
Luo 2015 intra Rad3 Rad3 357 372 13.7 x - 
Luo 2015, Robinson 2016 intra Rad3 Rad3 364 372 11.7 x - 
Luo 2015 intra Rad3 Rad3 447 476 11.9 x - 
Luo 2015 intra Rad3 Rad3 447 636 24.9 x - 
Luo 2015 intra Rad3 Rad3 476 30 16.3 x - 
Luo 2015 intra Rad3 Rad3 476 481 16.4 x - 
Robinson 2016 intra Rad3 Rad3 476 636 28.4 x - 
Robinson 2016 intra Rad3 Rad3 490 476 37.6 - low score 
Robinson 2016 intra Rad3 Rad3 490 636 43.2 - - 
Luo 2015 intra Rad3 Rad3 499 489 24.5 x - 
Robinson 2016 intra Rad3 Rad3 588 636 44.9 - - 
Luo 2015, Robinson 2016 intra Rad3 Rad3 605 125 18.4 x - 
Luo 2015 intra Rad3 Rad3 605 588 21.4 x - 
Luo 2015, Robinson 2016 intra Rad3 Rad3 605 636 24.3 x - 
Luo 2015 intra Rad3 Rad3 673 112 38.0 - - 
Luo 2015 intra Rad3 Rad3 673 125 39.6 - low score 
Luo 2015 intra Rad3 Rad3 673 489 10.2 x - 
Robinson 2016 intra Rad3 Rad3 673 490 7.1 x - 
Luo 2015 intra Rad3 Rad3 673 588 24.4 x - 
Luo 2015 intra Rad3 Rad3 673 636 42.8 - - 
Luo 2015 intra Rad3 Rad3 695 481 16.0 x - 
Luo 2015 intra Rad3 Rad3 695 490 12.0 x - 
Luo 2015 intra Rad3 Rad3 695 673 15.5 x - 
Luo 2015 inter Rad3 Ssl2 499 372 29.2 x - 
Robinson 2016 inter Rad3 Tfb1 180 334 14.3 x - 
Luo 2015 intra Ssl1 Ssl1 139 201 17.4 x - 
Luo 2015 intra Ssl1 Ssl1 139 205 14.7 x - 
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Luo 2015 intra Ssl1 Ssl1 197 201 7.2 x - 
Robinson 2016 intra Ssl1 Ssl1 312 321 24.9 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Ssl1 Ssl1 397 414 17.4 x - 
Murakami 2013, Luo 2015 intra Ssl1 Ssl1 397 420 15.3 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Ssl1 Ssl1 414 420 4.6 x - 
Luo 2015 intra Ssl1 Ssl1 433 397 10.6 x - 
Robinson 2016 inter Ssl1 Tfa1 201 284 21.9 x - 
Luo 2015 inter Ssl1 Tfb1 201 101 54.8 - - 
Robinson 2016 inter Ssl1 Tfb1 201 238 33.2 - positional variants 
Luo 2015 inter Ssl1 Tfb2 197 415 29.2 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 inter Ssl1 Tfb2 201 415 27.4 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 inter Ssl1 Tfb2 201 418 22.1 x - 
Luo 2015, Robinson 2016 inter Ssl1 Tfb2 201 419 22.4 x - 
Luo 2015 inter Ssl1 Tfb4 197 173 34.0 - - 
Luo 2015 inter Ssl1 Tfb4 197 207 27.4 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 inter Ssl1 Tfb4 315 319 17.8 x - 
Robinson 2016 inter Ssl1 Tfb4 321 319 11.4 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 inter Ssl1 Tfb4 321 323 10.5 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 inter Ssl1 Tfb4 397 95 20.8 x - 
Murakami 2013, Luo 2015 inter Ssl1 Tfb4 414 95 23.2 x - 
Robinson 2016 inter Ssl2 Rpb5 472 94 18.1 x - 
Luo 2015 intra Ssl2 Ssl2 523 372 25.7 x - 
Luo 2015 intra Ssl2 Ssl2 766 624 22.3 x - 
Robinson 2016 inter Ssl2 Tfa2 472 277 62.7 - only 1 spectral count 
Luo 2015 inter Ssl2 Tfb2 734 415 19.6 x - 
Robinson 2016 inter Tfa1 Tfb1 355 186 13.2 x - 
Murakami 2013, 
Robinson 2016 inter Tfa1 Tfb1 366 179 12.7 x - 
Murakami 2013, 
Robinson 2016 inter Tfa1 Tfb1 367 581 19.2 x - 
Luo 2015 inter Tfb1 Rad3 73 125 83.1 - low score 
Luo 2015 inter Tfb1 Rad3 101 95 87.3 - - 
Luo 2015 inter Tfb1 Rad3 120 125 60.0 - low score 
Robinson 2016 inter Tfb1 Rad3 334 183 14.4 x - 
Robinson 2016 inter Tfb1 Rad3 334 588 13.7 x - 
Luo 2015 inter Tfb1 Rad3 335 112 13.4 x - 
Luo 2015 inter Tfb1 Rad3 335 588 16.1 x - 
Luo 2015 inter Tfb1 Rad3 376 125 24.0 x - 
Luo 2015 inter Tfb1 Rad3 390 588 10.3 x - 
Robinson 2016 inter Tfb1 Rpb1 73 1093 116.7 - only 1 spectral count, low score 
Luo 2015 inter Tfb1 Ssl1 120 201 33.2 - - 
Luo 2015, Robinson 2016 inter Tfb1 Ssl1 238 205 21.4 x - 
Luo 2015 inter Tfb1 Ssl1 246 205 26.7 x - 
Robinson 2016 inter Tfb1 Ssl1 255 201 28.7 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 inter Tfb1 Ssl1 255 205 18.6 x - 
Robinson 2016 inter Tfb1 Tfa1 587 367 24.9 x - 
Luo 2015 intra Tfb1 Tfb1 47 101 11.5 x - 
Robinson 2016 intra Tfb1 Tfb1 47 112 9.8 x - 
Robinson 2016 intra Tfb1 Tfb1 57 65 24.3 x - 
Robinson 2016 intra Tfb1 Tfb1 73 65 15.8 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb1 Tfb1 73 70 9.0 x - 
Robinson 2016 intra Tfb1 Tfb1 73 71 6.5 x - 
Luo 2015 intra Tfb1 Tfb1 73 120 30.5 x - 
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Robinson 2016 intra Tfb1 Tfb1 83 47 15.8 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb1 Tfb1 83 70 11.7 x - 
Luo 2015 intra Tfb1 Tfb1 83 71 13.0 x - 
Luo 2015 intra Tfb1 Tfb1 83 291 41.3 - - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 101 112 16.1 x - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 101 120 28.4 x - 
Luo 2015 intra Tfb1 Tfb1 101 335 62.1 - - 
Robinson 2016 intra Tfb1 Tfb1 112 65 14.0 x - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 120 65 21.6 x - 
Luo 2015 intra Tfb1 Tfb1 120 70 21.7 x - 
Murakami 2013, Robinson 
2016 intra Tfb1 Tfb1 120 246 16.2 x - 
Luo 2015 intra Tfb1 Tfb1 120 279 14.8 x - 
Luo 2015 intra Tfb1 Tfb1 120 291 24.3 x - 
Murakami 2013, Robinson 
2016 intra Tfb1 Tfb1 171 574 23.1 x - 
Murakami 2013 intra Tfb1 Tfb1 171 581 22.1 x - 
Robinson 2016 intra Tfb1 Tfb1 227 179 20.7 x - 
Robinson 2016 intra Tfb1 Tfb1 227 255 14.4 x - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 227 267 20.6 x - 
Luo 2015 intra Tfb1 Tfb1 238 101 31.7 - low score 
Robinson 2016 intra Tfb1 Tfb1 238 120 26.3 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb1 Tfb1 238 255 11.2 x - 
Robinson 2016 intra Tfb1 Tfb1 238 279 23.5 x - 
Luo 2015 intra Tfb1 Tfb1 246 101 20.7 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb1 Tfb1 246 255 17.6 x - 
Luo 2015 intra Tfb1 Tfb1 246 276 26.1 x - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 246 279 19.5 x - 
Luo 2015 intra Tfb1 Tfb1 246 291 16.3 x - 
Robinson 2016 intra Tfb1 Tfb1 255 186 28.9 x - 
Robinson 2016 intra Tfb1 Tfb1 255 300 23.9 x - 
Robinson 2016 intra Tfb1 Tfb1 268 279 14.8 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb1 Tfb1 268 324 15.2 x - 
Robinson 2016 intra Tfb1 Tfb1 268 334 35.2 - only 1 spectral count 
Luo 2015 intra Tfb1 Tfb1 276 291 19.5 x - 
Luo 2015 intra Tfb1 Tfb1 291 70 39.9 - - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 291 295 5.9 x - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 291 300 10.4 x - 
Robinson 2016 intra Tfb1 Tfb1 291 324 20.3 x - 
Luo 2015 intra Tfb1 Tfb1 300 335 37.9 - low score 
Robinson 2016 intra Tfb1 Tfb1 300 384 23.6 x - 
Robinson 2016 intra Tfb1 Tfb1 324 267 15.9 x - 
Luo 2015, Robinson 2016 intra Tfb1 Tfb1 324 384 11.9 x - 
Luo 2015 intra Tfb1 Tfb1 335 384 19.6 x - 
Luo 2015 intra Tfb1 Tfb1 335 390 22.3 x - 
Luo 2015 intra Tfb1 Tfb1 376 384 12.3 x - 
Robinson 2016 intra Tfb1 Tfb1 384 268 20.4 x - 
Luo 2015 intra Tfb1 Tfb1 384 295 17.1 x - 
Luo 2015 intra Tfb1 Tfb1 498 508 15.0 x - 
Luo 2015 intra Tfb1 Tfb1 508 501 10.2 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb1 Tfb1 508 515 9.9 x - 
Luo 2015 inter Tfb1 Tfb3 291 10 51.1 - low score 
Luo 2015 inter Tfb1 Tfb4 83 323 95.4 - - 
Robinson 2016 inter Tfb1 Tfb4 101 323 92.4 - only 1 spectral count, low score 
Luo 2015 inter Tfb1 Tfb4 120 323 68.0 - - 
Supplementary Materials 
 
	 116 
Murakami 2013, Robinson 
2016 intra Tfb1 Tfb4 171 319 23.2 x - 
Luo 2015 inter Tfb1 Tfb4 483 108 6.8 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb2 Tfb2 238 262 12.4 x - 
Luo 2015, Robinson 2016 intra Tfb2 Tfb2 415 419 6.5 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 inter Tfb2 Tfb5 495 6 8.9 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb2 Tfb5 506 6 18.1 x - 
Luo 2015 inter Tfb3 Rad3 10 125 44.7 - - 
Luo 2015 inter Tfb3 Rad3 17 125 50.0 - low score 
Robinson 2016 inter Tfb3 Rad3 119 276 17.7 x - 
Luo 2015, Robinson 2016 intra Tfb3 Tfb3 17 57 11.8 x - 
Luo 2015 intra Tfb3 Tfb3 27 65 16.4 x - 
Luo 2015 intra Tfb3 Tfb3 61 67 14.9 x - 
Luo 2015 intra Tfb3 Tfb3 86 67 16.9 x - 
Murakami 2013 intra Tfb3 Tfb3 94 132 17.2 x - 
Murakami 2013, Luo 2015 intra Tfb3 Tfb3 119 132 8.7 x - 
Luo 2015 intra Tfb3 Tfb3 141 65 29.5 x - 
Luo 2015 intra Tfb3 Tfb3 141 67 26.0 x - 
Luo 2015 intra Tfb3 Tfb3 141 132 14.0 x - 
Luo 2015 inter Tfb4 Ssl1 108 397 42.3 - - 
Luo 2015, Robinson 2016 inter Tfb4 Tfb2 108 238 24.6 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb4 Tfb4 84 138 19.4 x - 
Luo 2015 intra Tfb4 Tfb4 95 108 23.6 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb4 Tfb4 95 138 29.4 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb4 Tfb4 131 138 15.9 x - 
Luo 2015, Robinson 2016 intra Tfb4 Tfb4 165 207 14.8 x - 
Murakami 2013, Luo 2015, 
Robinson 2016 intra Tfb4 Tfb4 173 207 10.1 x - 
Luo 2015 intra Tfb4 Tfb4 319 323 6.6 x - 
Luo 2015 intra Tfb4 Tfb4 321 323 5.7 x - 
Luo 2015 inter Tfb5 Ssl1 6 201 73.2 - - 
Luo 2015 inter Tfb5 Ssl2 60 721 17.0 x - 
Robinson 2016 intra Tfb5 Tfb5 46 6 13.7 x - 
Robinson 2016 intra Tfb5 Tfb5 60 51 14.4 x - 
 
 
b. TFIIH crosslinks from previous studies101,190,201 that were located up to 12 residues from the next residue 
modeled in this study. These crosslinks were additionally used to confirm TFIIH regions. For details also refer to 
Fig. 5.18. 
Study Link type Protein 1 Protein 2 Residue 1 Residue 2 
Robinson 2016 inter Tfa1 Ssl2 301 711 
Robinson 2016 intra Tfa1 Tfa1 284 295 
Robinson 2016 intra Tfa1 Tfa1 286 301 
Robinson 2016 inter Tfa1 Tfb2 295 415 
Murakami 2013 inter Tfa1 Tfb2 301 427 
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Table 8.6 | Newly obtained EDC-crosslinks.  
a. Summary and statistics of EDC-crosslinks in the PIC-cMed complex obtained in this study. 
PIC-cMed components Total number of crosslinks Number of crosslinks mappable on the PIC-cMed structure 
Total crosslinks 262 158 
Inter-protein crosslinks   
Total 109 65 
Pol II – Pol II 18 15 
Pol II – TFIIB 8 4 
Pol II – TFIIE 8 3 
Pol II – TFIIF 4 2 
Pol II – TFIIH 4 0 
Pol II – cMed 2 2 
TFIIA – TFIIA 2 2 
TFIIA – TFIIE 1 0 
TFIIA – TBP 1 0 
TFIIB – TBP 1 0 
TFIIA – TFIIF 3 0 
TFIIE – TFIIE 1 0 
TFIIE – TFIIF 2 1 
TFIIF – TFIIF 14 9 
TFIIE – TFIIH 11 10 
TFIIH – TFIIH 19 13 
TFIIH – cMed 3 0 
cMed – cMed 7 4 
Intra-protein crosslinks   
Total 153 93 
Pol II 35 34 
TFIIA 4 3 
TFIIB 5 4 
TBP 8 0 
TFIIE 3 3 
TFIIF 22 6 
TFIIH 59 34 
cMed 17 9 
 
 
b. List of single EDC-crosslinks. ‘Total Count’ refers to sum of spectral counts originating from both replicates 
and ‘Score’ refers to highest detected score value (Methods). Cα distances are indicated if structural information 
was available within a range of 4 residues from the cross-linked residue. Several crosslinks were used to guide 
TFIIE density interpretation and to confirm TFIIE-TFIIH interactions. For details also refer to the main text and 
Fig. 5.18. 
Link 
type Protein 1 Protein 2 Residue 1 Residue 2 Total Count Score Distance (Å) Alternative residue 
Intra Ccl1 Ccl1 45 286 2 3,93 NA - 
Intra Kin28 Kin28 32 37 2 6,72 NA - 
Intra Med1 Med1 375 389 1 8,88 NA - 
Intra Med1 Med1 377 389 1 8,01 NA - 
Intra Med14 Med14 420 544 2 3,84 7.8 418 
Intra Med14 Med14 539 544 2 10,84 8.0 - 
Intra Med17 Med17 386 416 1 9,73 9.5 413 
Intra Med17 Med17 386 418 2 13,55 NA - 
Intra Med17 Med17 418 427 3 11,05 NA - 
Intra Med17 Med17 419 427 2 15,78 NA - 
Intra Med17 Med17 421 427 2 23,03 5.2 424 
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Intra Med17 Med17 579 608 1 3,74 12.6 - 
Intra Med17 Med17 581 608 12 18,05 13.1 580 
Inter Med17 Med22 548 118 1 5,51 9.6 - 
Inter Med17 Med22 608 105 4 11,67 5.4 - 
Inter Med17 Med22 608 106 1 15,05 8.6 - 
Inter Med17 Med22 608 109 3 11,46 7.4 - 
Inter Med17 Med7 75 191 1 4,83 NA - 
Inter Med17 Med7 78 191 1 7,28 NA - 
Intra Med20 Med20 2 187 1 3,69 13.2 - 
Intra Med20 Med20 10 183 3 4,31 8.0 - 
Intra Med21 Med21 107 113 1 8,04 10.0 - 
Intra Med4 Med4 34 39 2 14,65 NA - 
Intra Med7 Med7 93 103 3 8,82 NA - 
Intra Med8 Med8 189 210 2 3,31 NA - 
Inter Med9 Med4 117 26 1 4,75 NA - 
Inter Med9 Rpb1 88 977 3 4,77 9.9 - 
Inter Med9 Rpb1 99 918 6 5,74 15.9 - 
Inter Rad3 Med7 389 1 2 9,7 NA - 
Intra Rad3 Rad3 68 225 8 10,59 13.3 - 
Intra Rad3 Rad3 132 269 1 12,46 23.4 - 
Intra Rad3 Rad3 268 336 2 3,21 10.1 - 
Intra Rad3 Rad3 269 336 2 8,01 13.7 - 
Intra Rad3 Rad3 276 389 3 7,67 15.8 - 
Intra Rad3 Rad3 276 394 1 3,91 24.3 - 
Intra Rad3 Rad3 281 389 35 14,94 12.8 - 
Intra Rad3 Rad3 336 340 6 18,42 5.9 - 
Intra Rad3 Rad3 578 605 2 5,13 11.8 - 
Intra Rad3 Rad3 605 608 1 12,22 8.9 - 
Intra Rad3 Rad3 605 674 1 3,3 28.7 - 
Intra Rad3 Rad3 613 673 3 6,58 11.7 - 
Intra Rad3 Rad3 636 640 4 4,69 6.0 - 
Inter Rad3 Tfb1 112 340 2 7,25 13.6 - 
Inter Rad3 Tfb1 605 340 1 4,94 7.0 - 
Inter Rad3 Tfb1 605 345 3 10,12 16.7 - 
Inter Rad3 Tfb1 605 346 1 5,3 17.8 - 
Inter Rad3 Tfb3 336 77 18 15,55 9.8 - 
Inter Rad3 Tfb3 343 74 3 8,51 8.9 - 
Intra Rpb1 Rpb1 39 49 11 10,7 7.0 - 
Intra Rpb1 Rpb1 186 193 4 9,02 4.3 197 
Intra Rpb1 Rpb1 186 195 5 8,77 4.3 197 
Intra Rpb1 Rpb1 368 398 5 5,71 10.2 - 
Intra Rpb1 Rpb1 724 728 3 3,73 6.0 - 
Intra Rpb1 Rpb1 833 1102 13 13 9.0 - 
Intra Rpb1 Rpb1 951 1290 1 9,74 9.9 - 
Intra Rpb1 Rpb1 1093 1074 13 6,87 24.9 - 
Intra Rpb1 Rpb1 1093 1309 3 6,16 10.0 - 
Intra Rpb1 Rpb1 1132 1206 12 10,42 10.2 - 
Inter Rpb1 Rpb11 368 8 6 15,99 16.8 - 
Inter Rpb1 Rpb2 481 987 1 6,02 10.7 - 
Inter Rpb1 Rpb2 483 987 8 5,53 6.4 - 
Inter Rpb1 Rpb2 486 979 6 5,71 12.3 - 
Inter Rpb1 Rpb2 486 1102 6 6,34 8.3 - 
Inter Rpb1 Rpb2 1144 262 47 6,27 13.0 - 
Inter Rpb1 Rpb5 945 201 5 9,17 8.4 - 
Inter Rpb1 Rpb7 2 65 1 12,31 15.6 3 
Inter Rpb1 Rpb9 1253 20 1 8,65 12.6 1254 
Inter Rpb1 Tfa1 193 71 4 6,95 19.2 197 
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Inter Rpb1 Tfa1 195 71 11 7,88 19.2 197 
Inter Rpb1 Tfa1 196 71 10 4,21 19.2 197 
Inter Rpb10 Rpb12 68 33 2 7,14 9.1 65 
Inter Rpb10 Rpb12 68 50 8 10,54 18.8 65 
Intra Rpb11 Rpb11 14 20 2 12,22 14.6 - 
Intra Rpb11 Rpb11 16 20 1 10,23 9.1 - 
Intra Rpb11 Rpb11 20 36 3 16,04 8.4 - 
Intra Rpb11 Rpb11 26 38 3 3,29 24.9 - 
Intra Rpb12 Rpb12 58 68 1 4,44 17.2 65 
Inter Rpb2 Rpb1 507 833 3 13,1 NA - 
Inter Rpb2 Rpb1 979 485 3 4,68 10.4 - 
Intra Rpb2 Rpb2 99 183 5 7,89 12.6 - 
Intra Rpb2 Rpb2 131 134 3 15,45 9.9 - 
Intra Rpb2 Rpb2 133 138 1 6,14 17.0 - 
Intra Rpb2 Rpb2 227 262 2 6,32 11.7 - 
Intra Rpb2 Rpb2 239 507 1 9,19 NA - 
Intra Rpb2 Rpb2 246 468 2 4,57 19.2 467 
Intra Rpb2 Rpb2 391 393 1 5,15 5.5 - 
Intra Rpb2 Rpb2 393 621 1 4,57 9.9 - 
Intra Rpb2 Rpb2 886 908 14 8,94 8.8 - 
Intra Rpb2 Rpb2 886 909 1 6,4 9.3 - 
Intra Rpb2 Rpb2 923 934 4 6,1 12.2 - 
Intra Rpb2 Rpb2 924 934 1 4,61 12.1 - 
Intra Rpb2 Rpb2 1057 1061 1 5,25 6.2 - 
Inter Rpb2 Tfg2 441 279 4 7,24 4.7 - 
Inter Rpb2 TFIIB 438 108 2 3,19 27.9 - 
Inter Rpb2 TFIIB 438 112 2 5,73 25.8 - 
Inter Rpb2 TFIIB 921 224 3 8,51 NA - 
Inter Rpb2 TFIIB 922 224 8 12,19 NA - 
Inter Rpb2 TFIIB 923 155 3 7,88 23.9 - 
Inter Rpb3 Rpb10 149 67 1 3,23 10.3 65 
Inter Rpb3 Rpb11 137 118 51 15,25 NA - 
Inter Rpb3 Rpb11 266 84 2 11,79 9.9 265 
Inter Rpb3 Rpb11 266 88 1 8,84 12.3 265 
Intra Rpb3 Rpb3 90 160 4 12,77 11.5 - 
Intra Rpb4 Rpb4 127 142 2 9,93 6.1 - 
Intra Rpb4 Rpb4 131 142 13 17,27 8.2 - 
Intra Rpb5 Rpb5 161 172 5 8,86 9.5 - 
Intra Rpb5 Rpb5 191 194 1 16,46 5.9 - 
Intra Rpb5 Rpb5 194 201 6 7,2 23.0 - 
Inter Rpb6 Rpb5 62 171 4 11,2 NA - 
Intra Rpb6 Rpb6 112 123 20 6,75 9.6 - 
Inter Rpb9 Tfg1 9 400 6 16,92 8.4 - 
Intra Ssl1 Ssl1 262 303 3 10,3 10.7 - 
Intra Ssl1 Ssl1 387 430 8 4,45 9.5 - 
Inter Ssl1 Tfa1 201 270 2 5,16 19.0 - 
Inter Ssl1 Tfa1 201 275 2 4,32 14.3 - 
Inter Ssl1 Tfa1 205 270 1 5,04 14.6 - 
Inter Ssl1 Tfa1 205 275 2 9,84 15.2 - 
Inter Ssl1 Tfb4 401 95 9 25,87 13.1 - 
Inter Ssl1 Tfb4 439 165 16 7,22 9.8 - 
Inter Ssl1 Tfb4 441 165 7 8,88 14.7 - 
Inter Ssl1 Tfb4 446 165 2 4,76 15.2 - 
Inter Ssl2 Med7 520 1 4 18,53 NA - 
Inter Ssl2 Ssl1 351 52 1 3,64 NA - 
Intra Ssl2 Ssl2 46 65 2 6,51 NA - 
Intra Ssl2 Ssl2 90 334 6 13,37 NA - 
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Intra Ssl2 Ssl2 228 304 4 4,61 NA - 
Intra Ssl2 Ssl2 510 520 2 10,53 25.1 - 
Intra Ssl2 Ssl2 510 521 2 3,71 23.7 - 
Intra Ssl2 Ssl2 617 624 1 6,12 10.7 - 
Intra Ssl2 Ssl2 758 827 2 3,71 NA - 
Intra Ssl2 Ssl2 762 791 3 5,79 NA - 
Intra Ssl2 Ssl2 762 827 2 3,82 NA - 
Intra Ssl2 Ssl2 768 827 1 3,28 NA - 
Intra Ssl2 Ssl2 774 835 1 3,53 NA - 
Intra TBP TBP 2 27 1 6,94 NA - 
Intra TBP TBP 2 44 1 7,29 NA - 
Intra TBP TBP 2 188 2 6,77 NA - 
Intra TBP TBP 27 35 3 4,88 NA - 
Intra TBP TBP 27 47 2 10,36 NA - 
Intra TBP TBP 47 52 1 3,83 NA - 
Intra TBP TBP 47 54 2 4,22 NA - 
Intra TBP TBP 47 108 1 9,2 NA - 
Inter Tfa1 Rpb1 222 188 10 3,21 NA - 
Inter Tfa1 Rpb1 222 193 18 11,9 NA - 
Inter Tfa1 Rpb1 222 195 16 9,64 NA - 
Inter Tfa1 Rpb1 222 196 47 9,75 NA - 
Intra Tfa1 Tfa1 1 195 2 11,53 10.7 4,194 
Inter Tfa1 Tfb1 345 189 2 6,08 11.7 349 
Inter Tfa1 Tfb1 347 189 1 6,74 11.7 349 
Inter Tfa1 Tfb1 349 189 14 9,55 11.7 - 
Inter Tfa1 Tfb1 350 189 11 9,59 12.6 - 
Inter Tfa2 Rpb1 294 193 1 4,4 NA - 
Inter Tfa2 Tfa1 294 195 3 9,73 NA - 
Intra Tfa2 Tfa2 140 149 5 7,23 15.7 - 
Intra Tfa2 Tfa2 273 277 1 6,41 6.1 - 
Inter Tfa2 Tfg2 133 335 2 6,42 8.3 - 
Inter Tfb1 Tfa1 57 411 1 3,4 8.3 - 
Inter Tfb1 Tfa1 57 412 1 3,44 9.4 - 
Intra Tfb1 Tfb1 65 118 2 11,74 17.7 - 
Intra Tfb1 Tfb1 118 279 3 8,85 11.2 - 
Intra Tfb1 Tfb1 166 173 2 3,86 6.3 168 
Intra Tfb1 Tfb1 268 320 7 15,09 12.4 - 
Intra Tfb1 Tfb1 291 305 2 5,17 10.0 - 
Intra Tfb1 Tfb1 322 324 7 11,97 5.3 - 
Inter Tfb1 Tfb4 458 43 1 3,13 NA - 
Inter Tfb1 Tfb4 636 323 8 15,83 14.4 - 
Inter Tfb2 Tfa1 449 301 7 11,53 NA - 
Intra Tfb2 Tfb2 168 175 19 21,6 7.0 - 
Inter Tfb2 Tfb4 326 166 1 7,8 NA - 
Inter Tfb2 Tfb5 449 51 9 12,01 12.0 - 
Inter Tfb2 Tfb5 463 1 2 7,28 7.5 2 
Inter Tfb3 Med6 154 143 4 8,37 NA - 
Inter Tfb3 Rad3 156 357 5 6,45 NA - 
Inter Tfb3 Rpb4 25 1 1 5,51 NA - 
Inter Tfb3 Rpb4 226 186 32 13,88 NA - 
Inter Tfb3 Rpb4 235 186 1 4,72 NA - 
Inter Tfb3 Rpb7 220 134 1 3,57 NA - 
Inter Tfb3 Ssl2 44 69 7 6,68 NA - 
Intra Tfb3 Tfb3 27 40 1 4,1 5.8 - 
Intra Tfb3 Tfb3 57 204 1 4,11 NA - 
Intra Tfb3 Tfb3 80 121 11 17,24 7.0 - 
Intra Tfb3 Tfb3 94 154 2 5,27 NA - 
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Intra Tfb3 Tfb3 94 156 1 3,39 NA - 
Intra Tfb3 Tfb3 159 163 2 7,5 NA - 
Intra Tfb3 Tfb3 180 192 4 7,51 NA - 
Intra Tfb3 Tfb3 180 226 1 5,66 NA - 
Intra Tfb3 Tfb3 181 192 1 6,38 NA - 
Intra Tfb3 Tfb3 182 192 3 6,44 NA - 
Intra Tfb3 Tfb3 182 226 3 8,35 NA - 
Intra Tfb3 Tfb3 192 204 2 8,81 NA - 
Intra Tfb3 Tfb3 192 207 5 9,96 NA - 
Intra Tfb3 Tfb3 192 210 1 8,02 NA - 
Intra Tfb3 Tfb3 204 235 1 5,41 NA - 
Intra Tfb3 Tfb3 207 235 2 8,48 NA - 
Intra Tfb3 Tfb3 226 265 1 5,4 NA - 
Intra Tfb4 Tfb4 84 127 5 5 12.1 - 
Intra Tfb4 Tfb4 84 128 16 5,86 8.4 - 
Intra Tfb4 Tfb4 89 102 1 9,98 15.0 103 
Intra Tfb4 Tfb4 102 123 2 10,97 9.1 103 
Intra Tfb4 Tfb4 102 127 1 7,97 10.9 103 
Intra Tfb4 Tfb4 108 123 7 14,01 10.8 - 
Intra Tfb4 Tfb4 108 127 10 11,52 14.4 - 
Inter Tfb5 Ssl2 6 46 2 3,24 NA - 
Inter Tfg1 Tfa1 91 269 1 3,89 NA - 
Intra Tfg1 Tfg1 60 68 4 16,07 NA - 
Intra Tfg1 Tfg1 60 69 3 12,16 NA - 
Intra Tfg1 Tfg1 89 97 2 5,16 NA - 
Intra Tfg1 Tfg1 274 411 1 12,18 NA - 
Intra Tfg1 Tfg1 274 416 1 9,12 NA - 
Intra Tfg1 Tfg1 280 289 8 15,2 NA - 
Intra Tfg1 Tfg1 281 289 1 9,22 NA - 
Intra Tfg1 Tfg1 411 419 2 9,31 7.6 415 
Intra Tfg1 Tfg1 658 671 5 14,2 NA - 
Intra Tfg1 Tfg1 658 672 3 11,72 NA - 
Intra Tfg1 Tfg1 671 704 2 8,68 NA - 
Inter Tfg1 Tfg2 93 99 1 4,99 5.8 97 
Inter Tfg1 Tfg2 93 103 7 13,91 10.7 97 
Inter Tfg1 Tfg2 94 103 3 6,24 10.7 97 
Inter Tfg1 Tfg2 97 94 1 5,98 15.9 - 
Inter Tfg1 Tfg2 97 99 16 6,18 5.8 - 
Inter Tfg1 Tfg2 100 94 2 3,47 6.4 - 
Inter Tfg1 Tfg2 125 130 5 14,97 9.1 - 
Inter Tfg1 Tfg2 126 130 35 17,99 6.1 - 
Inter Tfg1 Tfg2 126 132 5 14,32 10.0 - 
Inter Tfg2 Rpb1 2 196 1 6,84 NA - 
Inter Tfg2 Rpb1 186 196 3 8,63 NA - 
Inter Tfg2 Tfg1 100 91 1 3,15 NA - 
Inter Tfg2 Tfg1 103 92 7 15,12 NA - 
Inter Tfg2 Tfg1 110 91 1 4,9 NA - 
Inter Tfg2 Tfg1 114 91 1 3,2 NA - 
Inter Tfg2 Tfg1 194 411 1 4,8 NA - 
Intra Tfg2 Tfg2 23 54 1 12,75 NA - 
Intra Tfg2 Tfg2 31 206 1 3,28 NA - 
Intra Tfg2 Tfg2 38 142 2 5,73 NA - 
Intra Tfg2 Tfg2 38 206 1 6,03 NA - 
Intra Tfg2 Tfg2 54 141 6 15,33 11.5 58,138 
Intra Tfg2 Tfg2 54 142 5 9,35 11.5 58,138 
Intra Tfg2 Tfg2 79 245 1 5,75 15.5 244 
Intra Tfg2 Tfg2 80 114 1 3,59 13.6 110 
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Intra Tfg2 Tfg2 126 130 1 4,38 10.1 - 
Intra Tfg2 Tfg2 308 357 1 9,57 NA - 
Intra Tfg2 Tfg2 356 360 1 4,04 NA - 
Inter TFIIB Rpb2 100 470 2 9,2 NA  
Inter TFIIB Rpb2 184 865 8 3,85 14.2 - 
Inter TFIIB Rpb2 224 923 4 5,8 NA - 
Inter TFIIB TBP 343 241 2 3,82 NA - 
Intra TFIIB TFIIB 75 147 1 3,12 NA - 
Intra TFIIB TFIIB 88 155 5 11,85 9.8 - 
Intra TFIIB TFIIB 103 108 1 5,13 9.3 - 
Intra TFIIB TFIIB 155 219 4 6,87 14.8 218 
Intra TFIIB TFIIB 160 217 1 12,22 12.3 - 
Inter Toa1 TBP 169 110 2 3,83 NA - 
Inter Toa1 Tfg2 23 2 2 17,06 NA - 
Inter Toa1 Tfg2 24 2 1 12,39 NA - 
Inter Toa1 Tfg2 26 2 1 15,32 NA - 
Intra Toa1 Toa1 44 48 1 5,18 5.0 47 
Intra Toa1 Toa1 144 167 2 4,02 NA - 
Inter Toa1 Toa2 2 101 7 11,21 12.1 104 
Inter Toa1 Toa2 45 21 17 10,62 8.7 - 
Inter Toa2 Tfa2 24 20 2 7,93 NA - 
Intra Toa2 Toa2 2 42 2 5,4 9.6 5 
Intra Toa2 Toa2 59 88 9 15,94 4.8 - 
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3C rhinovirus protease 
°C degree celsius 
Å Ångstrom 
β-Me β-mercaptoethanole 
A absorbance value; ampere 
aa amino acid(s) 
AcNPV Autographa californica nuclear polyhedrosis virus 
A. fulgidis, Af Archaeoglobus fulgidis 
AMP-PNP adenosine 5’(β,γ-imido) triphosphate (lithium salt hydrate) 
AP alkaline phosphatase 
ApE A plasmid Editor 
Arg arginine 
Amp ampicillin 
ATP adenosine triphosphate 
attTn7 Tn7 transposon attachment site 
bp base pair(s) 
BLAST Basic Local Alignment Search Tool 
BRE TFIIB recognition element 
BS3 bis(sulfosuccinimidyl)suberate 
BSA bovine serum albumin 
BSD BTF2-like, synapse associated and DOS2-like 
c centi; concentration 
CAK cyclin-dependent kinase activating kinase 
CC closed complex 
CCD charge-coupled device 
CDK cyclin-dependent kinase 
cMed core Mediator 
cPIC core pre-initiation complex 
CS Cockayne syndrome 
CTD C-terminal domain 
C-terminus carboxy-terminus 
CTF contrast transfer function 
CV column volume(s) 
CycC cyclin C 
CycH cyclin H 
Da Dalton 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 
dd double distilled 
ddd triple distilled 
dGTP deoxyguanosine triphosphate 
DMSO dimethyl sulfoxide 
dNTP deoxynucleoside triphosphate 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
DPA day of proliferation arrest 
DPBS Dulbecco’s phosphate buffered saline 
DRD (DNA) damage recognition domain 
DTT dithiothreitol 
dsDNA double stranded deoxyribonucleic acid 
e- electron(s) 
E weighted extinction coefficient; elution 
E. coli Escherichia coli 
EDC 
1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide 
hydrochloride 
EDTA (ethylenedinitrilo)tetraacetic acid 
EM electron microscopy 
EMDB electron microscopy data bank 
et al. et alii 
EtOH ethanol 
EYFP enhanced yellow fluorescent protein 
eZnF extended zinc finger 
F, fw forward 
FeS iron-sulfur (cluster) 
FDR false discovery rate 
FSC Fourier shell correlation 
g gram(s) 
g standard gravity 
Gen gentamycin 
GTF general transcription factor 
GraFix gradient fixation 
GST glutathione S-transferase 
h hour(s) 
H2O water 
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
Hi5 High Five 
His histidine 
H. sapiens, 
Hs Homo sapiens 
HRP horseradish peroxidase 
HTH helix-turn-helix 
i.e. id est 
IgG immunoglobulin G 
IPTG isopropyl-β-D-1-thiogalactopyranoside 
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ITC initially transcribing complex 
k kilo 
Kan kanamycin 
kb kilobases 
L, l liter(s) 
lacO lac operon 
LB lysogeny broth/Luria-Bertani broth 
LIC ligation independent cloning 
m milli 
M mega; molar (mol/liter) 
µ micro 
MAT1 ménage-à-trois 1 
MBP maltose-binding protein 
MCN Multi-Cloning and expressioN 
MCS multiple cloning site 
MES 2-(N-morpholino)ethanesulfonic acid 
min minute(s) 
MOPS 3-(N-morpholino)propanesulfonic acid 
mRNA messenger ribonucleic acid 
MS mass spectrometry 
MSA multiple sequence alignments 
MT melting temperature 
MW molecular weight 
MWCO molecular weight cutoff 
n nano 
N2 nitrogen 
NCBI National Center for Biotechnology Information 
Ni-NTA nickel-nitrilotriacetic acid 
NER nucleotide excision repair 
NMR nuclear magnetic resonance 
nt nucleotide(s) 
NTE N-terminal extension 
N-terminus amino-terminus 
NTP nucleoside triphosphate 
OC open complex 
OD600 optical density at 600 nm 
O/N overnight 
ORF open reading frame 
p pico 
P phosphor(ylation); pellet 
Paf1 polymerase associated factor 1 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDB protein data bank 
P. furiosus, 
Pf Pyrococcus furiosus 
pH potential of hydrogen 
PHD pleckstrin homology domain 
PI protease inhibitor 
PIC pre-initiation complex 
PMSF phenylmethylsulfonyl fluoride 
Pol DNA-dependent RNA polymerase 
PolH polyhedrin 
polyA polyadenylation 
PTM post-translational modification 
PVDF polyvinylidene difluoride 
r, rv reverse 
RBS ribosomal binding site 
RING really important new gene 
RNA ribonucleic acid 
RNAse ribonuclease 
RNP ribonucleoprotein 
r.p.m. revolutions per minute 
rRNA ribosomal ribonucleic acid 
RTH Round-The-Horn 
s second(s) 
S. aureus Staphylococcus aureus 
S. cerevisiae, 
Sc Saccharomyces cerevisiae 
SBAT 1,1’-(suberoyldioxy) bisazabenzotriazol 
SDS sodium dodecyl sulfate 
SEC size exclusion chromatography 
Ser serine 
SF2 superfamily 2 
S. 
frugiperda, 
Sf 
Spodoptera frugiperda 
SGD Saccharomyces Genome Database 
SN supernatant 
snRNA small nuclear ribonucleic acid 
snoRNA small nucleolar ribonucleic acid 
S. pombe, Sp Schizosaccharomyces pombe 
ssDNA single stranded deoxyribonucleic acid 
SSE seconday structure element 
Ssl suppressor of stem-loop mutation 
Strep streptomycin 
SV40 simian-virus 40 
SWI/SNF SWItch/sucrose non-fermentable 
T temperature 
T. 
acidophilum, 
Tac 
Thermoplasma acidophilum 
TAE tris-acetate-EDTA 
TAF TBP-associated factor 
TBP TATA-box binding protein 
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TCEP tris(2-carboxyethyl)phosphine hydrochloride 
term terminal 
TEV tobacco etch virus 
TF transcription factor 
Tfa transcription factor A 
Tfb transcription factor B 
T. ni, Tn Trichoplusia ni 
Tn transposon 
Tris tris(hydroxymethyl)aminomethane 
tRNA transfer ribonucleic acid 
TSS transcription start site 
TTD trichothiodystrophy 
Tyr tyrosine 
U unit(s) 
UAS upstream activating sequence 
UV ultraviolet 
v volume 
V volt(s) 
v/v volume per volume 
vWA von Willebrand factor A 
w weight 
WCE whole cell extract 
WH winged helix 
w/v weight per volume 
X-Gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
XL crosslink(ing) 
XP xeroderma pigmentosum 
XPB xeroderma pigmentosum group B 
XPC xeroderma pigmentosum group C (complementing) protein 
XPD xeroderma pigmentosum group D 
YFP yellow fluorescent protein 
YPD yeast extract peptone dextrose 
Zn zinc 
ZnF zinc finger 
 
 
 
 
 
